Human sperm mitochondrial function : implications for male (in)fertility by Amaral, Maria Alexandra Barreto
  
HUMAN SPERM MITOCHONDRIAL FUNCTION: 
IMPLICATIONS FOR MALE (IN)FERTILITY 
Maria Alexandra Barreto Amaral 
Dissertação apresentada à Faculdade de Ciências e Tecnologia da 
Universidade de Coimbra para prestação de provas de Doutoramento em 
Biologia Celular 
 
 
Departamento de Zoologia 
Faculdade de Ciências e Tecnologia da Universidade de Coimbra 
2008 
  
  
iii 
 
 
 
 
“Science must set limits to knowledge, but should not set limits to imagination.” 
Bertrand Russel (1872-1970) 
 
 
 
“Whenever a theory appears to you as the only possible one, take this as a sign that 
you have neither understood the theory, nor the problem which it was intended to solve.” 
Karl Popper (1902-1994) 
 
 
First drawings of mammalian sperm (Antonius Leeuwenhoek, 1677). 
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RESUMO 
As mitocôndrias são organelos dinâmicos que geram ATP por fosforilação oxidativa. 
Este processo depende da existência de um gradiente electroquímico ao longo da membrana 
mitocondrial interna, gerado pelo bom funcionamento da cadeia respiratória mitocondrial, e 
cujos complexos proteicos são codificados por dois genomas: o genoma nuclear e o genoma 
mitocondrial. Os espermatozóides humanos contêm um número variável de mitocôndrias na 
peça intermédia, que são responsáveis pelo fornecimento de energia para as mais diversas 
funções celulares, incluindo a mobilidade dos gâmetas masculinos. Com o objectivo de 
clarificar o papel da mitocôndria e do seu genoma (ADNmt) no funcionamento dos 
espermatozóides e na (in)fertilidade masculina, procedeu-se à análise de uma série de 
aspectos celulares e moleculares relacionados com a mitocôndria. Para isso, usaram-se 
amostras de esperma de qualidade distinta, fornecidas por pacientes que recorreram a um 
laboratório de reprodução assistida. 
Mostrou-se, através da técnica de PCR em tempo real, que os espermatozóides 
humanos possuem um número variável de moléculas de ADNmt, e que o conteúdo em 
ADNmt é baixo, quando comparado com células somáticas. Além disso, este conteúdo parece 
ser inversamente proporcional à qualidade espermática. Numa tentativa de entender a razão 
pela qual amostras de diferente qualidade apresentam conteúdos dissimilares de ADNmt, 
procedeu-se ao estudo de duas proteínas relacionadas com a sua manutenção: a ADN 
polimerase gama (POLG, a única ADN polimerase existente na mitocôndria) e o factor de 
transcrição mitocondrial A (TFAM; que está envolvido nos processos de transcrição e 
replicação do ADNmt). Antes de mais, usando as técnicas de imunocitoquímica e “western-
blotting”, mostrou-se que espermatozóides humanos expressam estas duas proteínas na peça 
intermédia. Para além disso, a expressão destes dois factores parece estar correlacionada com 
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os principais parâmetros de avaliação da qualidade seminal (concentração, mobilidade e 
morfologia dos espermatozóides). Resultados semelhantes foram obtidos para a expressão de 
duas proteínas da cadeia respiratória: subunidades I e VIc da citocromo c oxidase (COXI e 
COXVIc, respectivamente). Paradoxalmente, a presença de POLG parece predizer, de forma 
inversa, o conteúdo em ADNmt. Este factor poderá, então, ter um papel na regulação do 
número de cópias de ADNmt em espermatozóides, embora os mecanismos desta possível 
regulação não tenham sido determinados.  
A relevância da POLG na função espermática foi também estudada a nível genético, 
tendo este estudo incidido particularmente numa região do gene que contém repetições de 
nucleótidos CAG de tamanho variável. Para isso, usaram-se as técnicas de PCR de 
fluorescência e sequenciação de ADN. Os resultados mostraram que, embora as amostras de 
pior qualidade apresentem uma maior incidência de heterozigotia, este polimorfismo não 
parece afectar os principais parâmetros seminíferos, nem o conteúdo em ADNmt, ou a 
expressão de POLG. Assim, e apesar do significado biológico destes variantes genéticos não 
ter sido clarificado, a sua análise não parece ter relevância clínica.  
Por outro lado, a análise de subpopulações de espermatozóides com capacidade de 
movimentação distinta (isoladas usando o método clássico de “swim-up”) confirmou a 
correlação entre a expressão das proteínas POLG e COXI e a mobilidade espermática. Além 
disso, o estudo de fracções de espermatozóides com diferente potencial de membrana 
mitocondrial (usando a sonda “MitoTracker Green” e um aparelho de “sorting” celular) 
sugeriu que a expressão destas proteínas contribui para a manutenção da função mitocondrial. 
A capacidade da sonda “MitoTracker Green” (bem como das sondas “MitoTracker 
Red” e “JC-1”) monitorizar o potencial de membrana mitocondrial em espermatozóides foi 
determinada usando microscopia de fluorescência, através da incubação de espermatozóides 
com disruptores do potencial, tanto antes como após a incubação com as sondas. Qualquer 
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uma das três sondas parece monitorizar o potencial de membrana de espermatozóides no 
momento da incubação. No entanto, nenhuma delas é suficientemente dinâmica para revelar 
alterações no potencial que ocorram após a incubação dos espermatozóides com as sondas.  
Por último, procedeu-se a um estudo preliminar usando diferentes marcadores 
celulares, com o intuito de determinar o possível valor clínico da análise dos seguintes 
parâmetros funcionais: potencial de membrana mitocondrial, integridade membranar, estado 
do acrossoma e estado da cromatina. Neste estudo foram usadas, não apenas amostras de 
pacientes que recorreram a um laboratório de reprodução assistida, mas também amostras de 
dadores saudáveis. Os resultados sugerem que todos os parâmetros avaliados são 
significantes, em especial a análise do potencial de membrana mitocondrial e da integridade 
membranar. 
 
  
 
  
xv 
ABSTRACT 
Mitochondria are dynamic organelles that generate ATP through oxidative 
phosphorylation, which takes place within the electron transfer chain (ETC) and depends on 
the existence of an electrochemical potential across the inner mitochondrial membrane. The 
ETC is the only cellular apparatus that is encoded by both the nuclear and the mitochondrial 
(mtDNA) genomes. Human sperm contain a variable number of mitochondria in the 
midpiece, where these organelles might supply sperm with energy for several proposes, 
including sperm motility. In order to better understand the role of mitochondria and its 
genome in human sperm function and male (in)fertility, a number of mitochondrial-related 
features was analysed in the present study, using distinct quality sperm samples from men 
attending an infertility clinic. 
Using real-time PCR, it was shown that human sperm possess a variable number of 
mtDNA molecules, which is invariable low when compared to somatic cells, and seems to be 
inversely proportional to sperm quality. In an attempt to understand why distinct quality 
sperm samples present dissimilar mtDNA content, two proteins related with its maintenance 
were studied: DNA polymerase gamma (POLG; the sole DNA polymerase in mitochondria) 
and mitochondrial transcription factor A (TFAM; which is involved in both the transcription 
and replication of mtDNA). Using both immunocytochemistry and western blotting, it was 
shown that human sperm express these proteins in the midpiece. Moreover, the expression of 
these factors seems to be correlated with sperm concentration, motility and morphology (the 
three main sperm quality parameters). Similar outcomes were obtained for two proteins of the 
ETC: cytochrome c oxidase subunits I and VIc (COXI and COXVIc, respectively). 
Paradoxically, the presence of POLG seems to negatively predict mtDNA copy number. 
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POLG may, therefore, play a role in regulating sperm mtDNA copy number, although the 
exact mechanism of this possible regulation remains undetermined. 
The relevance of POLG in sperm function was additional studied at the gene level, 
particularly on a variable-length CAG-repeat region, using both fluorescent PCR and DNA 
sequencing. Although poorer quality sperm samples presented a higher incidence of 
heterozygosity for the POLG CAG-repeat genotype, these polymorphisms did not seem to 
affect the three sperm principal parameters, nor mtDNA copy number or POLG expression. 
Thus, and while the biological meaning of these variants remains unclear, their clinical 
significant seems irrelevant. 
The analysis of subpopulations of sperm presenting distinct ability to swim (isolated 
using the classical swim-up procedure) confirmed the correlation between the expression of 
both POLG and COXI and sperm motility. Moreover, the study of sperm fractions with 
distinct mitochondrial membrane potential (MMP; using MitoTracker Green and a cell-sorter) 
suggested that the expression of these proteins contributes for the maintenance of 
mitochondrial function.  
The ability of MitoTracker Green (as well as MitoTracker Red and JC-1) to monitor 
sperm MMP was determined, using fluorescence microscopy, by incubating sperm with 
distinct MMP disrupters, either before or after the incubation with the probes. The three 
mitochondrial probes provided similar results, and seemed to monitor sperm MMP at the time 
of incubation. However, none of them was dynamic enough to reveal MMP alterations 
occurring after the incubation with the probes.  
Finally, a preliminary approach was conducted using distinct cellular markers, to 
determine the clinical value of the assessment of different sperm functional parameters: 
MMP, membrane integrity, acrosomal status and chromatin status. Importantly, these 
parameters were analysed not only in sperm samples from patients, but also from healthy 
xvii 
donors. All the traits analysed seem to be significant, with emphasis on both MMP and 
membrane integrity.  
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1. The mammalian sperm and male (in)fertility  
The mammalian sperm is the result of a series of cells divisions and maturational 
modifications that coordinately occur in the seminiferous tubules, within the testis, and which 
are subjected to hormonal control from the hypothalamic-pituitary axis. During 
spermatogenesis, diploid spermatogonial stem cells differentiate and undergo meiosis, 
producing haploid spermatids. These, in turn, and after complex morphological modifications, 
finally give rise to sperm (reviewed in de Kretser and Kerr, 1994). In this post-meiotic final 
process (termed spermiogenesis), the majority of the cellular components are remodelled: 1) 
the nucleus becomes tightly compacted, as nuclear histones are partially and sequentially 
replaced by transition proteins and protamines, enhancing chromatin condensation (reviewed 
in Dadoune, 2003); 2) the majority of the cytoplasm and typical somatic cell-type organelles 
are lost in the so called residual bodies, which are phagocyted by Sertoli cells; 3) the Golgi 
apparatus suffers conformational changes, contributing to the formation of the acrosome, a 
large secretory vesicle on the sperm head (Sinowatz and Wrobel, 1981; Moreno et al., 2000); 
4) a flagellum is formed; 5) some mitochondria are lost in the residual bodies, while the 
remaining rearrange in elongated tubular structures and are packed helically around the 
anterior portion of the flagellum (Otani et al., 1988); 6) the mitochondrial DNA copy number 
is reduced (Hecht et al., 1984). In the end, a functional sperm is a simple, differentiated and 
hydrodynamic-shaped cell perfectly adapted to its purpose: to fertilise an oocyte.  
This remarkable cell is composed of three main regions: the head, the midpiece and 
the tail (Fig. 1). The head comprises the nucleus (with a haploid set of chromosomes) and the 
acrosome (which covers the anterior part of the nucleus and contains hydrolytic enzymes that 
aid sperm penetration through oocyte vestments). The tail (or flagellum), essential for sperm 
motility, is composed by a central axoneme (consisting of a central pair of single microtubules 
surrounded by nine outer doublets) encircled by outer dense fibers and a fibrous sheath. In the 
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midpiece, apart from the axoneme, there are also a variable number of mitochondria wrapped 
around the outer dense fibers. 
  
Figure 1. Electron microscopy picture of human sperm (image captured by Dr Aurora Gabriel 
and provided by Dr Pedro Caballero-Campo, from Clinica Tambre Andrology Laboratory, 
Madrid, Spain). Human sperm is composed of three main regions: the head (which comprises the 
nucleus and the acrosome), the midpiece (where mitochondria are localized) and the tail (or 
flagellum). 
All the events occurring in spermatogenesis and spermiogenesis are supported by an 
accurate gene expression regulation, which includes the testis-specific expression of several 
genes, that either encode isoforms of somatic cell proteins such as, for example, lactate 
dehydrogenase subunit C – LDH-C4 (Machado de Domenech et al., 1972; Millan et al., 1987) 
and cytochrome CT  (Goldberg et al., 1977), or proteins with no homologues in somatic cells, 
such as protamines 1 and 2 (Wykes et al., 1995) and acrosin (Kashiwabara et al., 1990). On 
the other hand, the chromatin condensation caused by the replacement of histones by 
protamines ultimately results in cessation of transcription in mid-spermiogenesis 
(Kierszenbaum and Tres, 1978). To counteract this, the beginning of spermiogenesis is 
characterized by an elevated transcription activity, which is controlled by testis-specific 
transcription factors and coactivators (for reviews see Sassone-Corsi, 2002; Tanaka and Baba, 
2005). Also, there are a number of posttranscriptional events, including the processing and 
storage of mRNAs, that permit protein synthesis in transcriptionally silent spermatids 
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(reviewed in Braun, 1998; Eddy, 1998; Hecht, 1998; Grootegoed et al., 2000; Steger, 2001). 
Accordingly, in the last stages of spemiogenesis, gene expression is effectively controlled via 
translation.  
At the end of spermiogenesis, sperm are released from the seminiferous epithelium, an 
event called spermiation (Beardsley and O'Donnell, 2003), and undergo posttesticular 
maturation in the epididymis, where important physiological attributes are acquired, including 
the ability to swim and to fertilise an oocyte (reviewed in Yanagimachi, 1994; Cooper, 2007). 
The epididymis is also where sperm are stored until ejaculation. At ejaculation, sperm leave 
the epididymis and are mixed with the secretions of the accessory glands (seminal vesicles, 
prostate and bulbourethral glands), constituting the semen. In order to eventually fertilise an 
oocyte, ejaculated sperm must even endure a poorly defined process of final maturation in the 
female reproductive tract. This fertilising competence acquisition, which can also be 
consummated in vitro with appropriate media, is known as capacitation, and involves the 
activation of intracellular signalling cascades and the phosphorylation of certain protein 
residues, particularly tyrosines (reviewed in Visconti and Kopf, 1998). Capacitation is also 
associated with striking changes in sperm motility, designated as sperm hyperactivation 
(reviewed in Suarez, 1996; Suarez and Pacey, 2006). Only capacitated sperm are able to 
undergo the acrosome reaction (reviewed in Yanagimachi, 1994; Breitbart et al., 1997; 
Breitbart and Spungin, 1997; Nolan and Hammerstedt, 1997), an exocytotic episode by which 
the acrosomal membrane fuses with the sperm plasma membrane, resulting in the release of 
acrosomal contents. This event assists sperm-oocyte interaction, by aiding the penetration of 
sperm through the oocytes‟s protective layers. 
The sperm cell was long-established as a highly specialised cell merely committed to 
deliver the paternal genome to the oocyte, which contributes to the developing embryo, not 
only the maternal genome, but also the cytoplasm, organelles, and all the necessary proteins 
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and RNAs (at least until the embryo be able to produce its own). However, mounting 
evidence is changing this traditional view and sperm is no longer considered a simple “DNA-
carrier-cell”. Definitely, it is now known that sperm is responsible for introducing the sperm-
specific phospholipase C-zeta, an essential activating factor, without which the oocyte does 
not complete meiosis (Saunders et al., 2002; Swann et al., 2004; Knott et al., 2005; Saunders 
et al., 2007). Furthermore, in most mammals (excluding rodents) sperm also contributes with 
the centrosome (Schatten, 1994; Simerly et al., 1995; Palermo et al., 1997) and it is the sperm 
aster that brings together the male and female pronulei (Navara et al., 1994; Sutovsky et al., 
1996a).  
In addition, recent findings suggest a possible role for sperm RNA in early embryo 
development. Indeed, and although sperm are considered transcriptionally and translationally 
silent, the presence of a complex population of RNAs in ejaculated sperm is well documented, 
which is composed not only by mRNAs (Pessot et al., 1989; Kumar et al., 1993; Miller et al., 
1994; Wykes et al., 1997; Miller et al., 1999), but also by microRNAs (Ostermeier et al., 
2005b). While attempts to fully characterize the sperm transcriptome (Dadoune et al., 2005; 
Zhao et al., 2006) and to evaluate its possible prognostic value in male factor infertility 
(Ostermeier et al., 2002; Lambard et al., 2004; Ostermeier et al., 2005a; Carreau et al., 2007; 
Platts et al., 2007) have been carried out, the actual role of sperm RNA is a topic under debate 
(for recent reviews see Miller and Ostermeier, 2006; Boerke et al., 2007). Contradicting the 
established idea that the RNAs present in ejaculated sperm are merely the remains of 
spermiogenesis, with no functional meaning, it has been shown that, at least in vitro, human 
paternal mRNAs are delivered to the egg at fertilisation (Ostermeier et al., 2004). Moreover, 
significant amounts of a sperm RNA was shown to be responsible for a non-mendelian 
inheritance of an epigenetic change in mice (Rassoulzadegan et al., 2006), suggesting that 
paternal RNA can influence embryo development. Apart from this, sperm RNAs may 
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possibly be required by the sperm itself, to replace degraded proteins (Miller and Ostermeier, 
2006), which would imply that mature sperm could be able to synthesise proteins. 
Nevertheless, it is generally accepted that gene expression in mature sperm is 
restricted to the mitochondria. In fact, mammalian sperm seem to be able to synthesise both 
mitochondrial-encoded RNAs (MacLaughlin and Terner, 1973; Hecht and Williams, 1978; 
Alcivar et al., 1989) and proteins (Ahmed et al., 1984; Twaina-Bechor and Bartoov, 1994), 
although sperm mitochondrial translation failed to be proven at least in human (Diez-Sanchez 
et al., 2003b). More recently, however, incorporation of amino acids into polypeptides during 
sperm capacitation has been shown in different mammals, including humans, suggesting, for 
the first time, that mammalian sperm are able to synthesise nuclear-encoded proteins (Gur and 
Breitbart, 2006; 2008). These outcomes are particularly odd, not only because they seem to 
contradict the dogma that sperm are translationally silent cells (at least for nuclear-encoded 
proteins), but also because the results also suggest that translation of nuclear-encoded proteins 
occurs in mitochondrial-type ribosomes, an event with no equivalent in any other cell-type. 
Consequently, these data need confirmation and this issue is certainly controversial. 
To sum up, all the distinctive traits stated so far make sperm a very unusual cell, 
distinct, at different levels, from both somatic cells and oocytes. Although the uniqueness of 
sperm is well established, and despite the increasing knowledge on sperm biology, the fully 
characterisation of the features that distinguishes a good-quality sperm (i.e., with high 
fertilisation potential), are just beginning to be elucidated. This complete characterisation is 
imperative for applications such as the development of an effective male contraceptive, or a 
better diagnosis of male infertility (as well as the advance of new strategies to try to overcome 
this problem). 
Human infertility, generally defined as the failure to conceive after one year of regular 
intercourse in the absence of any kind of contraception, is a growing problem in developing 
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and industrialised countries (Skakkebaek et al., 2006), affecting approximately 15 % of 
couples. Concomitant with this, the use of assisted reproductive techniques (ART) 
experienced a widespread increase in the last years (Andersen and Erb, 2006). Of these, in 
vitro fertilisation (IVF), in which sperm is placed in contact with unfertilised oocytes in vitro, 
in order to facilitate fertilisation (Lopata et al., 1978); and intracytoplasmic sperm injection 
(ICSI), a micromanipulation procedure where a single sperm is inject into an oocyte (Palermo 
et al., 1992), are the most used techniques (Andersen et al., 2008).  
Mounting data from both clinical and epidemiological studies suggest that male 
reproductive health is diminishing, with a remarkable decline in semen quality (Andersson et 
al., 2008). The diagnosis of male infertility is usually based on the traditional analysis of 
semen quality, according to the World Health Organization guidelines (WHO, 1999) which 
defined the procedures for semen handling and processing and the parameters to evaluate (that 
together constitute a relatively standardised laboratory analysis called spermiogram) and also 
threshold values for these parameters (below which the sample is considered abnormal; Table 
I). This classical analysis focuses mainly in three principal parameters: sperm concentration, 
sperm motility and sperm morphology, rooted in which different aetiologies are defined. To 
this extent, a sample is considered normal (normozoospermic) if it contains at least 20 
millions of sperm per ml of semen, at least 50 % sperm with progressive motility, and at least 
15 % morphologically normal sperm. Low values of concentration, motility and morphology 
are designated oligozoospermia, asthenozoospermia and teratozoospermia, respectively. As 
theses aetiologies often occur in combination, combined names are also used; for example, a 
semen sample abnormal for the three parameters is called oligoasthenoteratozoospermic 
(OAT). 
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Table I – Reference values for the evaluation of human sperm quality (World Health Organization, 1999). 
Samples below these values are considered abnormal. The three principal parameters are sperm concentration, 
motility and morphology. 
Parameter Reference value (WHO, 1999)
Ejaculate volume ≥ 2 ml
Ejaculate pH ≥ 7.2
Total sperm number ≥ 40 million sperm /ejaculate
Sperm concentration ≥ 20 million sperm /ml ejaculate
Sperm motility ≥ 50% motile sperm
Sperm morphology ≥ 15% normal forms*
Sperm vitality ≥ 50% live sperm
 
* According to the strict criteria (Kruger et al., 1986). 
The possible causes behind low sperm quality are numerous and, indeed, male 
infertility is a complex disease, with a multitude of origins, that can be congenital or acquired, 
and genetic or non-genetic (Iammarrone et al., 2003). Genetic causes are usually studied at 
the chromosomal level, to expose possible abnormal karyotypes and/or meiotic disorders. In 
fact, the incidence of chromosomal anomalies in men attending infertility clinics is more 
frequent than in the general population (reviewed in Egozcue et al., 2000). Moreover, there 
are other well documented genetic anomalies that are correlated with male infertility, such as 
microdeletions in specific regions of the Y chromosome, and CFTR mutations (reviewed in 
Huynh et al., 2002), all of which manly related with low sperm counts. 
Noteworthy, the evaluation of semen quality, while relevant, is not sufficient to a 
complete diagnosis of male infertility, nor does it have an absolute prognostication value (i.e.: 
certain individuals presenting high semen quality cannot conceive, and others whose semen is 
considered abnormal can). Therefore, in recent years, a number of tests have been developed 
to monitor different aspects of sperm function, including motion parameters, capacitation, 
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acrosome reaction and sperm-oocyte interaction, among others (reviewed in Aitken, 2006; 
Lewis, 2007). The introduction of these already existing “functional” tests and the 
development of news ones will certainly contribute to a better understanding of male 
infertility. 
2. The mitochondrion  
2.1. The generation of cellular ATP 
Mitochondria are dynamic organelles present in almost all eukaryotic cells. It is 
generally accepted that these organelles have originated from primitive bacteria that formed 
endosymbiotic interactions with ancestors of eukaryotic cells, and ultimately became essential 
to the normal function of the host cells (Margulis, 1975; reviewed in Gray et al., 1999). The 
number, size, shape and distribution of mitochondria present in the cytoplasm differ not only 
from cell to cell, but also in a same cell, and seem to be a function of the cell‟s energy 
demands (Moyes et al., 1998; Okamoto and Shaw, 2005). This dynamics is achieved by a 
series of fission and fusion events (reviewed in Polyakov et al., 2003; Rube and van der 
Bliek, 2004), whose regulation is essential for maintaining the functionality of a 
mitochondrial population (reviewed in Detmer and Chan, 2007). While mitochondria are 
implicated in different cellular functions, such as homeostasis and cell death regulation 
(reviewed in McBride et al., 2006), its main purpose is believed to be the production of 
energy in the form of adenosine triphosphate (ATP), through oxidative phosphorylation 
(OXPHOS). 
The structure of a mitochondrion is intimately related with its function. It contains two 
membranes, an outer and an inner membrane, that together regulate the transport of molecules 
and create two different regions in the organelle: the matrix and the intermembrane space 
(Fig. 2). Due to the presence of porin channels, the outer membrane is permeable to molecules 
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and ions. On the contrary, the inner membrane, which is utterly infolded, forming cristae, is 
mostly impermeable, even to small molecules. As a result, the transport of molecules to the 
matrix depends on the activity of specific transporters within the inner membrane. The 
enzymes of the electron transfer chain (ETC), involved in the OXPHOS, are also localized in 
this membrane. Moreover, and except for glycolysis that occurs in the cytosol, all the other 
metabolic pathways of fuel oxidation, such as the Citric Acid Cycle (CAC), and the oxidation 
of both fatty acids and amino acids, occur in the mitochondrial matrix (Nelson and Cox, 
2000). 
 
Figure 2. Schematic representation of the structure of a mitochondrion. This organelle is 
composed of an outer and an inner membrane. The inner membrane encloses the matrix and is 
extensive infolded, forming cristae. The region between the two membranes is called 
intermembrane space. Adapted from http://www.sciencehelpdesk.com/unit/bg3/1. 
Mitochondrial OXPHOS is the major contributor to cellular ATP, being far more 
productive than the anaerobic ATP-generator processes (Pfeiffer et al., 2001). It depends on 
the activity of the five complexes of the ETC (Fig. 3, complexes I-V), four of which are 
involved in a series of oxidation and reduction steps that culminate in the reduction of 
molecular oxygen (O2) to produce water (H2O). Complex I – NADH-dehydrogenase (ND) - 
oxidizes nicotinamide dinucleotide (NADH; produced during different catabolic pathways, 
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such as glycolysis, the CAC and fatty acids oxidation), and complex II – Succinate 
dehydrogenase – and enzyme also operating in the CAC, accepts electrons from succinate. 
Electrons are then transferred from both Complexes I and II to Ubiquinone, which is 
subsequently oxidised by Complex III – Cytochrome c dehydrogenase. After this, there is a 
transfer of electrons to Cytochrome c and from this to Complex IV – Cytochrome c oxidase 
(COX) - and ultimately to O2, with the formation of H2O. The electron flow through 
Complexes I, III and IV is accompanied by the pumping of protons from the matrix to the 
intermembrane space, creating a transmembrane electrochemical gradient. The energy stored 
in this gradient is then used by Complex V – ATP synthase - to catalyse the synthesis of ATP 
from adenosine diphosphate (ADP) and inorganic phosphate (Pi). The transport of ADP in 
and ATP out of the mitochondrial matrix is accomplished by adenine nucleotide translocator 
(ANT).  
Importantly, the ETC is also the main source of reactive oxygen species (ROS) 
generation, which, in normal conditions, is balanced by various cellular antioxidant defences 
(reviewed in Turrens, 2003). At moderate concentrations, ROS play important roles in 
signalling pathways (reviewed in Thannickal and Fanburg, 2000). However, imbalanced ROS 
production results in cellular oxidative stress, which may cause damage to cellular 
macromolecules, such as lipids, DNA and proteins, and ultimately result in cell death 
(reviewed in Droge, 2002). 
  
  
 
Figure 3. The electron transfer chain. Electrons flow along the chain, resulting in the production of H2O. Protons (H
+
) are pumped into the mitochondrial intermembrane 
space, creating an electrochemical gradient across the inner mitochondrial membrane, which provides the energy for ATP synthesis. Most of the subunits for the complexes 
are encoded by nDNA. However, all of the complexes except for Complex II also have subunits encoded by mtDNA. Abbreviations: I, II, III, IV, V – Complexes I, II, III, IV 
and V, respectively. Ubiq – Ubiquinone. Cyt C – Cytochrome c. ANT – Adenine nucleotide translocator. nDNA- nuclear DNA. mtDNA – Mitochondrial DNA. Adapted from 
St. John et al. (2007). 
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2.2. The function of sperm mitochondria  
Mature mammalian sperm possess between 22 and 75 crescent-shaped mitochondria 
arranged end to end in the midpiece, where these organelles are packed helically around the 
anterior portion of the flagellum (Otani et al., 1988). The anchorage of the mitochondrial 
sheath to the axoneme is supported by the sub-mitochondrial reticulum, a complex of 
filaments that seems to sustain the mitochondrial organization in the midpiece (Olson and 
Winfrey, 1990). Furthermore, the outer membranes of sperm mitochondria are enclosed in a 
keratinous structure, the mitochondrial capsule, formed by disulfide bonds between cysteine- 
and proline-rich selenoproteins, including the sperm-specific phospholipid hydroperoxidase 
glutathione peroxidase (PHGPx; Ursini et al., 1999). Apparently, this structure confers 
mechanical stability, and is responsible for some distinctive features of sperm mitochondria, 
namely the resistance to hypo-osmotic stress, and the unfeasibility of completely isolating 
these organelles. 
As mentioned before, the organization of mitochondria in a sperm-like manner takes 
place during spermiogenesis, concomitantly with the loss of the majority of the cytoplasm. 
The fact that some mitochondria are retained in a very specialized region of sperm, while 
most of the cytoplasm is lost, suggests that these organelles might have a crucial role on 
sperm function. As mitochondria generate ATP through OXPHOS, these organelles might 
supply sperm with energy for several proposes, including flagellar propulsion and thus sperm 
motility (Summers and Gibbons, 1971). In accordance with this, electron microscopy 
observations have revealed that sperm from asthenozoospermic samples presented disordered 
mitochondrial appearance along with significantly shorter midpieces and fewer mitochondrial 
gyres than normozoospermic counterparts, while midpiece widths and tail lengths were 
similar (Mundy et al., 1995). However, the absolute reliance of sperm motility in OXPHOS-
derived ATP has been questioned, especially in those species whose sperm possess a very 
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long tail, such as mice, as it is doubtful that sufficient ATP can diffuse from the mitochondria 
to the distal end of the flagellum. In accordance, mammalian sperm possess various glycolitic 
enzymes in the principal piece (Krisfalusi et al., 2006; Kim et al., 2007). Moreover, the 
oxygen levels in the female reproductive tract, which sperm need to go through, are relatively 
low (Fischer and Bavister, 1993). 
In fact, the nature of the ATP generated for mammalian sperm motility, i.e., the 
relative significance of OXPHOS versus glycolysis, is a long-term debate that has been 
elegantly reviewed by others (Ruiz-Pesini et al., 2007; Storey, 2008). Early biochemical 
studies on the energy metabolism of mammalian sperm were done using hypotonically treated 
cells, i.e., with disrupted membranes, a simple method developed by Keyhani and Storey 
(1973a) to resolve the difficulty in isolating sperm mitochondria. These authors analysed 
respiration rates and oxygen consumption to assess mitochondrial activities with various 
substrates, in sperm from different species (Keyhani and Storey, 1973b; Storey and Keyhani, 
1974; Storey and Kayne, 1977; Storey, 1978; Storey and Kayne, 1978; Storey, 1980; Carey et 
al., 1981). Mitochondrial activity was observed in all cases, suggesting that OXPHOS is 
operating in mammalian sperm, and is responsible for the production of at least some of the 
ATP needed for sperm motility. The results were, though, species-specific, i.e., sperm from 
distinct species have dissimilar capabilities to metabolize different substrates. This led to the 
hypothesis that the mitochondrial activity of sperm of a certain species is adjusted to the 
substrate content of the female reproductive tract (Storey, 1980). Whatever the case may be, it 
has been shown that oxygen consumption strongly correlates with sperm motility 
(Bohnensack and Halangk, 1986; Halangk et al., 1990). The relevance of OXPHOS to 
mammalian sperm motility has also been analysed using mitochondrial inhibitors, namely 
rotenone, antimycine A, potassium cyanide, olygomicin, and others. Incubation of sperm with 
these drugs resulted in ATP depletion and/or decreased sperm motility, both in humans (Ford 
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and Harrison, 1981; de Lamirande and Gagnon, 1992; Ruiz-Pesini et al., 2000a; St John et al., 
2005), and other mammals (Halangk and Bohnensack, 1986; Pascual et al., 1996; Krzyzosiak 
et al., 1999), evidently showing that OXPHOS function is crucial to sperm motility. Clear 
evidence came also from a patient harbouring a mitochondrial point mutation causing a 
reduced activity of the Complex I of the ETC, and whose sperm presented low motility. The 
supplementation of the patient‟s sperm with succinate, a substrate for Complex II, 
circumventing the effect of the mutation, resulted in an increase in sperm motility (Folgero et 
al., 1993). The analysis of the enzymatic activities of the mitochondrial complexes have 
shown a positive correlation between those activities and sperm quality, particularly with 
sperm motility, and have also evidenced that control subjects present higher activities than 
asthenozoospermic individuals (Ruiz-Pesini et al., 1998; 2000b). 
On the other hand, and more recently, studies using mice models have questioned the 
importance of OXPHOS-derived ATP. In fact, it has been suggested that most of the energy 
required for sperm motility is definitely generated by the glycolytic pathway (Miki et al., 
2004; Mukai and Okuno, 2004). However, this has been challenged by others (Ford, 2006; 
Ruiz-Pesini et al., 2007). To this extent, Ford has pointed out some ideas that strongly 
reinforce the significance of OXPHOS to sperm motility, namely the fact that sperm can 
remain motile in sugar-free media, and that motility is not affected when glycolysis is 
inhibited. More than that, this author has proposed that the ATP produced in the midpiece 
may reach the distant parts of the sperm tail by using an adenylate kinase shuttle, or other 
shuttles (Ford, 2006).  
To conclude, the controversy on the importance of OXPHOS versus glycolysis in the 
sperm biology field has been confounded by possible changes during the lifetime of the male 
gamete, as well as by species-specific discrepancies. It is, however, undoubtedly well 
established that human sperm motility relies on OXPHOS-derived ATP. Then again, 
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mammalian sperm, like other cell types, seem to be versatile and able to use distinct metabolic 
pathways according to the substrates available. Similarly to somatic cells, the distinct 
metabolic pathways in sperm might be connected. For instance, the inactivation of transdolase 
(an enzyme of the pentose phosphate pathway) in a mice model resulted in loss of 
mitochondrial function, diminished levels of ATP, reduced sperm motility and, thus, male 
sterility (Perl et al., 2006). 
The link between mitochondrial-generated ATP and sperm motility and fertilisation 
competence has certainly been illustrated by the assessment of the sperm mitochondrial 
activity through the evaluation of the electrical potential across the inner mitochondrial 
membrane, usually referred as mitochondrial membrane potential (MMP). To this extent, 
diverse mitochondrial fluorescent probes have been used, such as Rodamine 123 (Rh123), 
3,3‟-dihexyloxacarbocyanide iodide [DiOC6(3)], the well-known range of MitoTracker probes 
and 5,5‟6,6‟-tetrachloro-1,1‟,3,3‟-tetraethylbenzimidazolyl carbocyanine iodide (JC-1). All 
these probes accumulate in mitochondria of living cells depending on the MMP and thus can 
be used to monitor functional mitochondria. In sperm, multiple studies, using either flow 
cytometry or fluorescence microscopy, have revealed a strong correlation between loss of 
mitochondrial function, monitored by low/inexistent MMP, and diminished motility in human 
(Evenson et al., 1982; Auger et al., 1989; Troiano et al., 1998; Donnelly et al., 2000; 
Marchetti et al., 2004) and other mammals (Garner et al., 1997; Gravance et al., 2001; Love 
et al., 2003; Spinaci et al., 2005). More than that, both sperm quality and fertilisation ability 
(measured as fertilisation rates after IVF) are strongly related with MMP, and thus with 
mitochondrial functionality (Kasai et al., 2002; Marchetti et al., 2002; Wang et al., 2003; Liu 
et al., 2004; Marchetti et al., 2004). Additionally, the results of one of these studies proposed 
that MMP is the most sensitive test to determine sperm quality (Marchetti et al., 2002). 
Indeed, and mirroring the importance of mitochondria to sperm function, subpopulations of 
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sperm with high MMP, isolated  using a cell-sorter, seem to be enriched in cells with elevated 
fertilisation capabilities (Gallon et al., 2006). 
3. The mitochondrial genome 
3.1. Mitochondrial DNA structure and function 
Mitochondria possess their own genome, the mitochondrial DNA (mtDNA), which is 
present in multiple copies, usually in the range of 10
3
-10
4
 copies per human somatic cell 
(Bogenhagen and Clayton, 1974; Shmookler Reis and Goldstein, 1983; Miller et al., 2003). 
Although not packaged with histones, this genome is organized in a DNA-protein structure 
called the nucleoid, each containing 1-10 mtDNA molecules (Satoh and Kuroiwa, 1991; 
Legros et al., 2004). Human mtDNA (Fig. 4) is a circular, double-stranded molecule 
containing 16,569 base pairs (bp), and encoding 13 polypeptides of the ETC (seven subunits 
of complex I, one component of complex III, the 3 catalytic subunits of complex IV, and two 
subunits of complex V; Fig. 3), along with the RNAs necessary for mtDNA translation, 
namely, 2 rRNAs (12S and 16S) and 22 tRNAs (Anderson et al., 1981). All other components 
of the ETC are nuclear-encoded and need to be targeted to the mitochondria. This makes the 
ETC unique in the cell, implying a correct intercommunication between the two genomes 
(nuclear and mitochondrial) for its proper assembly and function. The two mtDNA strands are 
referred as heavy (H-strand) and light (L-strand) because they possess different G+T content, 
and can, therefore, be separated on denaturing caesium chloride gradients. The H-strand 
encodes most of the information: the two rRNAs, 14 tRNAs and 12 of the 13 polypeptides; 
while the L-strand encodes the remaining tRNAs and a single polypeptide  (Attardi and 
Schatz, 1988). The mitochondrial genome is extremely compact, presenting no introns, and 
possessing only a major non-coding region – the displacement-loop (D-loop; Figs. 4, 5), 
which contains most of the cis-acting control elements of the replication and transcription 
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processes. The extreme economy of organization of this genome is also illustrated by the fact 
that some genes even overlap (ND4 and ND4L, ATPase 6 and 8; Anderson et al., 1981) and 
that others do not contain termination codons, as these are generated by post-transcriptional 
polyadenylation (Ojala et al., 1981). 
3.2.  MtDNA expression 
As noted above, mitochondria are not self-sufficient components in the cell, depending 
on nuclear-encoded proteins for their maintenance. These include mtDNA transcription and 
replication factors that are translocated to the mitochondria (Clayton, 1998). The replication 
of the mitochondrial genome is, however, independent from the cell cycle, and both 
transcription and replication of mtDNA occur at a greater rate than what is described for 
nuclear genes (Bogenhagen and Clayton, 1977). Moreover, and also particularly to this 
genome, mtDNA replication is intimately related to its transcription, as the initiation of 
replication depends on the transcription having occurred previously. 
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Figure 4. The human mitochondrial genome. This double-stranded molecule encodes 13 
polypeptides of the electron transfer chain. The heavy (H) strand encodes 12 of these polypeptides, 
along with the 14 tRNAs and the 2 rRNAs (outside circle), while the light (L) strand encodes a 
single polypeptide (ND6) and 8 tRNAs (inside circle). The D-loop is the major non-coding region 
and contains the origin of replication of the H-strand (OH), as well as the promoter regions of both 
strands (HSP, LSP). The origin of replication of the L-strand (OL) is located at about 2/3 of the 
molecule length, in between tRNAs genes. tRNAs are identified by their respective one-letter 
codes. The localisation of the common 4977 Kb deletion and of some point mutations and their 
associated diseases are also depicted. Adapted from Mitomap (2008). 
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Figure 5. Transcription and replication of the mitochondrial genome. These processes are 
dependent on a number of nuclear-encoded factors that are translocated to the mitochondria, 
including: RNA polymerase (POLRMT); mitochondrial transcription factor A (TFAM); 
mitochondrial transcription factors 1 or 2 (TFB1M, TFB2M); RNA-processing endoribonuclease 
(RNase MRP); DNA polymerase gamma (POLG); mitochondrial single-strand binding protein 
(mtSSB). Other abbreviations: L, H1, H2 - transcription initiation sites; OH, OL – origin of 
replication sites; CSBs – conserved sequence boxes; F – phenylalanine tRNA gene; P – proline 
tRNA gene. See text for details. Adapted from St. John et al. (2007). 
Transcription of the mitochondrial genome (Fig. 5), which is mediated by the 
mitochondrial-specific RNA polymerase (POLRMT; Tiranti et al., 1997), requires at least two 
transcription factors: mitochondrial transcription factor A (TFAM; Fisher and Clayton, 1985; 
1988) and either mitochondrial transcription factor 1 or 2 (TFB1M and TFB2M, respectively; 
Falkenberg et al., 2002; McCulloch et al., 2002). Transcription can start at three different 
initiation sites localized in the D-loop, two for the H-strand (H1 and H2) and one for the L-
strand (L) (Montoya et al., 1982; 1983; Bogenhagen et al., 1984). H1 and L are located within 
independent promoter regions: the H-strand promoter (HSP) and the L-strand promoter (LSP), 
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respectively (Fig. 4), both of which contain enhancer elements that include binding sites for 
TFAM (Parisi and Clayton, 1991; Dairaghi et al., 1995). The interaction of TFAM with the 
enhancers permits POLRMT binding to mtDNA, in the presence of either TFB1M or TFB2M, 
and activation of transcription. Additionally, transcription termination seems to require 
mitochondrial transcription termination factors (MTERFs; Daga et al., 1993; Fernandez-Silva 
et al., 1997; Linder et al., 2005). The transcripts originated from H2 and L are long 
polycistronic molecules covering almost the whole strands that are then processed to originate 
mature RNAs (Ojala et al., 1981). In contrast, transcription commencing at H1, which occurs 
much more frequently than at H2, is linked to a transcription termination event occurring 
downstream from 16S rRNA, giving rise to a smaller molecule coding for the 2 rRNAs, along 
with 2 tRNAs (Montoya et al., 1983; Kruse et al., 1989). These distinct features of H1 and H2 
might have an important functional meaning, and seem to explain the differential regulation 
of rRNA versus mRNA transcription (Montoya et al., 1983).  
Mature transcripts are translated in mitocondrial ribosomes, or mitoribosomes, that are 
localized in the matrix. Mitoribosomes are distinct from cytosolic counterparts, but share 
some characteristics with bacterial ribosomes, and are sensitive to antibiotics that inhibit 
prokaryotic translation. However, they have a particularly small RNA content and, therefore, 
a low sedimentation coefficient (55S; Attardi and Ojala, 1971; Brega and Vesco, 1971). 
Mitochondrial translation arises by the use of the 22 mtDNA-encoded tRNAs only, which is 
possible because of a simplified codon-anticodon pairing scheme (Attardi and Schatz, 1988), 
and using a genetic code that differs from the “universal” one (Barrell et al., 1979).  
The regulation of mtDNA expression in individual tissues, and in response to distinct 
cellular energy demands, is far from being understood, and might be very complex (Bonawitz 
et al., 2006; Asin-Cayuela and Gustafsson, 2007). Regulation at the mitochondrial 
transcription level may involve distinct factors, and while TFAM has been proposed to play a 
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key role (Garstka et al., 1994; Montoya et al., 1997), recent reports are showing that other 
elements also contribute for this regulation, including mtDNA transcription activators (as 
TFB2M; Cotney et al., 2007) and repressors (as MTERF3; Park et al., 2007). Also, for the 
proper function of the mitochondrial ETC, the expression of mitochondrial and nuclear-
encoded subunits must be highly coordinated. Such a control seems to be accomplished by 
transcription factors, including nuclear respiratory factors 1 and 2 (NRF1 and NRF2), that 
regulate the expression of both nuclear-encoded ETC genes and of mitochondrial transcription 
and replication factors (Scarpulla, 1997; 2002). These activators, are, in turn, regulated by 
coactivators that respond to distinct physiological signals (Wu et al., 1999; Andersson and 
Scarpulla, 2001), rendering the overall regulation system tremendously complex. 
3.3.  MtDNA maintenance 
As stated above, the replication of the mitochondrial genome, which is absolutely 
necessary for mtDNA maintenance, is independent from the replication of the nuclear DNA 
(Bogenhagen and Clayton, 1977). However, its initiation is dependent on mtDNA 
transcription having occurred before, as transcription is responsible for the generation of the 
RNA primer necessary for the initiation of replication. 
MtDNA replication is catalysed by the mitochondrial-specific DNA polymerase 
gamma (POLG; Ropp and Copeland, 1996) and, according to the generally accepted model 
(Clayton, 1982), occurs asynchronously from two independent unidirectional origins. 
Essentially, replication starts at the origin of replication of the H-strand (OH, which is 
localized in the D-loop, directly downstream of the LSP; Fig. 4) and proceeds in a clockwise-
manner along the parental L-strand, to produce a new H-strand molecule. When 
approximately two-thirds of this new strand is produced, the origin of replication of the L-
strand (OL; Fig. 4) is exposed, and the synthesis of a new L-strand is initiated, in an 
anticlockwise manner (Wong and Clayton, 1985; Hixson et al., 1986). The initiation of 
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replication at OH is primed by a fragment of RNA that is generated by transcription from the 
initiation site L (Fig. 5). This transcript is processed by mitochondrial RNA processing 
endoribonuclease (RNase MRP; Lee and Clayton, 1997) and is then extended by POLG via 
DNA polymerisation. Transition from RNA to DNA synthesis is mediated through three 
conserved sequence blocks located in the D-loop (CSBI, CSBII and CSBIII; Xu and Clayton, 
1996). Replication from OH often arrests prematurely at short (15 bp) termination-associated 
sequences (TAS), thus generating the triplex-structure characteristic of the D-loop (Clayton, 
1982; Shadel and Clayton, 1997). When replication from the OH proceeds, OL is eventually 
exposed and both strands are replicated. The initiation of replication from OL requires the 
action of a mitochondrial specific primase (Wong and Clayton, 1985). In addition, POLG 
requires a number of other factors to perform the replication of both H- and L-strands. These 
include: a mitochondrial helicase (Twinkle; Hehman and Hauswirth, 1992; Korhonen et al., 
2003) mitochondrial single-strand binding protein (mtSSB; Hoke et al., 1990; Tiranti et al., 
1993; Farr et al., 1999) and mitochondrial-associated topoisomerases (Castora et al., 1985; 
Kosovsky and Soslau, 1991). Once replication of both strands is terminated, the newly-
synthesised molecules are separated, the RNA primers are removed, the remaining gaps are 
filled and the new molecules adopt their usual tertiary structure (Shadel and Clayton, 1997). 
More recently, the analysis of replication intermediates through two-dimensional (2D) 
agarose gel electrophoresis led to the proposal of an additional mechanism for mtDNA 
replication. According to this mechanism, replication of both strands begins at or near OH, 
proceeding synchronously around the entire circular molecule (Holt et al., 2000). Importantly, 
these authors suggested that both mechanisms of replication might exist, and reported a shift, 
from the predominant strand-asynchronous mechanism to the strand-coupled one, in cells 
recovering from transient mtDNA depletion. However, since this report, the precise 
mechanism of mtDNA replication has been the centre of a heated discussion with followers of 
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the “orthodox”, strand-asymmetric replication mode (Bogenhagen and Clayton, 2003; Brown 
et al., 2005) on one side, and strand-coupled mechanism supporters (Yang et al., 2002; 
Bowmaker et al., 2003; Yasukawa et al., 2005; 2006) on the other.  
Unlike nuclear genes, and consistent with the fact that a cell‟s mtDNA copy number is 
variable, the expression of mitochondrial-encoded genes can be regulated at the level of gene 
dose, implying that cells are able to adjust mtDNA replication according to its mtDNA 
content. While it is well established that a number of factors are required for mtDNA 
maintenance (namely the factors involved in replication and transcription), it is not clear how 
mtDNA levels are controlled. Such a control may be achieved by the levels of proteins 
involved in mtDNA replication, by the existing nucleotide pools, and ultimately, by any 
factors controlling these two (Moraes, 2001). To this extent, and using mice models, it has 
been shown that mtDNA copy number is directly proportional to TFAM levels, suggesting 
that this protein is a key regulator of mtDNA content (Ekstrand et al., 2004). Other factors 
that seem to be involved in this regulation include Twinkle, the mitochondrial helicase 
(Tyynismaa et al., 2004), as well as different proteins involved in cellular proliferation (Trinei 
et al., 2006; Kasashima et al., 2008). 
Studies with cultured mammalian cells presenting decreased mtDNA content, 
accomplished either by long-time incubation with ethidium bromide (Desjardins et al., 1985) 
or siRNA of TFAM (Jeng et al., 2008), have clearly settled that maintenance of mtDNA copy 
number and expression are crucial for mitochondrial function. Accordingly, mtDNA depletion 
is associated with a number of pathological conditions (see section 3.5). 
The maintenance of the mitochondrial genome in a cell depends not only on the 
replication process, ensuring that adequate amounts of mtDNA are present, but also on the 
existence of repair mechanisms to emend possible errors introduced during the replication 
process, as well as to remove damaged DNA. Importantly, the catalytic subunit of POLG, 
Alexandra Amaral 
26 
apart from its polymerase activity, also functions as 3‟ to 5‟ exonuclease, which largely 
contributes to the fidelity of mtDNA replication (Johnson and Johnson, 2001). Consistent 
with this, the expression of an exonuclease-deficient POLG fusion protein led to a major 
accumulation of mtDNA point mutations in cultured human cells (Spelbrink et al., 2000). 
Likewise, homozygous knockin mice expressing a proofreading-deficient POLG presented 
increased levels of mtDNA point mutations and deletions (Trifunovic et al., 2004). 
Furthermore, the POLG catalytic subunit is also implicated in base excision repair (BER) 
processes that correct oxidative damage to mtDNA, as it also possesses 5‟-deoxyribose 
phosphate lyase activity (Longley et al., 1998). Other enzymes participating in these repair 
processes have been described in mammalian mitochondria, including glycosylases, 
endonucleases and DNA ligases (reviewed in Graziewicz et al., 2006). Hence, and 
contradicting previous assumptions, it is now well established that mitochondria do possess 
DNA repair systems, but these seem to be scarcer that the ones operating in nuclear DNA (for 
reviews see Croteau et al., 1999; Larsen et al., 2005). Failure of any of these mitochondrial 
repair mechanisms can result in the development of mtDNA mutations and ultimately, in 
mitochondrial diseases (see section 3.5). 
3.4.  MtDNA inheritance 
Contradicting a established idea found in a number of textbooks, in most mammals, 
including humans, the entire sperm enters the oocyte at fertilisation (Ankel-Simons and 
Cummins, 1996). However, and also like in other mammals, human mitochondrial genome 
tends to be exclusively maternally inherited (Giles et al., 1980). This entails that the mtDNA 
of an embryo is only transmitted from the oocyte, and that sperm mtDNA (which is present in 
the midpiece that enters the oocyte at fertilisation) is diluted or destroyed. Definitely, and 
while there is some variability, oocytes contain the largest cellular mtDNA content - about 10
5
 
copies/cell (Reynier et al., 2001), and individual oocyte content seems to be indicative of its 
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quality (Almeida-Santos et al., 2006). Although oocyte mtDNA copy number is high, mtDNA 
sequence variants are rapidly segregated between generations. This observation suggested the 
existence of a genetic bottleneck for the transmission of the mitochondrial genome 
(Hauswirth and Laipis, 1982). Accordingly, a tight restriction event occurs during early 
oogenesis ensuring that only a small pool of molecules of mtDNA is present in primordial 
germ cells for transmission to the next generation (Jansen and de Boer, 1998). During oocyte 
maturation, these molecules are clonally amplified, so that each oocyte will contain multiple 
copies of a single population of mtDNA (Marchington et al., 1997).  
The basis for the strictly maternally inheritance of the mitochondrial genome are not 
completely understood. Mammalian sperm presents the lowest cellular mtDNA copy number 
- roughly 10
2
 copies/cell (Hecht et al., 1984; May-Panloup et al., 2003), three orders of 
magnitude lower than the oocyte‟s counterpart. Therefore, the simple dilution of paternal 
mtDNA after fertilisation guarantees that most of the embryo‟s mtDNA have a maternal 
origin. Furthermore, paternal mtDNA has been shown to be eliminated during early 
embryogenesis in intraspecific crosses in mice (Kaneda et al., 1995; Cummins et al., 1997), 
bovine (Sutovsky et al., 1996b) and non-human primates (Sutovsky et al., 1999b). On the 
other hand, paternal mtDNA leakage takes place in mice interspecific crosses (Gyllensten et 
al., 1991; Kaneda et al., 1995). The leaked paternal mtDNA is not, however, distributed to all 
tissues in hybrid individuals, nor transmitted to subsequent generations (Shitara et al., 1998). 
Paternal mtDNA inheritance has also been reported in sheep (Zhao et al., 2004) and in 
nonhuman primates produced by nuclear transfer (St John and Schatten, 2004). These leakage 
events, which barely happen in interspecific crosses (infrequent in nature), may result from a 
failure in the mechanism(s) of elimination of paternal mitochondria. Certainly, the selective 
destruction of mammalian sperm mitochondria (and hence, mtDNA) seems to be species-
specific, involving an ubiquitination process (Sutovsky et al., 1999a; 2000). Specifically, 
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mitochondria are ubiquitinated during spermatogenesis, and the ubiquitin tags are then 
masked by disulphide-bond cross-linking throughout epididymal transit. One of the 
ubiquitinated substrates appears to be prohibitin, a highly conserved mitochondrial protein 
(Thompson et al., 2003). Once inside the egg, disulphide-bonds are reduced and ubiquitin is 
exposed, leading to paternal mitochondria degradation by embryo proteasomes and 
lysosomes. Additionally and more recently, active digestion of sperm mtDNA upon 
fertilisation has been shown in the Japanese medaka fish, even before mitochondrial 
destruction (Nishimura et al., 2006). 
Studies of mtDNA transmission using good-quality human embryos are certainly 
restricted by ethical issues. Regardless, it seems that paternal mtDNA may persist until the 
blastocyst stage in some abnormal embryos (St John et al., 2000). Furthermore, paternal 
inheritance has been reported in a patient with a mitochondrial myopathy due to a pathogenic 
mtDNA 2 bp deletion (Schwartz and Vissing, 2002). Such a deletion was, however, only 
present in the patient‟s muscle, and not in other tissues. This case has certainly motivated the 
search for parallel outcomes in similar patients, but transmission of paternal mitochondrial 
genome failed to be proven in every single case (Filosto et al., 2003b; Taylor et al., 2003). 
Taken together, these results suggest that in humans, like in other mammals, paternal mtDNA 
leakage is an uncommon event, and such occasions may reflect a failure in the active 
destruction of sperm mitochondria/mtDNA in the developing embryo. 
3.5.  Mitochondrial disease  
The term “mitochondrial disease” is generally used to describe any disorder associated 
with anomalies of the mitochondrial OXPHOS, leading to inadequate levels of ATP (Zeviani 
and Carelli, 2003). As already mentioned, ATP production through OXPHOS implies the 
correct assembly and function of a number of mitochondrial proteins. As anticipated, 
mutation of any of the genes encoding these proteins can lead to ETC defects and thus, 
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mitochondrial disease. Since the ETC is the only cellular apparatus encoded by both the 
nuclear and the mitochondrial genomes, such disorders are unusual, as inheritance can either 
be Mendelian or mitochondrial. 
Importantly, mtDNA genetics presents some distinctive traits when compared to that 
of nuclear DNA. For instance and as previously mentioned, the mitochondrial genome tends 
to be maternally inherited. Moreover, this genome is polyploid (a single cell may contain 
hundreds of copies of mtDNA) and the diverse molecules are randomly distributed during cell 
division, a phenomenon called mitotic segregation (Wallace, 1986; Matthews et al., 1995). In 
a normal situation, all mtDNA molecules present in a cell, tissue or organism are identical, a 
condition termed homoplasmy. However, mtDNA alterations can occur, and in this case, both 
wild-type and mutated mtDNA molecules will co-exist (heteroplasmy). The phenotypic 
expression of a certain mtDNA mutation is dependent on the relative proportion of the 
mutated molecule, and in fact, clinical symptoms will only emerge when a critical threshold is 
reached (Chinnery et al., 1997). Such a threshold is different for each mutation, and may also 
vary between individuals and from tissue to tissue, according to the energetic demands, with 
the brain, heart and skeletal muscle being the most affected tissues (Wallace, 1999). These 
facts account for the existence of diverse clinical manifestations, confounding the diagnosis of 
a mtDNA disease (Chinnery et al., 1999).  
3.5.1.  MtDNA mutations 
Since the first reports stating an association between human mtDNA mutations and 
mitochondrial diseases were published (Holt et al., 1988; Wallace et al., 1988), the number of 
mutations described and their relationship with human disorders has been expanding (the 
commonest mtDNA mutations are depicted in Fig. 4; MITOMAP, 2008). These mutations 
include large-scale rearrangements (deletions and duplications; generally heteroplasmic and 
sporadic) and point mutations (that can be present in either homoplasmy or heteroplasmy, and 
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are usually maternally inherited). Any of these can affect one or more mtDNA-encoded ETC 
protein in particular, or change an rRNA or tRNA, with potential consequences in the 
expression of any mtDNA-encoded protein. Large-scale rearrangements include several genes 
and usually delete at least one tRNA, thus causing protein synthesis defects (Wallace, 2001). 
MtDNA large-scale rearrangements are thought to result from a clonal amplification 
of a mutation that has occurred in the maternal oocyte or during early embryo development 
(Chen et al., 1995). Because of the mtDNA mitotic segregation, different tissues may acquire 
distinct levels of rearranged molecules, and the eventual onset and severity of the disease will 
be dependent on the relative amount and tissue distribution of the mutation (Zeviani and Di 
Donato, 2004). Single large-scale deletions and duplications have been observed in sporadic 
conditions such as Kearns-Sayre Syndrome (KSS), a multisystem disorder with early onset, 
characterized by neuropathy, retinopathy and cardiomyopathy (Zeviani et al., 1988); 
Pearson‟s syndrome (PS), a fatal disease in childhood, characterized by severe anaemia (Rotig 
et al., 1990); and Progressive External Ophthalmoplegia (PEO), characterized by late-onset 
bilateral ptosis, muscle weakness and exercise intolerance (Shoffner et al., 1989). The most 
common deletion is approximately 5 kb long (the so called “common deletion”), comprising 
both protein-coding genes and tRNAs (as shown in Fig. 4).  
A vast number of maternally inherited point mutations have been described (some of 
which are illustrated in Fig. 4) that are associated with a range of clinical manifestations, 
particularly with neurodegenerative and neuromuscular disorders. For instance, heteroplasmic 
mutations are associated with Mitochondrial Encephalomyopathy with Lactic Acidosis and 
Stroke-like episodes (MELAS; Goto et al., 1990), Myoclonic Epilepsy and Ragged Red 
Fibres (MERRF; Shoffner et al., 1990) and also Neuropathy, Ataxia and Retinis Pigmentosa 
(NARP; Holt et al., 1990). Homoplasmic point mutations, which are generally limited to a 
single tissue, have been described in Leber Hereditary Optic Neuropathy (LHON), a disorder 
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that typically affects young adults, leading to loss of vision (Wallace et al., 1988), and also in 
Sensorineural Hearing Loss (SNHL; Prezant et al., 1993). 
The existence of a vast number of mtDNA mutations mirror a particular feature of the 
mitochondrial genome, namely its high mutation rate, which seems to be around 20 to 100 
times higher than that of nDNA (Wallace et al., 1987; Pesole et al., 1999). Several aspects 
may account for this: a) mtDNA is exposed to high levels of ROS generated by the ETC, 
which accumulate in the mitochondrial matrix and are highly mutagenic; b) the absence of 
protective histones; c) the existence of less effective repair mechanisms. Mutations can, 
therefore, result both from exogenous DNA injury and unrepaired replication errors (reviewed 
in Copeland et al., 2003). As a result, the mitochondrial genome acquires somatic mutations 
during normal life span, puzzling the distinction between neutral polymorphisms and 
pathologic mutations. 
While the disorders presented so far are relatively rare, the involvement of mtDNA 
mutations in more common diseases, such as in the neurodegenerative Parkinson‟s disease 
(PD) and Alzheimer‟s disease (AD), as well as in diabetes and cancer has also been proposed 
(reviewed in McFarland et al., 2007). Moreover, an accumulation of somatically acquired 
mtDNA mutations have been shown in a number of tissues throughout life, suggesting a key 
role for these mutations in the aging process (Corral-Debrinski et al., 1992; Hayakawa et al., 
1992; Zhang et al., 1998, just to give a few examples).  
3.5.2. Defects in nuclear-encoded genes 
The increased interest in mitochondrial diseases has been expanding our understanding 
of this issue, and it is now well established that diverse genes can be implicated. Importantly, 
there are certain mitochondrial diseases whose clinically manifestations are similar to those 
caused by mtDNA mutations, but follow a Mendelian pattern of inheritance. These are caused 
by defects on nuclear genes directly or indirectly involved in OXPHOS function, including 
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genes encoding structural components of the ETC complexes; assembly factors of the ETC 
complexes; proteins implicated in mitochondrial biogenesis; and, finally, mtDNA 
maintenance factors (for reviews see Zeviani and Carelli, 2003; DiMauro, 2004; Schapira, 
2006).  
Defects in any protein involved in the maintenance of the mitochondrial genome can 
potentially affect mtDNA stability either qualitatively or quantitatively, promoting the arising 
of multiple mtDNA mutations and/or depletion. In any case, it is a primary nuclear gene 
defect that is in the origin of a secondary mtDNA deficiency (Suomalainen and Kaukonen, 
2001). Most of these nuclear genes encode proteins mainly involved in mtDNA replication, 
either with a role in replication initiation, such as TFAM, or functioning at the replication 
fork, such as POLG and TWINKLE, or involved in mitochondrial nucleotide metabolism, 
such as Adenine Nucleotide Translocator 1 (ANT1), Thymidine Kinase 2 (TK2) and 
Deoxyguanosine Kinase (dGK) (reviewed in Copeland, 2008). Some of the information 
regarding the role of two of these proteins (POLG and TFAM) in mitochondrial disorders is 
listed below. 
3.5.2.1.  POLG  
As mentioned before, POLG is the sole DNA polymerase present in mitochondria, 
responsible for both mtDNA replication and repair. Human POLG comprises three subunits 
(Yakubovskaya et al., 2006): a 140 KDa catalytic subunit (encoded by POLG), and two 55 
KDa accessory subunits (encoded by POLG2). The catalytic subunit (Fig. 6), whose gene is 
located in chromosome 15q24-15q26 (Ropp and Copeland, 1996; Walker et al., 1997; Zullo 
et al., 1997), possesses both polymerase and 3‟to 5‟ exonuclease domains, the first catalyzing 
mtDNA replication and the second involved in proofreading and repair (Graves et al., 1998). 
It also comprises a linker region (located in between the exonuclease and the polymerase 
domains) that may be involved in subunit interaction, in DNA binding, and in functional 
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combination of the polymerase and the exonuclease activities (Graziewicz et al., 2006). The 
accessory subunit enhances DNA binding and promotes processivity and fidelity (Lim et al., 
1999; Longley et al., 2001) and is also probably involved in primer recognition (Fan et al., 
1999). 
As anticipated giving its role in mtDNA maintenance, POLG dysfunction may impair 
mitochondrial function and indeed, POLG is the main nuclear gene implicated in 
mitochondrial disorders. To date, more that 90 POLG mutations have been associated with a 
wide range of clinical phenotypes concurrent with mtDNA depletion and/or accumulation of 
mtDNA mutations and deletions (Fig. 7; Human Polymerase Gamma Mutation Database: 
http://tools.niehs.nih.gov/polg/index.cfm).  
 
Figure 6. Schematic representation of DNA polymerase gamma (POLG) and mitochondrial 
transcription factor A (TFAM). These proteins possess a mitochondrial targeting sequence, 
allowing their translocation to the mitochondria. POLG posses both polymerase and exonuclease 
activities. TFAM is a member of the High Mobility Group (HMG) family of proteins. Adapted 
from St. John et al. (2007). 
Alexandra Amaral 
34 
 
Figure 7. A vast number of POLG amino acids substitutions, caused by gene mutations, are 
associated with a range of human disease. These include: PEO, which can be autosomal dominant 
(blue boxes), autosomal recessive (green boxes) or sporadic (grey boxes); sensory ataxic 
neuropathies (yellow boxes); Alpers syndrome (pink boxes) and possible male infertility (orange 
box). Striped boxes represent substitutions associated with more than one disease. Adapted from 
Copeland (2008). 
The majority of these mutations are linked with PEO, either autosomal dominant 
(adPEO) or autosomal recessive (arPEO), both of which presenting large mtDNA deletions 
and respiratory chain dysfunction. The onset of this disease is in adulthood, and the clinical 
manifestations, while heterogeneous, include progressive weakening of the external eye 
muscle, ptosis, skeletal muscle weakness and exercise intolerance. The association between 
POLG missense mutations and PEO was first described by Van Goethem and colleagues 
(2001) and latter confirmed by several other studies (Lamantea et al., 2002; Agostino et al., 
2003; Di Fonzo et al., 2003; Filosto et al., 2003a; Van Goethem et al., 2003a; Mancuso et al., 
2004). Most POLG mutations are associated with arPEO and patients are often compound 
heterozygotes, i.e., with two different mutant POLG alleles. On the other hand, adPEO 
patients can be heterozygotes for the mutation and, in this case, mutations might produce a 
protein that competes with the wild-type POLG in a dominant negative way (Longley et al., 
2005). Interestingly, most adPEO mutations localise to the POLG polymerase domain and 
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change highly conserved aa residues, such as Arg943, Tyr955 and Ala957, that seem to be 
crucial for dNTP binding. In vitro experiments showed that such POLG alterations lead to 
decreased polymerase activity and reduced processivity and fidelity of the enzyme 
(Ponamarev et al., 2002; Graziewicz et al., 2004). More recently, transgenic mice with 
cardiac-targeted Y955C human POLG (a prevalent mutation where tyrosine is substituted 
with cisteine at codon 955) resulted in loss of heart mtDNA, cardiomyopathy and early death, 
clearly linking this mutation with cardiac dysfunction (Lewis et al., 2007). POLG presenting 
another common mutation, A467T (causing an alanine to threonine aa substitution at codon 
467), which co-segregates with arPEO, has decreased polymerase activity and fails to interact 
with the accessory subunit, at least in vitro (Chan et al., 2005).  
The diverse POLG mutations and their different effects on the enzyme may explain 
the heterogeneous phenotypic manifestations reported. Attesting to this diversity, mutations in 
POLG have been described in patients with sensory ataxic neuropathies (Van Goethem et al., 
2003a; 2003b; 2004; Gago et al., 2006), Parkinsonism and premature menopause (Luoma et 
al., 2004; Pagnamenta et al., 2006; Hudson et al., 2007), and Charcot-Marie-Tooth disease 
(CMT, Harrower et al., 2008), a motor and sensory neuropathy characterized by loss of 
muscle tissue and touch sensation. POLG mutations are also responsible for Alpers syndrome, 
a rare but severe autossomal mtDNA depletion condition that affects young children, and is 
characterized by progressive cerebral degeneration leading to mental deterioration, spasms, 
blindness, deafness, liver failure and eventually death (Naviaux and Nguyen, 2004; Davidzon 
et al., 2005; Naviaux and Nguyen, 2005; Nguyen et al., 2005; 2006). In addition, 
polymorphisms in the POLG CAG-repeat region, encoding a polyglutamine tract localised 
near the amino-terminal of the protein, are possibly associated with male infertility (see 
Chapter III). 
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3.5.2.2. TFAM  
TFAM is a member of the High Mobility Group (HMG) family of DNA-binding 
proteins and its human gene is located to chromosome 10q21 (Tiranti et al., 1995). The 
protein (Fig. 6) consists of two HMG boxes and a mitochondrial targeting sequence that 
allows its translocation to the mitochondria (Parisi and Clayton, 1991). Here, and as 
mentioned previously, it activates mtDNA transcription (Garstka et al., 1994), and it is also 
implied in replication, since transcription generates the RNA primer necessary for replication 
initiation (Chang et al., 1985; Xu and Clayton, 1996). TFAM has also been proposed to 
package mtDNA (Alam et al., 2003) and to be a key regulator of mtDNA copy number 
(Ekstrand et al., 2004). Loss of TFAM function has been correlated with distinct diseases, 
which is not surprising giving its roles in mtDNA maintenance and expression. To this extent, 
low levels of TFAM expression have been associated with mtDNA-depletion/mutations 
syndromes, such as infantile mitochondrial myopathy and encephalomyophathy disorders 
(Larsson et al., 1994; Poulton et al., 1994; Siciliano et al., 2000). Likewise, mice with 
disrupted TFAM in heart and muscle developed cardiac progressive respiratory chain 
deficiency caused by impaired mtDNA expression, and cardiomyopathy, mimicking diseases 
involving mtDNA mutations (Wang et al., 1999). In a similar work, disruption of TFAM in 
dopamine neurons lead to reduced mtDNA expression and respiratory chain deficiency in 
these cells and ultimately to a Parkinsonism phenotype (Ekstrand et al., 2007). In addition, 
certain TFAM variants are possibly associated with late-onset AD (Gunther et al., 2004; Belin 
et al., 2007; Alvarez et al., 2008). 
3.6. MtDNA and male infertility 
Human sperm function is dependent on mitochondrial OXPHOS-derived ATP, and 
hence, on the mitochondrial genome and its integrity. Several studies have been performed to 
determine if sperm mtDNA mutations or deletions can cause loss of sperm function and, 
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consequently, male infertility. Two main approaches have been used: while some studies have 
compared the incidence of mtDNA mutations and/or deletions in distinctive quality sperm 
samples (judged according to the WHO standards), others have focused on subpopulations of 
sperm within a same sample. In the last case, sperm is usually fractionated by a discontinuous 
Percoll (or equivalent) gradient, and poorer quality sperm, with low motility, is collected in 
the lower density fraction (Gorus and Pipeleers, 1981; Pousette et al., 1986). 
The first indications that mtDNA point mutations could be associated with male 
infertility came from case reports of patients harbouring the A3243G point mutation, with 
mitochondrial encephalomyopathies, who also presented decreased sperm motility (Folgero et 
al., 1993) or impaired reproductive function (Huang et al., 1994). The first was particularly 
informative, as it has been shown that incubation of the patient‟s sperm with metabolic 
supplements to bypass the ETC complex I (which presented reduced activity, most likely as a 
result of the mtDNA point mutation) increased sperm motility three-fold. These founder 
studies, while suggestive, were not entirely conclusive, as the mtDNA point mutation was 
found in somatic tissues, and sperm mtDNA were not accessed. Clear evidence came from the 
analysis of sperm of another patient harbouring the same point mutation, where a greater 
mutation load was identified in lower density Percoll fractions, and was also associated with 
reduced sperm motility (Spiropoulos et al., 2002). Less definitive, but equally interesting 
were the two reports of mutations in nucleotides 9055 (ATPase 6 gene) and 11719 and 11994 
(both in ND4 gene), the occurrence of which was significantly higher in sperm samples of 
men with poor semen parameters when compared to normozoospermic individuals (Holyoake 
et al., 2001; Selvi Rani et al., 2006). It is however worth mentioning that these two works 
were questioned by others, who claimed that there is no evidence that these particularly point 
mutations can influence sperm motility (Bandelt, 2007; Pereira et al., 2008). 
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The association between sperm mtDNA single large-scale deletions and male 
infertility has also been made, but, again, the results are conflicting. To this extent, in addition 
to the common 4977 bp deletion, two novel large deletions (7345 and 7599 bp) have been 
described in sperm. Analysis of fractionated different-quality sperm samples identified lower 
density fractions as presenting the highest frequency of occurrence of the deletions, along 
with a lower incidence of occurrence in sperm donor samples when compared to infertility 
patients (Kao et al., 1995; 1998). More importantly, a high negative correlation was found 
between mtDNA deletion incidence and sperm motility. It should however be pointed out that 
the relative proportion of deleted molecule compared to the wild-type mtDNA was very low 
(< 0.08% and < 0.3% for the common deletion and for the 7345 and the 7599 bp deletions, 
respectively). Furthermore, these works were not verified by others, either analysing only 
sperm (St John et al., 2001) or semen samples (Cummins et al., 1998). However, in a more 
recent study comparing sperm samples from fertile individuals and OAT patients, the mtDNA 
common deletion was suggested to be a frequent alteration in infertility (Dhillon et al., 2007), 
thus re-opening the debate.  
While the association of a particular large-scale deletion with male infertility is 
somewhat conflicting, the same is not true for the occurrence of multiple mtDNA 
rearrangements, that, when in high numbers, seem to be related with loss of sperm function. 
Interestingly, multiple deletions identified in the skeletal muscle of a patient with a 
mitochondrial disease were also identified in his sperm (Lestienne et al., 1997), again 
showing that OXPHOS dysfunction affecting one tissue was also characteristic of low sperm 
motility. Additionally, a latter study identified a high incidence of multiple deletions in sperm 
from a range of patients, irrespectively of sperm quality, suggesting that most sperm 
mitochondria present multiple DNA deletions (Reynier et al., 1998). The persistence of 
multiple deletions in normozoospermic samples were confirmed by others (St John et al., 
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2001), although this study also demonstrated an accumulation of multiple deletions in poorer 
quality sperm samples, with a greater number being observed in OATs. In accordance, 
analysis of high- and low-density sperm fractions showed that the former have a greater 
proportion of wild-type mtDNA molecules, along with a higher incidence of single and small 
deletions, while lower density fractions presented mainly double or multiple larger sized 
deletions (O'Connell et al., 2003). Significantly, both the number and size of mtDNA 
deletions in either testicular or ejaculated sperm are negatively correlated with ICSI 
pregnancy outcomes (Lewis et al., 2004), clearly showing the deleterious effect of mtDNA 
rearrangements in sperm function, even in those cases where the low motility is bypassed (by 
the introduction of sperm in the oocyte). These outcomes have been supported by 
transmitochondrial mice models carrying different proportions of the common deletion, where 
the accumulation of pathogenic mtDNA-derived ETC defects was responsible for male 
infertility (Nakada et al., 2006). 
Analysis of testicular and epididymal sperm of men with obstructive azoospermia (i.e. 
with normal spermatogenesis, but presenting no sperm in the ejaculate) has also provided 
some interesting results. It seems that testicular sperm possess more wild-type mtDNA 
molecules and lower incidence of multiple deletions (which are also smaller) than epididymal 
sperm (O'Connell et al., 2002b), which most probably accounts for the higher fertilisation 
rates reported with testicular when compared to epididymal sperm from patients with 
obstructions (Palermo et al., 1999). Additionally, fertile men also present mtDNA deletions in 
testicular sperm, but the mean size of these deletions is lower than in those men with 
obstructive azoospermia (O'Connell et al., 2002a). 
The influence of the mitochondrial genome in sperm is also typified by the suggestion 
that certain mtDNA haplogroups (groups of specific mtDNA types) are predisposed to 
reduced sperm motility in Caucasians. These variants are indicative of population lineages 
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and seem to be also associated with the susceptibility for certain diseases (Hofmann et al., 
1997), on one hand, and with longevity (De Benedictis et al., 1998), on the other. Specifically 
related to male infertility, it seems that haplogroup T is more abundant in asthenozoospermic 
patients, while haplogroup H is overrepresented in nonasthenozoospermic men (Ruiz-Pesini 
et al., 2000a). Supporting this, the two haplogroups showed differences in motility scores and 
in the enzymatic activities of mitochondrial complexes I and IV. It has also been revealed that 
there is apparently no link between mtDNA haplogroups and oligozospermia. A latter study 
by the same group showed differences in both sperm motility and vitality in sublineages of 
haplogroup U, which may be related to conserved missense mutations in COXIII and 
cytochrome c genes (Montiel-Sosa et al., 2006). However, others have contradicted these 
findings and argued that there is not enough evidence for a link between mtDNA variants and 
sperm concentration and motility (Pereira et al., 2005; 2007). 
Overall, and despite the controversies on the exact effect of a particular mtDNA point 
mutation, deletion or haplogroup in human sperm, there are clear evidences that alterations in 
the mitochondrial genome can compromise sperm motility and function. 
4. Aims 
In the present work, distinct aspects of mitochondrial function were assessed in human 
sperm in order to understand their biological and clinical significances. Specifically, the aims 
were: 
1) To determine if POLG and TFAM were expressed in mature human sperm, and 
understand if the expression of these and other mitochondrial proteins (COXI and 
COXVIc) were associated with sperm quality [both in distinct sperm samples 
(Chapter II) and different sperm subpopulations (Chapter IV)]; 
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2) To establish if mtDNA copy number was related with sperm quality, and study 
the possible role of POLG and TFAM in regulating mtDNA content in mature 
sperm (Chapter II); 
3) To ascertain if specific POLG polymorphisms were associated with sperm quality, 
and assess if these could affect sperm mtDNA copy number and the expression of 
mtDNA-related proteins (Chapter III); 
4) To compare distinct mitochondrial probes and clarify their ability to monitor 
sperm MMP (Chapter IV); 
5) To understand if POLG and COXI expressions were related with sperm MMP and 
sperm motility in subpopulations of human sperm (Chapter IV); 
6) To find out the clinical value of the assessment of sperm MMP and understand if 
and how this was related with other functional parameters (Chapter V). 
 
  
  
 
 
 
 
 
 
 
CHAPTER II 
THE EXPRESSION OF POLYMERASE GAMMA AND 
MITOCHONDRIAL TRANSCRIPTION FACTOR A AND THE 
REGULATION OF MITOCHONDRIAL DNA CONTENT IN 
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Abstract 
Human mitochondrial DNA (mtDNA) encodes 13 polypeptides of the electron transfer 
chain (ETC). A series of mtDNA rearrangements are associated with reduced sperm quality 
and, consequently, with male infertility. Moreover, low quality sperm seem to present 
abnormal mtDNA content. The replication of the mitochondrial genome is dependent on the 
nuclear-encoded DNA polymerase gamma (POLG) and mitochondrial transcription factor A 
(TFAM). However, the expression of these factors has never been accessed in mature sperm. 
In the present work, whether POLG and TFAM could have functional roles in post-
ejaculatory human sperm mtDNA has been determined. 
Sperm samples were categorized as: normozoospermic, samples with one or two 
abnormal sperm parameters and oligoasthenoteratozoospermics (OATs). These samples were 
analysed by real-time PCR for mtDNA copy number and immunocytochemistry and western 
blotting for patterns of expression for POLG, TFAM and two cytochrome c oxidase (COX; 
the Complex IV of the ETC) subunits: the mtDNA encoded COXI and the nuclear DNA 
encoded COXVIc.  
Paradoxically, good-quality sperm had fewer mtDNA copies but significantly more 
sperm expressing POLG, TFAM, COXI and COXVIc. On the other hand, the OAT group 
presented significantly higher mtDNA content and a lower percentage of sperm expressing 
POLG, TFAM, COXI and COXVIc. 
The reduction in mtDNA content in normal samples likely reflects normal 
spermiogenesis, whereas increases in POLG and TFAM expression possibly compensate for 
the low mtDNA content, maintaining mitochondrial homeostasis. 
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1. Introduction 
Mitochondria are dynamic organelles that provide eukaryotic cells with energy. The 
number of mitochondria per cell is variable, depending on the cell‟s requirement for ATP 
(Moyes et al., 1998). In mature mammalian sperm, there are between 22 and 75 mitochondria 
per sperm localised to the midpiece (Otani et al., 1988), where they provide energy for several 
proposes, including flagellar propulsion, and thus sperm motility. Mitochondria generate ATP 
through oxidative phosphorylation (OXPHOS) which takes place within the electron transfer 
chain (ETC) and is far more productive than anaerobic generation of ATP (Pfeiffer et al., 
2001). The importance of OXPHOS-derived ATP for sperm motility has been demonstrated 
through classical mitochondrial inhibitor experiments (see Chapter I). 
The ETC is the only cellular apparatus that is encoded by both the chromosomal and 
mitochondrial genomes. Human mtDNA, which tends to be maternally inherited (Giles et al., 
1980, see Chapter I), is approximately 16.6 kb in size and encodes 13 of the polypeptides 
contributing to the ETC along with 22 tRNAs and 2 rRNAs (Anderson et al., 1981). 
Mutation, deletion or depletion to any of these genes is associated with a range of 
mitochondrial diseases which can both impair cellular function and/or can be lethal (see 
Chapter I). 
A series of mtDNA rearrangements are associated with male infertility. For instance, 
the maternally inherited A3243G point mutation has been identified as the cause of poor 
sperm motility (asthenozoospermia) in a male presenting mtDNA disease (Spiropoulos et al., 
2002). In a similar case, addition of metabolic supplements to bypass a point mutation causing 
reduced activity of the ETC Complex I increased sperm motility three-fold (Folgero et al., 
1993). Single large-scale mtDNA deletions have also been associated with male infertility 
(Kao et al., 1995; 1998), although this association was not verified by others (Cummins et al., 
1998; Reynier et al., 1998; St John et al., 2001). However, an accumulation of multiple 
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deletions in poorer quality sperm samples has also been demonstrated (St John et al., 2001), 
with a greater proportion of wild-type molecules being present in higher density gradient 
fractions (corresponding to better quality subpopulations) than in lower density ones 
(O'Connell et al., 2003). 
In addition to other events, mammalian spermatogenesis is characterized by 
morphological modifications of mitochondria, reflecting the permanent change in the 
testicular microenvironment (De Martino et al., 1979). Concurrently, testis-specific 
mitochondrial proteins are expressed (reviewed in Meinhardt et al., 1999), including, for 
example, cytochrome CT (Goldberg et al., 1977) and COXVIb-2 (Huttemann et al., 2003). 
Moreover, during spermiogenesis, some mitochondria are lost in the residual bodies, while 
the remaining undergo subcellular reorganization (see Chapter I). Likewise, the number of 
mitochondrial molecules per haploid genome decreases 8- to 10-fold between meiosis and the 
end of spermiogenesis in mice (Hecht et al., 1984). This mtDNA down-regulation has been 
confirmed by others, not only in mice (Larsson et al., 1996), but also in human (Larsson et 
al., 1997) and rat (Rantanen et al., 2001) spermatogenesis. Despite this, and at least in mice, 
testicular mtDNA seems to be synthesised during meiosis and early spermiogenesis (Hecht 
and Liem, 1984). As mtDNA synthesis terminates in mid-spermiogenesis, the mtDNA found 
in mature sperm may have been synthesised in spermatids or earlier. 
It is evident that there is variability in the number of mtDNA molecules in different 
populations of human sperm with a tendency towards a greater proportion being present in 
poorer quality samples (Diez-Sanchez et al., 2003a; May-Panloup et al., 2003; Song and 
Lewis, 2008). The vast range in mtDNA content between these reports tends to be technique 
dependent although one other study contradicts this trend but still reports significant 
differences between good and poor quality samples (Kao et al., 2004). However, these 
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outcomes suggest that an association may exist between mtDNA copy number, sperm quality 
and regulation of mtDNA replication. 
The replication of mtDNA is controlled by nuclear-encoded replication factors that are 
translocated to the mitochondria (see Chapter I). Both the mitochondrial-specific DNA 
polymerase gamma (POLG; Ropp and Copeland, 1996) and mitochondrial transcription factor 
A (TFAM; Fisher and Clayton, 1985; 1988) are required.  
POLG comprises two subunits: a catalytic subunit (POLG), with both polymerase and 
3‟to 5‟exonuclease activity, and an accessory subunit (POLG2), which confers processivity. 
The importance of POLG has certainly been documented using mice models. To this extent, 
homozygous knockin mice expressing a proof-reading deficient POLG presented increased 
levels of mtDNA point mutations and deletions, and showed reduced lifespan and premature 
onset of aging-related phenotypes, including reduced fertility (Trifunovic et al., 2004). 
Furthermore, POLG homozygous knockout mice died during early embryonic development 
with severe mtDNA depletion (Hance et al., 2005). In humans, mutations in POLG are 
associated with the accumulation of mtDNA deletions in diseases such as progressive external 
ophtalmoplegia and Parkinsonism and premature menopause; and with mtDNA depletion 
syndromes such as Alper‟s disease (see Chapter I). Polymorphisms in the CAG-repeat region 
of POLG are possible associated with male infertility (see Chapter III). However, the 
expression of POLG in the testis or in mature sperm has never been determined. 
TFAM is a high mobility group protein that activates mtDNA transcription in 
mammals (Parisi and Clayton, 1991; Garstka et al., 1994) and, consequently, the generation 
of the RNA primer necessary for the initiation of mtDNA replication (see Chapter I). Mice 
knockout studies have suggested that TFAM is a regulator of mtDNA copy number with 
heterozygous knockouts displaying decreased mtDNA content and OXPHOS deficiency of 
the heart. Homozygous knockout embryos exhibited severe mtDNA depletion, loss of 
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OXPHOS, and died post-gastrulation (Larsson et al., 1998). In the human, low levels of 
TFAM expression have been associated with mtDNA-depletion syndromes, such as infantile 
mitochondrial myopathy and encephalomyophathy disorders (see Chapter I). In human, 
mouse and rat, testis-specific TFAM transcripts result in down-regulation of TFAM protein 
levels in mitochondria, as they either encode a nuclear protein isoform (mouse - Larsson et 
al., 1996) or are not translated (human - Larsson et al., 1997; rat - Rantanen et al., 2001). This 
has been suggested to account for the reduction in mtDNA copy number that occurs during 
mammalian spermatogenesis. Consequently, one could speculate that TFAM is poorly 
regulated during spermatogenesis in patients presenting a greater number of sperm mtDNA 
molecules. Moreover, this could also be the case for POLG. 
In the present work, it has been sought to determine whether mtDNA copy number is 
uniformly regulated in different quality sperm samples, and whether there is a relationship 
between mtDNA copy number and the expression of POLG and TFAM. These outcomes 
were then assessed in terms of frequency of two ETC proteins and its presence in varying 
populations of sperm. 
2. Materials and methods 
Chemicals 
All chemicals were supplied by Sigma Chemical Company (St. Louis, MO, USA), 
unless stated otherwise.  
Biological Material 
All patients were recruited from the Fertility Clinic (University Hospitals of Coimbra, 
Portugal) and were undergoing routine semen analysis or fertility treatment involving both in 
vitro fertilisation (IVF) and intracytoplasmatic sperm injection (ICSI). They signed informed 
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consent forms, and all human material was used in accordance with the appropriate ethical 
and Internal Review Board (IRB) guidelines provided by the University Hospitals of 
Coimbra. 
Fresh semen samples were obtained by masturbation after 3 to 5 days of sexual 
abstinence and routine seminal analysis was performed according to the World Health 
Organization Guidelines (WHO, 1999). In order to isolate sperm from both seminal plasma 
and round cells, semen samples were prepared by density gradient centrifugation using 
ISolate
 
Sperm Separation Medium (Irvine Scientific, Santa Ana, CA, USA), according to the 
manufacturer‟s protocol. Samples were categorized based on sperm concentration, motility 
and morphology. For morphology analysis semen smears were prepared on microscopy slides 
and then treated with the Diff–Quik stain set (Dade Behring Inc., Newark, USA). Sperm 
morphology was assessed using the strict criteria (Kruger et al., 1986). Samples were 
categorised as: normal (normozoospermic samples, i.e. concentration ≥ 20 x 106 sperm/ml, ≥ 
50% motile sperm, ≥ 15% normal forms); 1- or 2-defects (samples with one or two abnormal 
parameters) or OAT (oligoasthenoteratozoospermic samples, i.e. samples with low sperm 
concentration, motility and morphology), according to WHO (1999) criteria. 
Extraction of total DNA 
As samples were prepared using density gradient centrifugation, it was able to 
eliminate the possibility of contaminating somatic cells. However, before DNA extraction, the 
absence of contaminating cells was confirmed by light microscopy. DNA from isolated sperm 
samples was extracted according to the whole blood DNA isolation protocol using the 
Puregene DNA Isolation Kit (Flowgen, Nottingham, UK) supplemented with 1.5 μl of 20 
mg/ml Proteinase K and 12 μl of 1 mol/l DTT and incubated overnight at 55˚C, as described 
previously (St John et al., 2001). The addition of DTT, not generally used in DNA extraction 
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procedures for other cell types, is used in sperm, both to break nucleus disulphide bounds, and 
to dissociate mitochondria from the mitochondrial sheath (Sutovsky et al., 1997).  
mtDNA/Beta-Globin quantification 
For mtDNA quantification, an external standard of 152 bp PCR product was 
generated, using primers D41 and D56 (Reynier et al., 2001, see Table I). Reaction conditions 
were as follows: initial denaturation at 94˚C for 3 min, 35 cycles of 94˚C for 30 sec, 53˚C for 
30 sec and 72˚C for 1 min, and final extension at 72˚C for 3 min. In order to determine the 
number of sperm in each sample, quantification of the housekeeping gene Beta-Globin was 
also carried out. An external standard of 268 bp PCR product was generated, using primers 
previously described (Wykes and Krawetz, 2003, see Table I) with the following reaction 
conditions: initial denaturation at 95˚C for 5 min, 35 cycles of 95˚C for 30 sec, 56.5˚C for 30 
sec and 72˚C for 1 min, and final extension at 72˚C for 5 min. For both genes, the 25 μl final 
volume reaction mixture contained 50 ng of total DNA, 1 x PCR Buffer (BioLine, London, 
UK), 1.5 mM MgCl2 (BioLine), 200 μM dNTPs (BioLine), 0.5 μM of each primer and 2.5 U 
BioTaq DNA polymerase (BioLine). PCR products were run on 1% agarose gels, and 
products size confirmed against a 100 bp DNA ladder (Bioron, Ludwigshafen, Germany). 
Standards were purified using the QIAquick Gel Extraction Kit (Qiagen, London, UK), as 
described in the manufacturer‟s protocol. After spectrophotometer quantification, a series of 
10-fold dilutions were prepared to generate a standard curve for each gene. It was considered 
that the number of molecules of double-stranded DNA present in 1 ng of a 152 bp fragment 
(mtDNA) was 6 x 10
9 
molecules, and that 1 ng of a 268 bp fragment (Beta-Globin) contained 
3.4 x 10
9
 double-stranded DNA molecules. 
Real-time PCR was performed using a 72-well Rotorgene-3000
TM
 4 Channel 
Multiplexing System machine and analysed with version 6 software (Corbett Research, 
Mortlake, NSW, Australia). PCR mixtures were prepared using a CAS-1200 Robotic Liquid 
Alexandra Amaral 
52 
Handling System (Corbett Robotics, Queensland, Australia). Reaction mixtures (15 μl final 
volume) contained 7.5 μl 2x SensiMix (2x SensiMix DNA Kit, Quantace, London, UK), 0.3 
μl 50x SYBR  Green solution (2x SensiMix DNA Kit), 330 μM each primer (see Table I) and 
2 μl of each standard (range: 2 x 10-2 to 2 x 10-8 ng/μl) or 2.5 ng/μl DNA samples solutions. 
Each reaction was run in triplicate both for standards and samples, as well as for negative 
controls. An aliquot from a positive control was used in triplicate on each occasion to 
determine the repeatability of each reaction. Each reaction was repeated at least once.  
Table I. Primers used for mtDNA quantification. 
Forward primer Reverse primer 
Annealing 
Temp
Product 
size 
(5’→3’) (5’→3’) (ºC) (bp)
mtDNA cga aag gac aag aga aat aag g ctg taa agt ttt aag ttt tat gcg 53 152
Beta-Globin caa ctt cat cca cgt tca cc gaa gag cca agg aca ggt ac 56.5 268
Gene
 
Accession numbers are as follows: J01415 for mtDNA, and V00499 for Beta-Globin. 
For mtDNA, reactions were performed as follows: initial denaturation at 95˚C for 10 
min, followed by 45 cycles with denaturation at 95˚C for 10 sec, annealing at 53˚C for 10 sec, 
and extension at 72˚C for 15 sec. For Beta-Globin, reactions consisted of an initial 
denaturation at 95˚C for 10 min, 45 cycles with denaturation at 95˚C for 15 sec, annealing at 
56.5˚C for 15 sec, and extension at 72˚C for 20 sec. Data were acquired in the FAM/Sybr 
channel during the extension phase. For each of the 45 cycles, a step of 76˚C for 15 sec (for 
mtDNA) and 81˚C for 20 sec (for Beta-Globin) with data acquisition was added, in order to 
exclude fluorescence generated by potential primer-dimers. Melt curve analysis was 
performed by ramping from 65
o
C to 99
o
C at 1
o
C intervals and data acquired from the 
FAM/Sybr channel. 
Only reactions with high efficiency (> 88%) were considered, and only standard 
curves with a Pearson correlation coefficient of at least 0.99 were taken into account. As each 
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sample was run in triplicate on two separate occasions, six values were considered for each 
sample. To correct for pipetting errors, the highest and lowest values obtained were discarded, 
and the remaining four were averaged (Bustin, 2000). The standard deviation and coefficient 
of variation (CV) were also calculated and only values with low CVs (maximum 10%) were 
considered reliable. 
POLG, TFAM, COXI and COXVIc detection 
Immunocytochemistry (ICC) 
Immunocytochemistry for individual proteins was performed separately using the 
following primary antibodies: rabbit anti-human POLG polyclonal antibody (ab2969, Abcam, 
Cambridge, UK), goat anti-human TFAM polyclonal antibody (sc-19050, Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), mouse anti-human COXI monoclonal antibody (A-
6403, Molecular Probes, Eugene, OR, USA) and mouse anti-human COXVIc monoclonal 
antibody (A-6401, Molecular Probes). For secondary staining, Alexa Fluor 488 goat anti-
rabbit IgG (A-11008, Molecular Probes), Alexa Fluor 488 donkey anti goat IgG (A-11055, 
Molecular Probes) and AlexaFluor 488 goat anti-mouse IgG (A-1101, Molecular Probes) 
antibodies were used. A general procedure was performed as described previously (Ramalho-
Santos et al., 2000), with minor modifications. Sperm were attached to coverslips, fixed for 
40 min with 2% (v/v) formaldehyde in phosphate-buffered saline (PBS; pH 7.2)  and 
permeabilised in 1% Triton X-100 (v/v) in PBS for 20 min at room temperature. Non-specific 
antibody reactions were blocked by 30 min incubation in PBS containing 1 mg/ml BSA and 
100 mM glycine. Samples were then incubated with the primary antibody solubilised in the 
blocking solution at 1:200, 1:50, 1:500 and 1:200 dilutions for POLG, TFAM, COXI and 
COXVIc, respectively, overnight, at 37  C. Control experiments without primary antibodies 
were also performed. Coverslips were washed for 30 min in PBS containing 0.1% Triton X-
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100 (v/v), and then incubated with the appropriate secondary antibody at a 1:200 dilution in 
blocking solution for 40 min at 37º C. After rinsing again, the coverslips were mounted on a 
microscope slide in a drop of Vectashield mounting medium containing the nucleic acid-stain 
4‟,6 diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA) and 
sealed with nail polish. Slides were examined using a Zeiss Axiophot II microscope (Carl 
Zeiss, Göttingen, Germany) equipped with a triple band pass filter and 200 sperm per 
coverslip were counted in at least four different fields, in order to determine the percentage of 
stained sperm. 
Sodium dodecyl-sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting 
Sperm pellets were ressuspended in lysis buffer (25 mM TRIS, 1 M NaCl, 1% Triton, 
1 mM CLAP, 0.2 mM PMSF, and 0.01 mM DTT) and briefly sonicated. After 1 hour, the 
clear supernatants obtained following centrifugation were diluted in denaturing solution (1:2 
dilution) and incubated at 95˚C for 5 min. Samples were run on sodium dodecyl-sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a PVDF membrane 
(Roche Diagnostics Corporation, IL, USA) overnight in transferring buffer [190 mM TRIS, 
25 mM glycine, 20% (v/v) methanol]. Membranes were blocked with TRIS Buffer Saline also 
containing 0.1% (v/v) Tween 20 (TBST) and 5% skim dried milk for 45 min and incubated 
overnight at room temperature with the primary antibodies described above 
(Immunocytochemistry section), diluted in TBST. After washing 5 times for 5 min each in 
TBST, the blots were incubated for 1 h at room temperature with the appropriate (anti-rabbit, 
anti-goat or anti-mouse) alkaline phosphatase conjugated antibody (Amersham Biosciences 
UK Limited, Buckingamshire, UK), 1:20000 diluted in TBST. The bands were developed 
using the ECF-substrate system, according to the manufacturer‟s recommendations 
(Amersham).  
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Statistical analysis 
Statistical analysis was carried out using SPSS for Windows (version 13, Chicago, IL, 
USA). All variables were checked for normal distribution using the one-sample Kolmogorov-
Smirnov test. For ICC and mtDNA copy number analysis, the different groups were 
compared using the one-way ANOVA test (or the Kruskal-Walli‟s non parametric test when 
distributions were not normal). Post-Hoc analyses were done using Tukey‟s test or Dunnet‟s 
test, depending on whether equal variances were assumed or not. Pearson‟s and Spearman‟s 
tests, for parametric and non-parametric data, respectively, were applied to assess the 
correlations of the principal semen parameters (concentration, motility and morphology) with 
both ICC and mtDNA copy number results, as well as between ICC outcomes and mtDNA 
copy numbers. P < 0.05 was considered significant. 
3. Results 
Assessment of mtDNA copy number 
In order to determine whether sperm mtDNA was distributed evenly amongst sperm of 
differing qualities, the number of copies of mtDNA per sperm was quantified in 42 samples 
comprising the three patient groups (normal group, 1- or 2-defects group, and OAT group). 
The mean number of mtDNA copies per haploid genome was determined by the ratio of 
mtDNA to Beta-Globin molecules through real-time PCR. The mean (± SEM) mtDNA copy 
number for all samples analysed was 21.6 ± 5.8 (range 0.6 - 206.1). Comparing the three 
groups individually (Table II; Fig. 1), it is evident that mtDNA copy number per sperm 
increases as sperm quality decreases. To this extent, the normal group possessed 6.8 ± 1.8 
mtDNA copies per sperm and the 1- or 2-defects group 11.3 ± 4.5, whereas the OAT group 
possessed 46.7 ± 15.0. The OAT group was statistically different from both the normal group 
(P = 0.001) and the 1- or 2-defects group (P < 0.05). Moreover, there was a significant 
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negative correlation between the number of mtDNA molecules per sperm and sperm 
concentration (R = -0.561, P < 0.001) and morphology (R = -0.467, P = 0.002). The same was 
not verified for motility, although there was a tendency towards this (R = -0.285, P = 0.067). 
Table II. Mean mtDNA copy number for the normal, 1- or 2-defects and OAT groups. SEMs and ranges are also 
indicated. 
Normal group
1- or 2-Defects 
group
OAT group Total
(n=14) (n=14) (n=14) (n=42)
Mean ± SEM 6.8 ± 1.8
a
11.3 ± 4.5
a
46.7 ± 15.0
b 21.6 ± 5.8
Range 0.2 – 22 0.6 – 63.8 0.7 – 206.1 0.2 – 206.1
 
The mean mtDNA copy number for all the samples analysed is indicated (Total). Superscripts a and b 
denote a significant difference between groups (normal vs. OAT, P < 0.01; 1- or 2-defects vs. OAT, P < 
0.05). 
 
Figure 1. MtDNA copy number per sperm in the normal, 1- or 2-defects and OAT groups. The 
mtDNA copy number is significantly higher in the OAT group (a and b denote statistically 
significant differences: normal vs. OAT, P < 0.01; 1- or 2-defects vs. OAT, P < 0.05). 
Expression and localisation of POLG  
To determine whether POLG persisted in mature sperm having completed 
spermiogenesis and thus mtDNA replication, POLG expression was analysed using ICC, in 
93 sperm samples, comprising the three patient groups. As anticipated, POLG localised to the 
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midpiece, the compartment housing the mitochondria (Fig. 2a), and POLG expression was 
confirmed by western blotting (Fig. 2c). ICC demonstrated that most of the sperm in each of 
the samples were stained in the midpiece (mean % ± SEM = 73.0 ± 1.6), whereas the 
remainder presented no staining. Interestingly, in almost all samples, some sperm were also 
stained in a ring-like structure localised between the head and the midpiece (referred here as 
the „ring‟; Fig. 2b; mean % ± SEM = 29.3 ± 2.5). The mean percentage of sperm stained in 
the midpiece (mean % ± SEM = 79.3 ± 2.3 for the normal group; 72.9 ± 2.3 for the 1- or 2-
defects group; and 62.8 ± 2.8 for the OATs) was significantly lower in the OAT group when 
compared with the other 2 groups (normal vs. OAT, P < 0.01; 1- or 2-defects vs. OAT, P < 
0.05; Fig. 2d). In relation to the mean percentage of sperm stained both in the midpiece and 
the ring (mean % ± SEM = 35.9 ± 4.5, 30.6 ± 3.5 and 14.9 ± 3.8 in the normal, 1- or 2-defects 
and OAT groups, respectively), the OAT group was also significantly different from the other 
groups (normal vs. OAT and 1-or 2-defects vs. OAT, P < 0.05; Fig. 2e). 
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Figure 2. Expression and localisation of POLG in human sperm. A, B) POLG expression and 
localisation detected by immunocytochemistry (ICC). Human sperm express POLG in the 
midpiece (A, B - green) and in a ring structure localised between the head and the midpiece (B - 
green). Nuclear DNA is stained with DAPI (blue). C) POLG expression detected by western 
blotting. The molecular weight of human POLG is 140 kDa (right). A ladder band of 250 kDa is 
also shown (left). D) Percentage sperm stained in the midpiece using an anti-human POLG 
antibody (ICC) in the normal, 1- or 2-defects and OAT groups. Data are expressed as means ± 
SEM. The mean percentage of sperm stained in the midpiece is significantly lower in the OAT 
group. a and b denote significant differences (normal vs. OAT, P < 0.01; 1- or 2-defects vs. OAT, 
P < 0.05). E) Percentage sperm stained in the midpiece and the ring using an anti-human POLG 
antibody (ICC) in the normal, 1- or 2-defects and OAT groups. Data are expressed as means ± 
SEM. The mean percentage sperm stained in the midpiece and the ring is significantly lower in the 
OAT group. a and b denote significant differences (normal vs. OAT and 1- or 2-defects vs. OAT, 
P < 0.05). 
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Expression and localisation of TFAM  
As the initiation of mtDNA replication depends on transcription having occurred 
previously, the expression and localisation of TFAM in mature human sperm was also 
investigated. In the 47 samples analysed, the majority of sperm from each sample were 
stained in the midpiece (mean % ± SEM = 65.6 ± 2.5; Fig. 3a), whereas the remaining all 
showed no staining. TFAM expression was confirmed by western blotting (Fig. 3b). 
Comparison between the three groups revealed that the percentage of sperm stained in the 
midpiece decreased from the normal group (mean % ± SEM = 72.8 ± 4.2; Fig. 3c) to the 1- or 
2-defects group (64.2 ± 3.6) to the OATs (54.9 ± 4.4). The OAT group was significantly 
different from the normal group (P < 0.05).  
 
 
Figure 3. Expression and localisation of TFAM in human sperm. A) TFAM expression and 
localisation detected by immunocytochemistry (ICC). Human sperm express TFAM in the 
midpiece (A - green). Nuclear DNA is stained with DAPI (blue). B) TFAM expression detected by 
western blotting. The molecular weight of human TFAM is 25 kDa (right). A ladder band of 37 
kDa is also shown (left). C) Percentage of sperm stained in the midpiece using an anti-human 
TFAM antibody (ICC) in the normal, 1- or 2-defects and OAT groups. Data is expressed as means 
± SEM. The mean percentage of sperm stained in the midpiece is significantly lower in the OAT 
group. a and b denote significant differences (normal vs. OAT, P < 0.05). 
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Expression of mtDNA and nuclear-encoded genes of the ETC  
To determine whether the expression of ETC proteins would be influenced by mtDNA 
copy number and by the expression of mtDNA replication factors, the expression of two 
cytochrome c oxidase (COX; the Complex IV of the ETC) subunits, COXI (mtDNA encoded) 
and COXVIc (nuclear-encoded) were examined. A total of 92 and 78 samples were analysed 
for COXI and COXVIc, respectively. Both antibodies stained the midpiece of the majority of 
sperm in each sample (mean % ± SEM = 79.0 ± 1.3 for COXI and 65.5 ± 2.5 for COXVIc; 
Figs. 4a, 4a‟). The OAT group (mean % ± SEM = 68.5 ± 3.7) was distinct from the other two 
in the mean percentage of sperm expressing COXI in the midpiece (84.4 ± 1.7 for normals; 
79.2 ± 1.7 for the 1- or 2-defects), representing significant differences to the normal (P < 
0.001) and the 1- or 2-defects (P < 0.01) groups (Fig. 4c). On the other hand, the three groups 
were distinct from each other for COXVIc staining in the midpiece (mean % ± SEM = 75.3 ± 
4.5 for the normal group; 67.0 ± 3.1 for the 1- or 2-defects; and 45.5 ± 5.2 for the OAT group; 
normal vs. OAT, P < 0.001; 1- or 2-defects vs. OAT, P < 0.01; normal vs. 1-or 2-defects, P < 
0.05; Fig. 4c‟). Differences in the expression of both COXI and COXVIc between the OAT 
and normal groups were also confirmed by western blotting (Figs 4b, 4b‟).  
Correlation of individual sperm parameters with POLG, TFAM, COXI and 
COXVIc expression 
To understand if the expression of POLG, TFAM, COXI and COXVIc were correlated 
with sperm quality, the three principal sperm parameters (concentration, motility and 
morphology) were analysed for the samples used to determine protein expression by ICC. To 
this extent, a positive correlation was found between the mean percentage of sperm 
expressing POLG, TFAM, COXI and COXVIc, as determined by ICC, and each of the three 
principal sperm parameters (Table III). 
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Figure 4. Expression and localisation of COXI and COXVIc in human sperm. A, A’) COXI and 
COXVIc expression and localisation detected by immunocytochemistry (ICC). Human sperm 
express COXI (A - green) and COXVIc (A‟ – green) in the midpiece. Nuclear DNA is stained with 
DAPI (blue). B, B’) COXI and COXVIc expression in a normal and an OAT sample detected by 
western blotting. B) The molecular weight of human COX 1 is 57 kDa. Two ladder bands of 25 
and 75 kDa are shown. The normal sample (left band) presents a higher level of expression of 
COXI than the OAT sample (right band). B‟) The molecular weight of human COXVIc is 8.8 kDa. 
A ladder band of 15 kDa is also shown. The normal sample (right band) presents a higher level of 
expression of COXVIc than the OAT sample (left band). C, C’) Percentage sperm stained in the 
midpiece using anti-human COXI and anti-human COXVIc antibodies (ICC) in the normal, 1- or 
2-defects and OAT groups. Data are expressed as means ± SEM. C – COXI) The mean percentage 
sperm stained in the midpiece is significantly lower in the OAT group. a and b denote significant 
differences (normal vs. OAT, P < 0.001, 1- or 2-defects vs. OAT, P < 0.01). C‟ – COXVIc) The 
mean percentage sperm stained in the midpiece is significantly lower in the 1- or 2-defects and 
OAT groups. a, b and c denote significant differences (normal vs. 1- or 2-defects, P < 0.05, normal 
vs. OAT, P < 0.001, 1- or 2-defects vs. OAT, P < 0.01). 
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Table III. Values for the correlations (R) between the percentages of sperm stained with POLG, TFAM, COXI 
and COXVIc antibodies and the three principal sperm parameters.  
POLG TFAM COXI COXVIc
(n= 93) (n=47) (n=92) (n=78)
R = 0.318 R = 0.335 R = 0.322 R = 0.388
(P  < 0.01) (P  < 0.05) (P  < 0.01) (P  < 0.001)
R = 0.304 R= 0.323 R = 0.294 R = 0.343
(P  < 0.01) (P  < 0.05) (P < 0.01) (P  < 0.05)
R = 0.436 R = 0.302 R = 0.430 R = 0.403
(P  < 0.001) (P  < 0.05) (P  < 0.001) (P < 0.001)
Sperm concentration
Sperm motility
Sperm morphology
 
 
POLG and TFAM expression and mtDNA copy number  
As both POLG and TFAM are involved in mtDNA replication, and TFAM is believed 
to be a regulator of mtDNA copy number, the relationship between the expression of these 
proteins and mtDNA copy number was determined. Paradoxically, a negative correlation was 
found between the percentage of sperm expressing POLG and mtDNA content (R = -0.557, P 
= 0.01). However, and unexpectedly, no correlation was found between TFAM expression 
and mtDNA copy number (P = 0.548).  
mtDNA copy number and COXI and COXVIc expression 
As COXI is mtDNA encoded, it could be expected that cells with higher mtDNA 
content would express more COXI. However, a negative correlation was found between 
mtDNA copy number and the percentage of cells expressing COXI (R = -0.566, P = 0.01). As 
COXI and COXVIc are two subunits of the same complex, mtDNA content could influence 
COXVIc expression. However, no correlation was observed between mtDNA copy number 
and the percentage sperm expressing COXVIc (P = 0.098).  
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4. Discussion 
The long standing debate concerning the nature of the ATP generated for sperm 
function, i.e. on the relative importance of glycolysis versus OXPHOS, has been often 
confounded by possible changes during the male gamete lifetime, as well as by species-
specific differences (for recent reviews see Ford, 2006; Ruiz-Pesini et al., 2007). However, in 
humans it has been well established that sperm require mitochondrial ATP generated through 
OXPHOS (Ruiz-Pesini et al., 1998; 2000a; 2000b). It would thus be expected that good 
quality sperm express a significant amount of ETC proteins, when compared to low quality 
(OAT) samples, and indeed, the present study has shown that this is the case, both for 
mitochondrial (COXI) and nuclear-encoded proteins (COXVIc). In accordance, the 
expression of each of the two COX subunits was found to positively correlate with each of the 
three principal sperm parameters. These results imply the existence of a functional mtDNA 
complement in normal sperm, and, indeed, the analysis of samples from men with maternally 
inherited mtDNA mutations revealed decreased sperm motility (Folgero et al., 1993; 
Spiropoulos et al., 2002). Likewise, a patient with maternally inherited large-scale mtDNA 
deletions presented oligozoospermia (Lestienne et al., 1997), whereas OAT patients appear to 
have acquired a higher number of spontaneously derived large-scale deletions (St John et al., 
2001; O'Connell et al., 2003). These outcomes have been supported by the recent finding that 
a pathological maternally inherited mtDNA deletion was responsible for male infertility in a 
transmitochondrial mouse model (Nakada et al., 2006). 
Paradoxically, the expression of a mtDNA-encoded ETC protein (COXI) was 
inversely correlated with mtDNA content, while no correlation was found for a nuclear-
encoded ETC protein (COXVIc). This suggests that other factors are affecting COXVIc 
expression, that, at least in rat, seems to be regulated by nuclear respiratory factors 1 and 2 
(NRF1- Evans and Scarpulla, 1990; NRF2- Ongwijitwat et al., 2006). However, it has also 
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been shown that the expression of ETC proteins (both mitochondrial- and nuclear-encoded) 
increases as sperm quality increases, while the opposite pattern occurred with mtDNA 
content. Thus, while human sperm possess a range of mtDNA molecules, OAT samples have 
a significantly higher content compared to either the normal group or the 1- or 2-defects 
group. This is in accordance with previous work demonstrating that sperm from poorer 
quality semen samples are also indicative of higher numbers of mtDNA copy (Diez-Sanchez 
et al., 2003a; May-Panloup et al., 2003; Song and Lewis, 2008). In agreement, a negative 
correlation seems to exist between mtDNA content and sperm concentration (present study; 
Song and Lewis, 2008), motility (Diez-Sanchez et al., 2003a) and morphology (this study). 
These outcomes imply that there are errors in the regulation of mtDNA replication in men 
who will ultimately present poor quality sperm. The high mtDNA content in OAT sperm may 
therefore be an indicator of defective spermiogenesis, and may also reflect problems in energy 
metabolism in both testicular cells and mature male gametes.  
TFAM not only functions as a transcription factor but, as it activates the generation of 
the primer necessary for mtDNA replication, is thought to also regulate mtDNA copy number 
(Ekstrand et al., 2004). To this extent, a number of investigations indicate a positive 
correlation between mtDNA content and TFAM levels in various mammalian cells (Larsson 
et al., 1994; Poulton et al., 1994; Davis et al., 1996; Li et al., 2000; Seidel-Rogol and Shadel, 
2002; Joseph et al., 2004; Kanki et al., 2004). This is perhaps best exemplified during the 
final stages of murine spermatogenesis. Here, as meiosis II is completed, creating a haploid 
chromosomal complement, mtDNA content is reduced  (Hecht et al., 1984). This is 
concurrent with the expression of an isoform of TFAM lacking the mitochondrial targeting 
sequence and thus preventing its translocation to the mitochondrion (Larsson et al., 1996). In 
humans, TFAM is simply down-regulated in testicular sperm (Larsson et al., 1997), most 
likely to match the fewer copies of mtDNA present. However, the present work shows that, 
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not only is TFAM present in mature ejaculated human sperm, but, unlike events that take 
place in other cell types, more TFAM is present in high quality sperm samples, which have 
lower mtDNA content. This is also supported by the abundance of TFAM transcripts in 
mature ejaculated sperm from fertile men (Zhao et al., 2006). Likewise, overexpression of 
TFAM in cultured human cells resulted in outcomes similar to TFAM knockdown, namely in 
mtDNA depletion (Pohjoismaki et al., 2006). The results presented here would indicate a high 
transcription rate per mtDNA molecule in normal sperm, to ensure that mtDNA-encoded 
proteins (such as COXI) are produced in sufficient amounts, overcoming the low mtDNA 
content. The consistent expression of COXVIc, a nuclear-encoded ETC protein, in theses 
same samples, would suggest that this is a highly regulated process. Alternatively, sperm 
TFAM, COXI and COXVIc may have been produced during spermatogenesis, prior to the 
mtDNA copy number decrease. It should however be mentioned that there are currently no 
data to support any of these hypotheses. Another interesting possibility is that TFAM could 
also be packaging sperm mtDNA, similar to what happens in somatic cells (Alam et al., 
2003). This, in good-quality sperm, would ensure protection from oxidative stress induced 
DNA damage, which sperm mtDNA has a higher susceptibility for than the highly condensed 
chromosomal DNA (Sawyer et al., 2003; Bennetts and Aitken, 2005).  
Although TFAM has a role in the initiation of mtDNA replication by activating the 
synthesis of the primer for extension by POLG, mtDNA replication is highly dependent on 
this sole mtDNA polymerase being present. The role of POLG as a regulator of mtDNA copy 
number tends to be cell-type specific. For example, in some cultured human cells subjected to 
mtDNA depletion, the levels of POLG transcripts and protein have been shown to be similar 
to non-depleted cells, suggesting that POLG expression is constitutive, even in the complete 
absence of mtDNA (Davis et al., 1996). Accordingly, in a cell line derived from a patient 
triploid for the POLG locus (SA15q-3), the increased levels of POLG transcripts, compared to 
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control cells, were not accompanied by an increase in mtDNA levels (Schultz et al., 1998). 
On the other hand, inducible expression of a dominant negative POLG in HEK293 cells 
resulted in mtDNA depletion, whereas this was reversible following suppression of the 
mutator gene (Jazayeri et al., 2003). Furthermore, POLG heterozygous knockout mice 
developed normally, despite a small reduction in mtDNA levels, while homozygous knockout 
embryos died between embryonic days 7.5 and 8.5 through severe mtDNA depletion (Hance 
et al., 2005). Interestingly, overexpression of TFAM in POLG heterozygous knockout mice 
resulted in elevated mtDNA levels and increasing amounts of POLG transcripts, suggesting 
that POLG expression can be induced when up-regulation of mtDNA replication is required 
(Hance et al., 2005). To this extent, the results of the present study show a negative 
correlation between mtDNA copy number and the percentage of sperm expressing POLG, 
even in the presence of TFAM. Consequently, these outcomes could be explained by the 
increased expression of POLG attempting to compensate for the low mtDNA content, as 
occurs in mtDNA depleted cells (Lloyd et al., 2006). A similar mechanism takes place in 
early pre-implantation development of in vitro fertilised incompetent oocytes, where up-
regulation of POLG and TFAM transcripts and proteins occurs in an attempt to rescue the low 
mtDNA levels (Spikings et al., 2007). This rescue mechanism does not seem to be effective in 
mature sperm, possibly due to the intervention of other, as yet unidentified, regulatory factors. 
On the other hand, and as speculated for TFAM, COXI and COXVIc, sperm POLG may have 
been produced during spermatogenesis, at a stage prior to the reduction of mtDNA content. 
Smaller mtDNA molecules seem to have a replicative advantage (Moraes, 2001) and 
this could be the case in spermatogenesis giving rise to OAT sperm, as OAT samples often 
present multiple large-scale mtDNA deletions (St John et al., 2001). Consistent with this, 
there is a strong negative correlation between human sperm mtDNA copy number and 
mtDNA integrity (Song and Lewis, 2008). On the other hand, the high amount of mtDNA in 
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OAT sperm could be due to either: a) failure to reduce copy number; or b) continued 
replication. Either option would result in the down-regulation of POLG expression. 
Alternatively, POLG would simply not be up-regulated due to an excessive initial amount of 
mtDNA, explaining why POLG expression is lower in the OAT group. In any case, the low 
levels of TFAM, COXI and COXVIc in OAT samples suggest that spermatogenesis is 
severely impaired at the mitochondrial level. 
In conclusion, it is evident that high quality sperm have very low levels of mtDNA 
compared to other fully differentiated somatic cells (Miller et al., 2003). The possible 
biological significance of this finding could be to facilitate the elimination of paternal mtDNA 
following fertilisation and thus ensure maternal inheritance of this genome (Larsson et al., 
1997). This work also suggests that POLG, possibly in conjunction with other factors, may 
play a role in regulating mtDNA copy in human sperm: unlike TFAM, the presence of POLG 
seems to (negatively) predict mtDNA copy number. However, the mechanisms for this 
possible regulation remain undetermined. Furthermore, it became clear that the expression of 
mtDNA maintenance factors and of components of the ETC (either mtDNA- or nuclear DNA-
encoded) is associated with sperm quality, which indirectly illustrates the importance of both 
mitochondria and its genome in human sperm function. 
 
  
 
 
  
 
 
 
 
 
 
 
CHAPTER III  
THE RELEVANCE OF POLG CAG REPEATS 
POLIMORPHISM IN HUMAN SPERM QUALITY 
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Abstract  
The gene for the catalytic subunit of human DNA polymerase gamma (POLG), the 
sole DNA polymerase present in mitochondria, possesses a CAG-repeat region of variable 
length, which encodes a polyglutamine tract. The potential effect of the absence of the 
common 10 CAG-repeat allele in sperm quality, and male infertility, has been the subject of a 
recent debate, with different studies presenting conflicting results. On the other hand, the 
functional significance of this polymorphism in human sperm has not been defined. In the 
present study, whether POLG CAG-repeat polymorphisms are associated with sperm quality, 
and also whether these can affect sperm mtDNA maintenance, have been investigated. 
Sperm samples were categorised as: normozoospermics; samples with one or two 
abnormal sperm parameters; and oligoasthenoteratozoospermics (OATs). These samples were 
analysed by fluorescent PCR to determine the POLG CAG-repeat genotype; real-time PCR 
for mtDNA copy number; and immunocytochemistry for POLG expression.  
The OAT group presented a significantly higher incidence of heterozygosity for the 
POLG CAG-repeat genotype. However, this polymorphism did not seem to affect each of the 
three sperm principal parameters, nor mtDNA copy number or POLG expression. 
These results support, to some extent, the original findings that an association between 
sperm quality and POLG CAG repeats does exist. However, the biological significance of 
these variants in male infertility remains unclear, as these do not seem to affect mtDNA 
maintenance.  
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1.  Introduction 
In recent years, a number of studies have considered the possible association between 
certain genetic polymorphisms (gene sequence variants) and male infertility (for a recent 
review see Tuttelmann et al., 2007). These include genes on the Y chromosome, as well as 
genes involved in endocrine regulation of spermatogenesis, just to give some examples. The 
role of a particular polymorphism in human sperm quality is often difficult to establish seeing 
that different outcomes are frequently obtained in independent studies. This is especially so 
because, in contrast with certain gene mutations that are definitely associated with 
spermatogenesis impairments, polymorphisms are only considered predisposing factors to 
infertility (Krausz and Giachini, 2007). This implies that their effect on sperm (dys)function 
most probably depends on other genetic and/or environmental factors. Despite this, 
understanding the role of gene polymorphisms in sperm quality is particularly important, 
since it is anticipated that most of the idiopathic infertility cases (i.e., infertility with unknown 
causes) have a genetic origin. 
Human sperm motility seem to depend on OXPHOS-derived ATP and hence, on 
mitochondria and mtDNA integrity. Indeed, mtDNA haplogroups, mutations and deletions 
have been associated with male infertility (see Chapter I). The integrity of the mitochondrial 
genome depends, among other factors, on the activity of DNA polymerase gamma (POLG, 
the sole DNA polymerase present in mitochondria). The catalytic subunit of POLG is 
expressed in the midpiece of ejaculated human sperm (where mitochondria are localised) and 
its expression seems to be indicative of sperm quality (see Chapter II, Amaral et al., 2007).  
Unlike other species, human POLG comprises a CAG-repeat region at its 5‟ end (see 
Fig. 7 in Chapter I) that gives rise to a polyglutamine tract (Ropp and Copeland, 1996). This 
region, usually 10 codons long (constituting the „common allele‟), is variable in length, with 
reports of alleles containing between 5 and 15 repeats (Rovio et al., 1999; 2001; 2004). The 
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frequency of the 10 CAG-repeat allele varies slightly in the populations analysed so far, but is 
always higher than 80% (Rovio et al., 2004; Malyarchuk et al., 2005). The second most 
common allele contains 11 CAG repeats and, in most cases, is present in combination with 
the 10 CAG-repeat allele, i.e. in heterozygosity. Heterozygosity is also the rule for the other 
≠10 alleles. The absence of the common allele, either in heterozygosity (10/≠10) or in 
homozygosity (≠10/≠10) is then sporadic, suggesting that it may have a deleterious effect in 
POLG function. However, it does not seem to play a role in mitochondrial diseases with 
multiple mtDNA deletions or depletion (Rovio et al., 1999). On the other hand, the POLG 
CAG-repeat polymorphism is probably a risk factor for testicular cancer (Nowak et al., 2005; 
Jensen et al., 2008).  
The effect of POLG CAG-repeat polymorphisms in sperm quality and function is 
unclear, as a series of contradictory results have been documented. In a wide-ranging study, a 
significant increase in the homozygous mutant genotype (≠10/≠10), as well as in the 
heterozygous genotype (10/≠10), has been described in infertile men when compared with a 
fertile cohort (Rovio et al., 2001). Furthermore, a correlation between the lack of the common 
allele and idiopathic infertility (undefined fertility disorders, but presenting normal semen 
parameters) was identified in a Danish population (Jensen et al., 2004). However, analysis of 
an Italian (Krausz et al., 2004) and a French (Aknin-Seifer et al., 2005) cohort determined the 
frequency of the homozygous mutant genotype to be similar in both infertile and 
normozoospermic fertile men. Likewise, no significant differences in the frequency of each 
genotype were found in Italian men with low sperm counts (oligozoospermia) when compared 
to normozoospermics (Brusco et al., 2006). In a more recent study, the combined frequency 
of heterozygous and homozygous mutant POLG genotypes was actually higher in 
normozoospermic than non-normozoospermic men, contrary to what had been anticipated 
(Harris et al., 2006). These authors hypothesised that the results obtained by Rovio et al. and 
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Jensen et al. could be caused by the presence of mutations somewhere else in the POLG gene. 
To test this possibility, they analysed the three exonuclease motifs of POLG, but no mutations 
were found in all the samples tested. The most recent study (Westerveld et al., 2008) analysed 
a large cohort of individuals with different ethnicities and concluded that the absence of the 
common allele is not associated with a clinically significant decrease in sperm quality.  
However, and despite the variability in the distinct studies, the functional significance 
of any of these genetic correlations has not been defined in sperm. In the present study, 
whether POLG CAG-repeat polymorphisms are associated with sperm quality in a series of 
patients classified according to the WHO (1999) criteria was investigated. Importantly, a 
group of oligoasthenoteratozoospermic (OAT) patients, that present all three principal sperm 
parameters below the defined cut-offs, were included. This group has not been included in the 
studies performed so far, or at least has never been analysed in isolation. Moreover, it has also 
been assessed whether polyglutamine-repeat length can affect sperm mtDNA copy number, as 
well as POLG expression (and, as a consequence, the expression of TFAM, COXI and 
COXVIc – see Chapter II).  
2. Materials and methods 
Chemicals 
All chemicals were supplied by Sigma Chemical Company (St. Louis, MO, USA), 
unless stated otherwise.  
Biological Material 
Patients were recruited from the Fertility Clinic and fresh semen samples (n=135) 
were processed and categorized as described previously (Chapter II, Materials and methods 
section).  
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Extraction of total DNA 
DNA from isolated sperm samples was extracted according to the whole blood DNA 
isolation protocol using the Puregene DNA Isolation Kit (Flowgen, Nottingham, UK) with 
minor modifications, as formerly described (Chapter II, Materials and methods section). 
Molecular analysis of POLG CAG repeats 
Fluorescent PCR amplification of 287 bp of the POLG gene (accession number 
X98093) was performed in 50 μl reactions using primers (forward: ggt ccc tgc acc aac cat ga; 
reverse: ctt gcc cga aga ttt gct cgt) and conditions as described previously (Jensen et al., 
2004). The forward primer was labelled with a fluorescent tag. Each reaction contained 5 ng 
of total DNA, 1 x PCR Buffer (BioLine, London, UK), 1.5 mM MgCl2 (BioLine), 200 μM 
dNTPs (BioLine), 125 nM of each primer and 2.5 U BioTaq DNA Polymerase (BioLine). 
Negative controls, with H2O instead of DNA, were performed in each run. Reaction 
conditions were as follows: initial denaturation at 98ºC for 5 min, 40 cycles of 98ºC for 30 
sec, 63ºC for 1 min and 72ºC for 1 min 45 sec and final extension at 72ºC for 5 min. The size 
of the DNA fragments obtained was determined using a Capillary Electrophoretic Genetic 
Analysis System (CEQ
TM
 8000, Beckman Coulter Inc, Fullerton, CA, USA). Mixtures 
containing 0.2 μl PCR products, 30 μl CEQ sample loading solution (Beckman Coulter Inc) 
and 0.8 μl CEQ 400-bp DNA size standards (Beckman Coulter Inc) were analysed.  
For conventional PCR, non-labelled primers were used. Reaction mixtures were 
similar to the ones used for fluorescent PCR, except for the amount of DNA (200 ng) and the 
concentration of primers (0.5 μM each). PCR products were resolved on 3% agarose gels and 
product size confirmed against a 100 bp DNA ladder (Bioron, Ludwigshafen, Germany). The 
PCR products were excised from the agarose gels and purified using the QIAquick Gel 
Extraction Kit (Qiagen, London, UK) as described in the manufacturer's protocol. The 
purified DNA was then sequenced using the automated direct sequencing protocol (Hopgood 
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et al., 1992) using an ABI PRISM BigDye terminator v 3.1 cycle sequencing kit (Applied 
Biosystems, Foster City, CA, USA).  
Determination of mtDNA content  
mtDNA content was determined by the ratio of copies of mtDNA to Beta-Globin, as 
described before (Chapter II, Materials and methods section). 
POLG, TFAM, COXI and COXVIc expression 
The expression of these proteins was detected by immunocytochemistry (ICC), as 
previously explained (Chapter II, Materials and methods section). 
Statistical analysis 
Statistical analysis was carried out using SPSS for Windows (version 13, Chicago, IL, 
USA). Pearson Chi-square test was used to compare POLG CAG variants (allele and 
genotype frequencies) in the different groups defined. All numerical variables were checked 
for normal distribution using the one-sample Kolmogorov-Smirnov test. For sperm 
parameters, ICC and mtDNA copy number analysis, the two different-genotype groups were 
compared using Independent-samples t-test (or the non parametric Mann-Whitney U test 
when distributions were not normal). P < 0.05 was considered significant. 
3. Results 
POLG CAG repeats polymorphisms  
The CAG-repeat region of the POLG gene have been analysed in groups of patients 
attending an infertility clinic, according to the WHO criteria (1999). These patients were 
categorised as normal (sperm with normal parameters); patients possessing 1- or 2-defects 
(sperm with one or two abnormal parameters); and oligoasthenoteratozoospermic patients 
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(OAT; samples with three abnormal parameters). Samples were examined by fluorescent PCR 
followed by fragment analysis. These outcomes were verified by conventional PCR and 
DNA-sequencing (Fig. 1). CAG repeats ranging from 9 to 13 codons were identified. After 
the „common‟ 10 repeat allele, the most frequent allele consisted of 11 codons (Table I). The 
frequency of the 11 CAG repeats allele was significantly higher (P < 0.05; Table I) in the 
OAT group (21.4%) compared with both the normal group (12.5%) and the 1- or 2-defects 
group (8.2%). Likewise, the combined frequency of ≠10 alleles (i.e., 9, 11, 12 and 13) was 
also higher (P < 0.05; Table I) in the OAT group (23.2%) compared with the others (16.2% 
and 9.7% in the normal and in the 1- or 2-defects groups, respectively). 
Table I. Allelic frequency of the POLG CAG repeats for the normal, 1- or 2-defects and 
oligoasthenoteratozoospermic (OAT) groups. 
Allele Normal group
1- or 2-Defects 
group
OAT group Total
(no. of repeats) (n=80 alleles) (n=134 alleles) (n=56 alleles) (n=270 alleles)
9 0.012 0.000 0.000 0.003
10 0.838 0.903 0.768* 0.856
11 0.125 0.082 0.214* 0.122
12 0.025 0.015 0.000 0.015
13 0.000 0.000 0.018 0.004
≠10 0.162 0.097 0.232* 0.144  
The allelic frequencies of the POLG CAG repeats for all the samples are also indicated (Total). ≠10 
denotes the addition of the alleles 9, 11, 12 and 13. * P < 0.05. 
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Figure 1. Analysis of the CAG-repeat region of the POLG gene in human sperm samples. A) 
Agarose gel of PCR products of a 287 bp region of POLG containing the CAG-repeat tract. 
Legend: L- DNA ladder; S1, S2, S3 – Samples 1 (heterozygous 10/11), 2 (homozygous 10/10) and 
3 (heterozygous 10/13), respectively; Ct+ - Positive control (blood sample); Ct- - Negative control 
(without DNA). B, B’) Fragment analysis of two samples: B (homozygous 10/10), B‟ 
(heterozygous 10/11). C, C’) DNA sequencing of two samples: C (homozygous 10/10), C‟ 
(heterozygous 10/11). 
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Combining the two alleles for each man allowed patients to be categorized into one of 
the three possible genotypes: homozygous wild-type (10/10), heterozygous (10/≠10) and 
homozygous mutant (≠10/≠10). Of 135 men, 96 (71.1%) were homozygous wild-type and 39 
(28.9 %) were heterozygous. A different distribution of the genotypes was observed in the 
three groups analysed (Fig. 2), with heterozygosity being higher in the OAT group (46.4%) 
than in the normal and in the 1- or 2-defects groups (32.5% and 19.4 %, respectively; P < 
0.05). 
However, by comparing each of the three principal sperm parameters (concentration, 
motility and morphology) individually, no differences were found between the genotypes (P = 
0.298 for concentration and P = 0.417 for motility and morphology; Table II). 
 
Figure 2. POLG CAG-repeat genotype distribution in the normal, 1- or 2-defects and OAT 
groups. The values represent the percentage of homozygous wild-type and heterozygous 
individuals found in each of the three groups. The distribution of the genotypes is different in the 
OAT group (P < 0.05). 
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Table II. Sperm principal parameters for the homozygous wild-type (10/10) and the heterozygous (10/≠10) 
groups. Values indicate means ± SEM. P > 0.05 for the three parameters. 
Homozygous              
wild-type group 
Heterozygous group
(n=96) (n=39)
Concentration (millions sperm/ml) 54.9 ± 6.4 58.4 ± 13.9
Motility (% progressive motile sperm) 45.0 ± 2.1 41.7 ± 3.9
Morphology (% normal sperm) 13.7 ± 0.6 12.7 ± 1.2
Sperm  parameter
 
 
MtDNA copy number and POLG CAG-repeat genotype 
To determine whether the POLG CAG-repeat genotype influences sperm mtDNA 
content, the mtDNA copy number of 38 samples (22 homozygous wild-type and 16 
heterozygous for POLG CAG-repeat variants) were compared. The mean mtDNA copy 
number was higher in the heterozygous men compared to the homozygous wild-type group 
(Table III). However, this difference was not statistically significant (P = 0.261). 
Table III. Sperm mtDNA copy number and expression of POLG, TFAM, COXI and COXVIc for the 
homozygous wild-type (10/10) and the heterozygous (10/≠10) groups. Values indicate means ± SEM. For 
mtDNA copy number ranges are also indicated. P > 0.05 for each parameter. 
Parameter
Homozygous                                 
wild-type group
Heterozygous group
16.8 ± 6.0 27.0 ± 12.6
(0.2 – 100.1) (0.7 - 206.1)
% Sperm expressing POLG 72.2 ± 2.4 72.7 ± 3.2
% Sperm expressing TFAM 64.9 ± 4.1 73.7 ± 3.7
% Sperm expressing COXI 79.6 ± 2.1 79.4 ± 2.8
% Sperm expressing COXVIc 71.1 ± 2.7 63.0 ± 7.6
mtDNA copy number
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The effect of POLG CAG repeats in POLG, TFAM, COXI and COXVIc proteins 
expression  
In order to determine whether specific POLG CAG-repeat genotypes would affect the 
expression of POLG, TFAM, COXI and COXVIc, the ICC outcomes between the distinct 
POLG CAG repeats genotypes (homozygous wild-type: n= 40 for POLG, n= 25 for TFAM, 
n= 41 for COXI, and n=33 for COXVIc; heterozygous: n=17 for POLG, n=8 for TFAM, n=18 
for COXI, and n=12 for COXVIc) have been compared. Similar to the results obtained for 
sperm parameters and mtDNA copy number, the two genotypes showed no significant 
differences in the mean percentage sperm expressing each of the proteins (P values range 
from 0.226-0.956; Table III). 
4. Discussion 
The gene for the catalytic subunit of POLG possesses a series of CAG repeats which 
can vary in number (Rovio et al., 1999), thus encoding a mtDNA polymerase with distinct 
numbers of glutamines. The occurrence of proteins with CAG repeats-encoded polyglutamine 
tracts is widespread, and these are recurrently of variable length. While the functions of CAG 
repeats are often unclear, the association between the expansion of CAG repeats in different 
genes and certain neurodegenerative disorders is well documented (for reviews see Ross et 
al., 1999; Zoghbi and Orr, 2000; Orr, 2001; Shao and Diamond, 2007). These are usually 
called polyglutamine diseases, and typically involve neuronal cell death. The classical 
example is Huntington disease, where expansion of a polyglutamine tract in the protein 
huntingtin is at the origin of neuronal dysfunction, leading to progressive neurological 
symptoms, and ultimately to death.  
On the other hand, the role of certain CAG-repeat variants in male infertility is not 
completely understood as different studies reporting on the same gene have often presented 
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discordant outcomes. This is certainly the case for the length variation of the CAG-repeat 
region of the androgen-receptor (AR) gene, that has been positively (Tut et al., 1997; Komori 
et al., 1999; Mifsud et al., 2001; Mengual et al., 2003) and negatively (Giwercman et al., 
1998; Dadze et al., 2000; Ferlin et al., 2004; Lavery et al., 2005) associated with infertility. 
The results seem to depend on the geographic origin of the populations studied, suggesting 
that the genetic background may possibly play a role in the expression of the AR defects 
(Yong et al., 2003). 
Such disparity is also certainly typical for the POLG CAG-repeat region. To this 
extent, two studies have demonstrated an association between the absence of the common 
allele and male infertility, either typified by a range of sperm quality defects (Rovio et al., 
2001), or by idiopathic infertility (Jensen et al., 2004). However, this association was not 
identified in populations of Italian (Krausz et al., 2004; Brusco et al., 2006) and French 
(Aknin-Seifer et al., 2005) infertile men. Likewise, a recent study in a large cohort of men of 
distinct ethnicities suggested that POLG variants have no influence on sperm quality 
(Westerveld et al., 2008). The results of the present study do not show an association between 
each of the three principal sperm parameters, when assessed independently, and POLG 
genotypes, which is in agreement with Krausz et al. (2004), Aknin-Seifer et al. (2005), 
Brusco et al. (2006) and Westerveld et al. (2008). However, a higher frequency of the 
heterozygous genotype in OAT samples, when compared to the normal and 1- or 2- defects 
groups, was found in this study, which is similar to the original outcomes of Rovio et al. 
(2001).  
Importantly, the functional meaning of the length variation of the POLG CAG-repeat 
region in sperm has not yet been elucidated. As POLG alleles are segregated during 
spermatogenesis, samples from heterozygous individuals will present sperm with 10 CAG 
repeats and sperm with ≠ 10 CAG repeats. If the absence of the common allele were to affect 
Chapter III 
83 
the enzymatic properties of POLG, it is anticipated that an accumulation of mtDNA mutations 
and/or an alteration in mtDNA copy number would occur in heterozygous and homozygous 
mutant men, due to the presence of sperm with ≠ 10 repeats. However, and while in the 
present study all samples with a mutant allele were heterozygous, no relation between 
mtDNA copy number and POLG CAG-repeat variants was found. Furthermore, it is also 
apparent that the incidence of mtDNA nucleotide substitutions is similar for each of the 
POLG genotypes (Harris et al., 2006). 
Therefore, and at least in human sperm, it seems that the length of the POLG 
polyglutamine tract does not affect the main enzymatic activities of the polymerase, namely 
the replication and repair of the mitochondrial genome. In accordance, mutant POLG alleles 
seem not to be involved in phenotypic defects in other tissues. For instance, the allelic 
frequencies of the POLG trinucleotide repeat have been shown to be similar in patients with 
mitochondrial diseases when compared to healthy controls (Rovio et al., 1999). Similar 
outcomes were described for patients with Parkinson disease (Taanman and Schapira, 2005), 
while this has been contradicted by others (Luoma et al., 2007). 
Perhaps most striking of all is that the deletion of the POLG CAG-repeat region in 
cultured human cells resulted in the continued unaffected enzymatic properties of POLG, 
although the expression of the protein was moderately up-regulated (Spelbrink et al., 2000). 
Thus, one could hypothesise that the expression of POLG would be affected in sperm 
possessing a mutant POLG CAG-repeat allele. However, this study has shown that the 
percentage of sperm expressing POLG was not significantly different in samples from 
different POLG genotypes. This is equally so for TFAM and for two COX subunits: COXI 
(mtDNA encoded) and COXVIc (nuclear DNA encoded), which also validates that the less 
frequent POLG CAG-repeat variants do not impair the expression of sperm mitochondrial 
proteins. 
Alexandra Amaral 
84 
Consequently, these cumulative outcomes suggest that there is currently no direct 
functional association between POLG CAG-repeat variants and male infertility, with a 
possible exception in men with very poor sperm quality (OATs). This suggests that the 
absence of the POLG common allele in sperm may affect, in certain circumstances (not yet 
identified, but probably operating only in very poor sperm samples) POLG function. As 
polyglutamine tracts are generally considered as interfaces for protein-protein interactions, 
Rovio and colleagues (2001) have proposed that a sperm-specific protein could interact with 
the polyglutamine region of POLG and that this interaction would be affected when the tract 
length is altered. This interaction could be deleterious in OAT samples, if such a protein 
would also be mildly impaired in these samples. 
In fact, gene polymorphisms cannot explain fertility impairments per se, since they are 
also present in normozoospermic fertile men, although at a lower frequency. Thus, they 
should be viewed as predisposing factors, that would only have clinical significance in the 
presence of specific environmental factors or in association with certain genetic background, 
infections, altered hormonal status, etc (Tuttelmann et al., 2007). These factors might 
contribute to the different outcomes described in the literature for the effects of distinct gene 
polymorphisms in male infertility, of which POLG is only one example. Recently, it has been 
revealed that the frequency of the three POLG CAG-repeat genotypes is dependent on ethnic 
background (Westerveld et al., 2008). Furthermore, these authors have also shown that POLG 
genotypes can have distinct effects on sperm concentration and motility in cohorts of men of 
different ethnic and geographic origin. 
In conclusion, while the biological significance of POLG CAG-repeat variants in male 
infertility remains unclear, the heterozygous genotype seems to be associated with very poor 
quality sperm. In fact, this study, to an extent, supports the original findings that an 
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association between sperm quality and POLG CAG repeats does exist. However, these 
variants do not directly affect POLG expression, nor mtDNA maintenance. 
 
  
 
 
  
 
 
 
 
 
 
 
CHAPTER IV  
THE ASSESSEMENT OF MITOCHONDRIAL MEMBRANE 
POTENTIAL AND THE EXPRESSION OF 
MITOCHONDRIAL PROTEINS IN SUBPOPULATIONS OF 
HUMAN SPERM 
 
 
 
The results presented in this Chapter are in preparation for submission. 
 
Part of the methodology described in this Chapter has also been published in: 
Ramalho-Santos, J., Amaral, A., Sousa, A. P., Rodrigues, A. S., Martins, L., Baptista, M., Mota, P. C., Tavares, 
R., Amaral, S. and Gamboa, S. (2007) Probing the structure and function of mammalian sperm using optical and 
fluorescence microscopy. In: Méndez-Vilas, A. and Díaz, J. (Eds) Modern Research and Educational Topics in 
Microscopy, 1: 394 - 402. 
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Abstract 
The production of ATP through oxidative phosphorylation depends upon the existence 
of a mitochondrial membrane potential (MMP), which relies on the correct function of the 
mitochondrial electron transfer chain, and hence, on its proteins. Mounting evidences have 
shown that MMP, assessed using specific mitochondrial probes, is correlated with human 
sperm motility and fertilisation ability. However, the capacity of distinct probes to 
dynamically evaluate sperm MMP has not been determined. In the present study, sperm 
samples were independently incubated with MitoTracker Green (MT-G), MitoTracker Red 
(MT-R) and JC-1 and the results were analysed and compared by fluorescence microscopy. 
The ability of each probe to monitor MMP was determined by incubating sperm with MMP 
disruptors, either before or after the incubation with the probes. Moreover, subpopulations of 
sperm with distinct MMP were isolated using MT-G and a cell-sorter. These subpopulations 
were analysed for the expression of two mitochondrial proteins: DNA polymerase gamma 
(POLG) and cytochrome c oxidase I (COXI). A similar analysis was also performed in 
subpopulations of sperm isolated by the classical swim-up procedure. 
The three mitochondrial probes provided similar results, and were able to monitor 
changes in MMP when sperm were previously incubated with MMP-disruptor drugs. 
However, only JC-1 could, to a small extent, mirror MMP alterations when the drugs were 
added after the incubation with the probes. The expression of both POLG and COXI was 
significantly higher in subpopulations of MT-G positive sperm, when compared to 
subpopulations of MT-G negative sperm. Similar outcomes were obtained for the comparison 
between the swim-up migrated and non-migrated fractions of sperm. 
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1. Introduction 
Cellular mitochondrial membrane potential (MMP) and its changes are commonly 
monitored using permeant cationic fluorescent probes, such as carbocyanine, rhodamine and 
rosamine derivatives, which accumulate in either isolated or cellular mitochondria depending 
on MMP. Different methods can be used to evaluate fluorescence intensities after staining 
cells with these probes, including fluorescence microscopy, spectrofluorometry and flow 
cytometry  (reviewed in Solaini et al., 2007).  
The importance of MMP to mammalian sperm motility, and hence, function, has been 
recognized for a long time. Initial studies relied on the use of flow cytometry to measure 
fluorescence intensities of sperm samples stained with both the classical rhodamine 123 dye 
(Rh123, to assess sperm MMP) and either ethidium or propidium iodide (to determine sperm 
viability). Using this approach, it has been determined that both human sperm motility and 
viability are correlated with MMP (Evenson et al., 1982; Auger et al., 1989). Similar 
outcomes were obtained in cryopreserved bovine sperm using not only Rh123, but also 
5,5‟,6,6‟-tetrachloro-1,1‟,3,3‟-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) and 
MitoTracker Green, a carbocyanine-based probe from Molecular Probes (Garner et al., 1997).  
Similarly to Rh123, other probes such as MitoTrackers and 3,3‟-
dihexyloxacarbocyanine iodide [DiOC6(3)] accumulate in mitochondria according to MMP, 
fluorescing either green or red, depending on the probe. On the other hand, JC-1 is known by 
its unique property of discriminating between high and low MMP. This molecule exists in 
two distinct forms: monomeric, fluorescing green, and the so-called J-aggregate, emitting red-
orange fluorescence. In the presence of a high MMP, J-aggregates are formed, and 
fluorescence changes reversibly from green to red-orange. Thus, mitochondria with high 
MMP fluoresce orange, while mitochondria with low MMP fluoresce green (Smiley et al., 
1991).  
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JC-1 has been extensively used to study sperm function, not only in men (Troiano et 
al., 1998; Donnelly et al., 2000; Kasai et al., 2002; Marchetti et al., 2004), but also in other 
mammalian species including equines (Gravance et al., 2000; Love et al., 2003), rats 
(Gravance et al., 2001), boars (Huo et al., 2002; Spinaci et al., 2005) and rams (Martinez-
Pastor et al., 2004). These reports confirmed the original findings that mammalian sperm 
motility is related with mitochondrial functional status. Moreover, and at least for human 
sperm, it has also been shown that sperm fertilisation potential correlates with MMP assessed 
using either JC-1 (Kasai et al., 2002; Marchetti et al., 2004) or DiOC6(3) (Marchetti et al., 
2002; 2004). Studies using DiOC6(3), which has recently become popular, have also shown a 
negative correlation between sperm MMP and both DNA fragmentation and the generation of 
ROS (Marchetti et al., 2002; Wang et al., 2003). Taken together, these cumulative outcomes 
strongly suggest that MMP is an indicator of the sperm functional status, and may have an 
important clinical value. 
The efficacy of the various mitochondrial probes to monitor MMP is usually 
established by using specific drugs that: a) inhibit the ETC (such as antimycin, rotenone and 
cyanide); b) eliminate the mandatory link between the respiratory chain and the 
phosphorylation system (OXPHOS uncouplers); c) make the inner mitochondrial membrane 
permeable to specific ions (ionophores, such as valinomycin and nigericin), which also 
uncouple electron transfer from phosphorylation. In either case, MMP is disrupted and the 
mitochondrial production of ATP is diminished. This kind of experiments should be 
performed in every study using mitochondrial probes, as differences may exist between 
probes batches, equipments, concentrations and incubation times, and, most likely, cell types. 
For example, when studying sperm, it is important to consider that sperm mitochondria are 
distinct from the somatic cell counterparts, as they are enclosed in the so-called mitochondrial 
capsule (see Chapter I).  
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In most of the studies performed so far, the ability of distinct mitochondrial probes to 
monitor human sperm MMP has been shown in control experiments using uncouplers, either 
before or during the incubation of sperm with the probe. To this extent, JC-1, DiOC6(3), 
Chloromethyl-X-rosamine (MitoTracker Red CMX-Ros) and tetramethylrhodamine ethyl 
ester (TMRE), coupled to flow cytometry, have been shown to accurately monitor human 
sperm MMP (Marchetti et al., 2004). Importantly, the results obtained were similar for the 
four probes, suggesting that a variety of probes can be used to study human sperm MMP. 
However, none of the studies have asked the question of whether any of these probes 
are dynamic, i.e., if once inside mitochondria, the probes are able to mirror MMP alterations. 
In the first part of the present study, fluorescence microscopy was used to study and compare 
the ability of two carbocyanines (JC-1 and MitoTracker Green) and of a rosamine 
(chloromethyl-dihydro-X-rosamine; MitoTracker Red CM-H2XRos) to react to human sperm 
MMP alterations, occurring either before or after the incubation of the cells with the probes. 
Three distinct drugs were used: potassium cyanide (KCN; which blocks cytochrome c 
oxidase, the complex IV of the ETC); p-trifluoromethoxy carbonyl cyanide phenylhydrazone 
(FCCP; a weak acid that carries protons across the inner mitochondrial membrane, thus 
abolishing the proton gradient and hence, the electrochemical potential); and valinomycin (a 
potassium ionophore that dissipates the electrical potential).  
The maintenance of sperm MMP requires an accurate function of the ETC which, in 
turn, depends on the proper assembly and communication between distinct nuclear and 
mitochondrial proteins (see Chapter I). These comprise all the subunits that constitute the 
ETC complexes (which are encoded by both chromosomal and mitochondrial genes), as well 
as the factors that control the expression of these subunits. It has been previously shown that 
the expressions of two mitochondrial specific proteins, DNA polymerase gamma (POLG), 
and cytochrome c oxidase I (COXI) are correlated with sperm quality (see Chapter II, Amaral 
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et al., 2007). Specifically, it was shown that human samples present a number of sperm 
expressing these proteins in the midpiece, and that this number is higher for better quality 
samples. On the other hand, it is well established that human sperm samples are very 
heterogeneous, presenting subpopulations with distinct biochemical and physiological 
characteristics. For this reason, only a small subpopulation of sperm in a sample is able to 
fertilise an oocyte (Holt and Van Look, 2004). Thus, one of the major challenges in modern 
andrology is to better characterise, distinguish and isolate this particular subpopulation. 
Would “better quality” subpopulations have improved mitochondrial parameters? 
The classical swim-up procedure (Lopata et al., 1976) is routinely used to obtain a 
population of highly motile sperm for many ARTs. This very efficient technique is based on 
the movement of sperm from a pre-washed pellet in to an overlaying medium, and is 
characterized by the recovery of > 90% motile sperm (reviewed in Henkel and Schill, 2003). 
In the present study, this procedure was used to isolate and compare subpopulations of motile 
and immotile sperm, in terms of the expression of both POLG and COXI. Similarly, and to 
determine if the expressions of both POLG and COXI are correlated with sperm MMP, 
subpopulations of sperm with polarised and non-polarised mitochondria were also isolated 
and compared. For this purpose, the mitochondrial probe MitoTracker Green and a cell-sorter 
were used to separate stained and unstained sperm from each sample. Similar approaches 
have been used by others to isolate sperm with better fertilisation potential, based on 
mitochondrial function (Auger et al., 1993; Gallon et al., 2006). 
Hence, the aims of the present work were dual: to compare distinct mitochondrial 
probes and clarify their ability to truly monitor MMP in human sperm; to understand if POLG 
and COXI expressions are related with both sperm MMP and sperm motility in 
subpopulations of human sperm. 
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2. Material and Methods 
Chemicals 
All chemicals were supplied by Sigma Chemical Company (St. Louis, MO, USA), 
unless stated otherwise.  
Biological Material 
Patients were recruited from the Fertility Clinic and fresh semen samples were 
processed and categorized as described previously (Chapter II, Material and Methods 
section).  
Determination of sperm mitochondrial and membrane integrity status 
1) MitoTracker Green (MT-G), MitoTracker Red (MT-R) and JC-1 labelling 
MitoTracker® Green FM (M-7514), MitoTracker® Red CM-H2XRos (M-7513) and 
5,5‟,6,6‟-tetrachloro-1,1‟,3,3‟-tetraethylbenzimidazolylcarbocyanine iodide (JC-1; T-3168) 
were purchased from Molecular Probes (Eugene, Oregon, USA). Primary stock solutions of 1 
mM (both MitoTrackers) and 3.8 mM (JC-1) were prepared in DMSO, stored at -20ºC and 
protected from light. Secondary stock solutions were prepared in phosphate-buffered saline 
(PBS; pH 7.2), immediately prior using. For labelling, live sperm suspensions (10 millions of 
sperm/ml PBS) were separately incubated with a) 20 nM MitoTracker Green; b) 150 nM 
MitoTracker Red; c) 2 μM JC-1, for 10 min at 37 ºC, in the dark.  
2) LIVE/DEAD Sperm Viability Kit 
The LIVE/DEAD® Sperm Viability Kit (L-7011, Molecular Probes) consists of two 
DNA-binding fluorescent dyes: SYBR® 14 (which is membrane-permeant and thus stains all 
sperm nuclei, fluorescing bright green) and propidium iodide (PI; that only penetrates sperm 
nuclei with compromised membrane integrity, fluorescing red, which overwhelms the green 
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fluorescence exhibited by SYBR-14). Primary stock solutions of 1 mM SYBR and 2.4 mM PI 
were prepared in DMSO (SYBR) and water (PI), and stored at -20º C, protected from light. 
Secondary stock solutions were prepared in PBS, immediately before using and sperm 
samples (already incubated with MT-G, MT-R or JC-1, as described) were simultaneously 
incubated with SYBR (100 nM) and PI (240 nM), for an additional 10 min, at 37 ºC, in the 
dark.  
3) Sperm categorization and counting 
After the 20 min total incubation, sperm suspensions were mounted on a microscope 
slide and observed using a Zeiss Axiophot II microscope (Carl Zeiss, Göttingen, Germany) 
equipped with a triple band pass filter. Sperm were categorized according to patterns of 
staining for both the mitochondria and the nucleus. For each slide, at least 200 sperm in at 
least four different fields were observed and categorized.  
Incubation with mitochondrial inhibitors and uncouplers  
In order to study and compare the response of each of the mitochondrial probes (MT-
G, MT-R and JC-1) to altered mitochondrial status, live sperm suspensions were incubated in 
either the presence or absence (controls) of  a) 5 mM potassium cyanide (KCN; blocks 
cytochrome c oxidase) for 30 min; b) 1 μM p-trifluoromethoxy carbonyl cyanide 
phenylhydrazone (FCCP; a mitochondrial uncoupling agent) for 2 h; c) 1 μM valinomycin (a 
potassium ionophore that dissipates the mitochondrial electrical gradient) for 2 h. The 
concentrations used are in the ranges described in the literature for KCN (Ruiz-Pesini et al., 
2000a; St John et al., 2005) and FCCP and valinomycin (Keij et al., 2000; Kalbacova et al., 
2003). As FCCP and valinomycin stock solutions were dissolved in ethanol, control 
experiments for these chemicals included similar amounts of ethanol. The incubation with the 
drugs KCN, FCCP and valinomycin was performed in two distinct experimental conditions: 
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a) before incubation with the mitochondrial probes; b) after incubation with the mitochondrial 
probes.  
Isolation of subpopulations of sperm  
a) With distinct mitochondrial membrane potential  
To separate subpopulations of sperm with distinct mitochondrial membrane potential, 
live sperm suspensions were incubated with MT-G for 20 min at 37ºC, as previously 
described. Sperm were then sorted with a BD FACSAria
TM
 cell-sorting system (BD 
Biosciences, Becton, Dickinson and Company, NJ, USA) at a 488 nm wavelength, leading to 
the isolation of two subpopulations of sperm for each sample: MT-G positive sperm and MT-
G negative sperm. 
b) With distinct progressive motility (Swim-up) 
To separate subpopulations of sperm with distinct progressive motility, samples were 
processed by the routine swim-up procedure using Sperm Preparation medium (Medicult, 
Jyllinge, Denmark). Briefly, sperm pellets were gently covered with the medium and 
incubated for 30 min at 37º C, allowing the motile sperm to swim-up to the medium. For each 
sample, two subpopulations were isolated: sperm that migrated to the medium (referred here 
as “migrated sperm”); sperm that did not migrate (referred herein as “non-migrated sperm”). 
POLG and COXI expression 
The expression of these proteins was detected by immunocytochemistry (ICC), as 
previously explained (Chapter II, Materials and Methods section), except for the secondary 
antibodies: Alexa Fluor 594 goat anti-rabbit IgG (A-11012, Molecular Probes) and Alexa 
Fluor goat anti-mouse IgG (A-11005, Molecular Probes) were used for POLG and COXI, 
respectively. 
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Statistical analysis 
Statistical analysis was carried out using SPSS for Windows (version 13, Chicago, IL, 
USA). All variables had a normal distribution, as established by the one-sample Kolmogorov-
Smirnov test. Paired-samples T-test was used to compare the results obtained with the 3 
mitochondrial probes. Comparison between controls and a) KCN; b) FCCP; c) valinomycin; 
were performed using independent-samples T-test, as the requisites for paired-samples T-test 
were not fulfilled. Comparisons between ICC outcomes in distinct subpopulations of sperm 
were also carried out using independent-samples T-test. Pearson‟s test was applied to assess 
the correlations between the three mitochondrial probes and between these and sperm 
motility. P < 0.05 was considered significant. 
3. Results 
Comparison between distinct mitochondrial probes 
To compare MitoTracker Green (MT-G), MitoTracker Red (MT-R) and JC-1 staining 
in human sperm, 40 sperm samples were incubated with each of the probes, individually, 
along with the LIVE/DEAD Sperm Viability Kit. The use of the viability kit had two 
purposes: to stain sperm heads, so that all sperm, even those not stained with the 
mitochondrial probes, could be visualized; to assess sperm membrane integrity, which also 
evaluates sperm viability. As anticipated, the three mitochondrial probes (MT-G, MT-R and 
JC-1) stained the sperm midpiece, the compartment housing the mitochondria (Fig.1). 
Samples incubated with MT-G and MT-R presented both midpiece-stained sperm (green and 
red, respectively; referred here as “Mito +”) and unstained sperm (referred herein as “Mito –
“). On the other hand, sperm incubated with JC-1 presented three midpiece staining patterns: 
orange (almost always accompanied with green; Fig.1); green (together constituting 
“Mito+”); and unstained (“Mito-“). Unsurprisingly, the viability kit stained all sperm heads 
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(where the nucleus is localized) green (“Live”) or red (“Dead”). Combining the head and 
mitochondria staining patterns allowed sperm to be categorized in the following categories: 1) 
“Live, Mito+”; 2) “Dead, Mito-“; 3) “Live, Mito-“; 4) “Dead, Mito+”. As expected, the 
majority of sperm in each sample belonged to the categories 1 and 2 (Table I).  
 
Figure 1. Human sperm labelled with mitochondrial probes. A) MitoTracker Green (green 
midpiece). B) MitoTracker Red (red midpiece). C) JC-1 (orange and green midpiece). Nuclear 
DNA is stained with SYBR-14 (green heads). 
Table I. Distribution of data for the patterns of staining of sperm samples (n=40) incubated with the Live/Dead 
sperm viability kit along with a) MitoTracker Green (MT-G); b) MitoTracker Red (MT-R); c) JC-1. Data are 
expressed as mean percentages ± SEM. 
A Dead/Mito- Live/Mito-
MT-G 11.1 ± 1.8 2.5 ± 0.7
MT-R 13.4 ± 1.5 2.0 ± 0.5
JC-1 16.8 ± 1.4 3.3 ± 0.7
B Live/Orange Live/Green Dead/Mito- Live/Mito- Dead/Orange Dead/Green
JC-1 44.8 ± 4.0 27.7 ± 4.3 16.8 ± 1.4 3.3 ± 0.7 0.7 ± 0.3 6.7 ± 1.4
74.9 ± 1.7 9.8 ± 1.1
72.5 ± 1.9 7.4 ± 1.4
Live/Mito+ Dead/Mito+
73.3 ± 2.0 13.2 ± 1.6
 
A) “Live” denotes sperm head stained green; “Dead” denotes sperm head stained red; “Mito+” and 
“Mito-“ denote stained and unstained midpieces, respectively. B) For JC-1, “Orange” and “Green” 
midpieces are discriminated. See text for details. 
For simplification, to compare the distinct mitochondrial probes, results were analysed 
as percentage of sperm with viability (“Live”; sum of the categories 1 and 3), and as 
percentage of sperm with stained mitochondria (“Mito+”; category 1 plus category 4) only. 
Comparing the outcomes obtained with the viability kit, it was observed that the mean 
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percentage of “Live” sperm was, as expected, independent from the mitochondrial probe used 
(mean ± SEM = 75.7 ± 1.7 for MT-G; 76.8 ± 1.5 for MT-R; 75.8 ± 1.6 for JC-1; Ps > 0.05; 
Fig.2). This indicated not only that the viability kit provided very consistent results, but also 
that the mitochondrial probes used did not interfere with the kit. On the other hand, and while 
the results for the distinct mitochondrial probes were highly correlated (Table II), the mean 
percentage of sperm with stained mitochondria was different for JC-1 (79.9 ± 1.7) compared 
with both MT-G (86.5 ± 2.1; P <0.001) and MT-R (84.6 ± 1.7; P < 0.001; Fig.2). Moreover, 
there were significant differences between viability and mitochondrial staining with each of 
the mitochondrial probes (Ps < 0.001 for both MT-G and MT-R; P < 0.01 for JC-1; Fig. 2), 
evidencing that the viability kit and the mitochondrial probes stained different cellular 
features. Nevertheless, for each probe, the viability and mitochondrial values were highly 
correlated (Table II).  
 
Figure 2. Comparison between the percentage of sperm viability and of sperm with stained 
mitochondria of samples (n=40) incubated with the Live/Dead sperm viability kit along with a) 
MitoTracker Green (MT-G); b) MitoTracker Red (MT-R); c) JC-1. Data are expressed as mean 
percentages ± SEM. a and b denote significant differences between JC-1 and MT-G and MT-R (P 
< 0.001 for both). Asterisks denote, for each mitochondrial probe, differences between sperm 
viability and sperm with stained mitochondria (**P < 0.01; ***P < 0.001). 
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Table II. Values for the correlations (R) between a) viability values (blue blackground); b) mitochondrial 
staining using MitoTracker Green (MT-G), MitoTracker Red (MT-R) and JC-1 (pink background); c) Viability 
and mitochondrial staining (green background). P < 0.001 in all cases. See text for details. 
Viability Viability Viability MT-G MT-R
MT-G MT-R JC-1 staining staining
Viability MT-R 0.726
Viability JC-1 0.788 0.628
MT-G staining 0.585
MT-R staining 0.712 0.833
JC-1 staining 0.591 0.643 0.764  
 
 
 
Effect of KCN, FCCP and Valinomycin  
To evaluate whether each of the mitochondrial probes stains sperm mitochondria 
according to MMP, samples were previously incubated in either the presence or absence 
(control) of a) the ETC-inhibitor KCN; b) the mitochondrial uncoupling agent FCCP; c) the 
potassium ionophore valinomycin. Additionally, and to evaluate the capacity of the dyes to 
respond to MMP alterations after entering mitochondria, a second set of experiments were 
done in which the samples were first incubated with the mitochondrial probes and then with 
the drugs.  
KCN 
The pre-incubation of sperm with 5 mM KCN for 30 min resulted in significant 
decreases in both sperm viability (as assessed by the Live/Dead sperm viability kit) and 
mitochondrial staining with the three mitochondrial probes (Fig. 3a). Importantly, the 
decrease in mitochondrial staining was more accentuated than the decrease in the percentage 
of viable sperm, showing that, at least in some sperm, the loss of mitochondrial staining was 
not related with sperm dying. Indeed, the mean percentage of “Live, Mito-“ sperm was 
significantly higher in samples pre-incubated with KCN (means ± SEM = 26.4 ± 2.9; 34.6 ± 
8.7 and 28.6 ± 2.0 for MT-G, MT-R and JC-1, respectively) compared to controls (4.8 ± 3.0 
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for MT-G, P < 0.01; 2.0 ± 1.8 for MT-R, P < 0.01; 3.2 ± 1.2 for JC-1, P < 0.001). Thus, the 
incubation with KCN resulted in a decrease in mitochondrial staining, irrespectively of the 
mitochondrial probe used. Moreover, and while the decrease in mitochondrial staining seemed 
more accentuated in JC-1, no significant differences were found when comparing the threes 
probes. Noteworthy, for JC-1 staining, the KCN pre-incubation resulted in significant 
decreases in both the “orange” staining (% relative to control = 0.6 ± 0.6; P < 0.001) and the 
“green” staining (% relative to control = 19.2 ± 14.3; P < 0.05).  
Incubation with KCN after staining with the probes (n=5) resulted in a similar 
decrease in sperm viability (Fig. 3b). On the other hand, the mean percentage of sperm stained 
in the midpiece decreased only slightly for JC-1. In accordance, JC-1 staining was 
significantly different from that of both MT-G and MT-R. Importantly, such decrease in JC-1 
staining occurred particularly for the “orange” pattern (% relative to control = 35.1 ± 13.2; P 
< 0.05). Conversely, the mean percentage of sperm with green midpiece increased, but this 
was not significant (% relative to control = 148.6 ± 25.5; P > 0.05).  
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Figure 3. Effect of KCN in sperm viability and mitochondrial staining. Sperm was stained with 
the Live/Dead Sperm viability kit and 1) MitoTracker Green; 2) MitoTracker Red; 3) JC-1. KCN 
a) Incubation with KCN before staining with the nuclear and mitochondrial probes (n=5). KCN b) 
Incubation with KCN after staining with the nuclear and mitochondrial probes (n=5). For each 
case, the percentages of viable sperm and of sperm with stained mitochondria were determined. 
Data are expressed as means ± SEM of percentages relative to controls. Asterisks denote 
significant differences relative to controls (*P < 0.05; **P < 0.01; ***P < 0.001). a and b  denote 
significant differences between the mitochondrial probes (JC-1 vs. MT-G, P < 0.05; JC-1 vs. MT-
R, P < 0.01). 
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FCCP 
Incubation of sperm with 1 μM FCCP for 2 h, either before or after incubation with the 
dyes, resulted in a slight decrease in sperm viability, but this was not statisticaly significant 
(Ps > 0.05; Fig. 4). Similarly to the results with KCN, when sperm samples were pre-
incubated with FCCP, the mean percentage of sperm stained in the midpiece decreased for the 
three mitochondrial probes (Fig. 4a). Thus, in the experimental conditions used here, it was 
possible to alter mitochondrial staining without affecting sperm viability. Moreover, the 
results were similar (P > 0.05) for the three mitochondrial probes. The incubation of sperm 
with FCCP after incubation with the probes resulted in a decrease in the mean percentage of 
sperm stained in the midpiece for JC-1 only (Fig. 4b). However, when comparing the three 
probes, no differences were found (P > 0.05). Remarkably, the decrease in JC-1 stained sperm 
was only significant when considering the two patterns of staining together (“orange” and 
“green”), for both experimental conditions (i.e., incubation with FCCP before and after 
staining with the mitochondrial probes). 
Valinomycin 
Similarly to the outcomes obtained with KCN and FCCP, the pre-incubation of sperm 
with 1 μM valinomycin for 2 h resulted in a significant decrease in the mean percentage of 
sperm stained in the midpiece for the three mitochondrial probes (Fig. 5a). For JC-1, there 
was a significant decrease in the “orange” staining (% relative to control = 8.2 ± 2.4; P < 
0.001) and a significant increase in the “green” staining (% relative to control = 390.2 ± 95.8; 
P < 0.05). Incubation with valinomycin after staining with the mitochondrial probes resulted 
in no significant differences relative to control (Fig.5b). 
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Figure 4. Effect of FCCP in sperm viability and mitochondrial staining. Sperm was stained with 
the Live/Dead Sperm viability kit and 1) MitoTracker Green; 2) MitoTracker Red; 3) JC-1. FCCP 
a) Incubation with FCCP before staining with the nuclear and mitochondrial probes (n=5). FCCP 
b) Incubation with FCCP after staining with the nuclear and mitochondrial probes (n=5). For each 
case, the percentages of viable sperm and of sperm with stained mitochondria were determined. 
Data are expressed as means ± SEM of percentages relative to controls. Asterisks denote 
significant differences relative to controls (*P < 0.05; **P < 0.01). 
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Figure 5. Effect of valinomycin in sperm viability and mitochondrial staining. Sperm was stained 
with the Live/Dead Sperm viability kit and 1) MitoTracker Green; 2) MitoTracker Red; 3) JC-1. 
Valinomycin a) Incubation with valinomycin before staining with the nuclear and mitochondrial 
probes (n=5). Valinomycin b) Incubation with valinomycin after staining with the nuclear and 
mitochondrial probes (n=5). For each case, the percentages of viable sperm and of sperm with 
stained mitochondria were determined. Data are expressed as means ± SEM of percentages 
relative to controls. Asterisks denote significant differences relative to controls (**P < 0.01; ***P 
< 0.001).  
Mitochondrial probes and sperm motility 
As the percentage of sperm stained with MT-G, MT-R and JC-1 seem to depend on 
MMP, the relationship between the staining with the three mitochondrial probes and sperm 
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motility has been determined, in the 40 samples analysed. To this extent, a positive 
correlation was found between the mean percentage of sperm stained with each of the three 
probes and the percentage of sperm with progressive motility (% a+b; Table III). Moreover, 
and as expected, there was a negative correlation between mitochondrial staining and the 
percentage of immotile sperm (% d). Noteworthy, the motility of the samples used was high 
(mean ± SEM = 60.7 ± 2.8) and almost all samples were normal for this parameter. 
Table III. Values for the correlations (R) between the mean percentage of sperm stained with a) MitoTracker 
Green (MT-G); b) MitoTracker Red (MT-R); c) JC-1; and sperm motility assessed according to the World 
Health Organization guidelines (WHO, 1999). *P < 0.005; **P < 0.001. 
Sperm with              
progressive motility
Immotile sperm
 (%  a+b)  (%  d)
MT-G 0.353* - 0.368*
MT-R 0.426** - 0. 429**
JC-1 0.318* - 0.321*  
 
Expression of POLG and COXI in subpopulations of sperm  
a) MitoTracker positive versus MitoTracker negative 
To understand if POLG and COXI expressions are correlated with sperm MMP, sperm 
samples were stained with MT-G, which, had been shown to stain human sperm according to 
the mitochondrial status at the time of incubation (above). After staining, a FACSaria sorter 
was used to separate two subpopulations from each sample (Fig. 6a): MitoTracker positive 
sperm (with polarised mitochondria) and MitoTracker negative sperm (with depolarised 
mitochondria). The distinct subpopulations were studied and compared for the expression of 
POLG and COXI evaluated by ICC (n=31). MitoTracker-positive subpopulations presented a 
higher percentage of sperm expressing POLG (65.3 ± 4.1) and COXI (63.2 ± 2.7) than 
MitoTracker-negative subpopulations (42.0 ± 4.9; P < 0.01, for POLG; and 38.2 ± 2.7; P < 
0.001, for COX I; Fig.6a‟).  
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Figure 6. Subpopulations of human sperm present distinct mitochondrial-traits. A) Representative 
histogram of a sperm sample incubated with MitoTracker Green. Two subpopulations can be 
isolated using cell-sorting: MitoTracker positive (stained sperm) and MitoTracker negative 
(unstained sperm). A’, B) Expression of POLG and COXI in subpopulations of human sperm with: 
A‟) distinct mitochondrial membrane potential; B) distinct motility. Sperm subpopulations, 
recovered after cell sorting (A‟) or the swim-up procedure (B) were independently stained with a) 
anti-human POLG antibody; b) anti-human COXI antibody. The percentage of stained sperm was 
determined. Data are expressed as means ± SEM. Asterisks denote significant differences between 
the subpopulations (*P < 0.05; **P < 0.01; ***P < 0.001). 
b) Migrated versus non-migrated 
To determine if the expression of the mitochondrial proteins POLG and COXI is 
related with the ability of sperm to swim, the classical swim-up procedure was used to 
separate sperm with distinct motility from a same sample. This procedure allowed the 
recovering of two subpopulations: the migrated subpopulation (containing motile sperm), and 
the non-migrated subpopulation (enriched in non-motile sperm). POLG (n=34) and COXI 
(n=30) expressions were analysed using ICC, as described for the sorted subpopulations. 
Comparison between the two subpopulations revealed that the percentage of sperm expressing 
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both POLG and COXI was significantly higher in migrated (mean % ± SEM = 57.7 ± 3.4 for 
POLG, and 76.1 ± 4.1 for COXI) than in non-migrated sperm (48.6 ± 2.9 and 63.5 ± 4.4 for 
POLG and COXI, respectively; Ps < 0.05; Fig.6b), but the difference was smaller than in the 
sorted subpopulations. 
4. Discussion 
The mitochondrial generation of ATP depends upon the existence of a transmembrane 
electrical gradient generated by the activity of the ETC. The maintenance of this 
mitochondrial membrane potential (MMP) is thus essential for mitochondrial function. This 
parameter can be monitored using a wide range of permeant cationic fluorochromes, that 
accumulate in the negatively charged mitochondrial matrix, depending on the magnitude of 
the transmembrane potential (Johnson et al., 1981; Smiley et al., 1991; Solaini et al., 2007). 
These probes have been used in a variety of mammalian cells to study alterations in 
mitochondrial function during, for example, cell proliferation and differentiation 
(Darzynkiewicz et al., 1981; 1982) and apoptosis (Metivier et al., 1998; Poot and Pierce, 
1999; Jayaraman, 2005).  
A number of recent studies have shown a strong association between the percentage of 
human sperm exhibiting high MMP, determined by the extent of probe uptake [particularly 
JC-1 and DiOC6(3)] assessed by flow cytometry, and both sperm motility and fertilisation 
competence (Troiano et al., 1998; Kasai et al., 2002; Marchetti et al., 2002; 2004). In the 
present study, sperm MMP has been determined by fluorescence microscopy using two 
MitoTracker probes, Green FM (MT-G) and Red CM-H2XRos (MT-R), and also JC-1, 
independently. The use of fluorescence microscopy, while having some disadvantages 
compared to flow cytometry, namely the impracticability of counting thousands of cells, 
presents the advantage of permitting the examination of the staining patterns. Notably, this 
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procedure allowed the observation that a sperm sample stained with JC-1 invariably presents 
three subpopulations: 1) sperm presenting an orange midpiece; 2) sperm with a green 
midpiece; 3) sperm with unstained midpiece. Although not generally reported in the literature, 
the existence of a percentage of sperm without JC-1 staining has also been reported in bulls 
(Garner et al., 1997). These outcomes may imply that, at least in sperm, JC-1 stains 
mitochondria with high MMP orange (which seldom represent the entire population of 
mitochondria in a given sperm cell), and mitochondria with medium or low membrane 
potential green. Untained sperm may present depolarised mitochondria. This is supported by 
the results presented here, where sperm previously incubated with KCN, FCCP or 
valinomycin, showed a significant increase in the percentage of non-stained cells when 
compared to controls. The reliability of JC-1 to measure human sperm MMP has also been 
proven by others using mitochondrial uncouplers (Troiano et al., 1998; Marchetti et al., 
2004).  
As expected, sperm stained with either MT-G or MT-R presented only two 
subpopulations: sperm with stained midpiece and unstained sperm. The results were very 
similar for these two probes, and were also highly correlated. Furthermore, and similarly to 
JC-1, the MitoTrackers were able to respond to MMP alterations induced by either inhibition 
of the ETC (pre-incubation with KCN), or OXPHOS uncoupling (pre-incubation with FCCP 
or valinomycin). Thus, the two subpopulations might represent sperm with polarised 
mitochondria (stained midpiece) and sperm presenting depolarised mitochondria (unstained 
midpiece). These outcomes contradict the established notion that MT-G stains mitochondria 
independently of MMP. Indeed, MT-G has been used in somatic cells to reveal the amount of 
mitochondria per cell (Metivier et al., 1998; Poot and Pierce, 1999). However, MT-G staining 
intensity has been proven to change following treatment with various MMP-altering drugs, in 
three different human cell lines (Keij et al., 2000), although this has been contradicted by 
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others (Pendergrass et al., 2004). Additionally, the response of MT-G to FCCP disturbances 
in rat cultures seems to depend on cell-type (Buckman et al., 2001). Measurement of MT-G 
fluorescence intensity with a fluorometer has been used in human sperm to estimate 
mitochondrial activity (Meseguer et al., 2004). However, no experiments were undertaken to 
prove the effectiveness of MT-G to monitor MMP in human sperm, so one cannot compare 
the results presented here with previous work at this level.  
The use of either chloromethyl-X-rosamine (MitoTracker Red CMXRos) or of its 
reduced form chloromethyl-dihydro-X-rosamine (MitoTracker Red CMH2XRos, used in this 
study) to monitor MMP in somatic cells is much more consensual (Macho et al., 1996; Poot et 
al., 1996; Poot and Pierce, 1999; Pendergrass et al., 2004). Moreover, and in accordance with 
the results presented here, flow-cytometry analysis of human sperm has shown that MT-R 
CMXRos effectively responds to mitochondrial uncouplers (Marchetti et al., 2004). 
Unsurprisingly, and as has been described in bulls (Garner et al., 1997), a high 
correlation was found between sperm MMP, monitored by each of the three mitochondrial 
probes, and sperm viability. Moreover, the results for the three mitochondrial probes also 
correlate well, which is in accordance with other reports using not only JC-1 and 
MitoTrackers, but also DiOC6(3) and TMRE (Garner et al., 1997; Marchetti et al., 2004). 
These cumulative outcomes suggest that, at least in mammalian sperm, the distinct 
mitochondrial probes provide comparable results. 
However, the mean percentage of stained sperm has been shown here to be slightly 
lower for JC-1 when compared to both MitoTrackers. Furthermore, JC-1 was the only probe 
to be able to slightly respond to MMP alterations in the experiments where samples 
previously stained with the mitochondrial probes where incubated with KCN or FCCP. Thus, 
once inside mitochondria, none of the probes were able to clearly reveal modifications in 
MMP, although JC-1 seems to be, to some extent, more dynamic than both MT-G and MT-R. 
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This dynamism seems to be more pronounced in somatic cells, given that the incubation of 
human (Smiley et al., 1991) and rat (Mathur et al., 2000) cell cultures with mitochondrial 
uncouplers, after incubation with JC-1, resulted in a more significant decline in orange 
staining, accompanied by an increase in green staining. The inability of both MitoTrackers to 
respond to MMP alterations after entering mitochondria may be related with their structure. 
Indeed, both possess chloromethyl moieties, which can bind to thiol groups of proteins, 
enhancing the retention of the probes (Poot et al., 1996). 
In any case, MT-G, MT-R and JC-1 seem to be good enough to monitor sperm MMP 
at the time of incubation. In addition, the percentage of sperm presenting polarised 
mitochondria, determined by each of the mitochondrial probes, was shown to equally 
correlate with sperm motility. Moreover, and while this was not quantified, it was also 
observed that the incubation of sperm with the mitochondrial drugs resulted in reduced 
motility, particularly for KCN (data not shown). Thus, these outcomes, in accordance with 
others (Troiano et al., 1998; Donnelly et al., 2000; Kasai et al., 2002; Marchetti et al., 2002; 
2004), seem to confirm that, among other factors, human sperm motility depends on the 
presence of polarised mitochondria. 
In the second part of this study, MT-G was used to separate and compare 
subpopulations of sperm with functional and non-functional mitochondria (presenting 
polarised and depolarised mitochondria, respectively). The choice of MitoTracker instead of 
JC-1 had two main practical reasons. First, it is simpler to separate and compare two 
subpopulations of sperm instead of three. Also, cell-sorting could not be done exactly at the 
same time after the incubation period for all samples, as would be ideal. Thus, the use a non-
dynamic probe seemed better, since all samples were separated according to the mitochondrial 
status at the time of incubation. MT-R seemed less adequate to use, as some non-specific 
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staining was observed in most of the samples (not shown), which would compromise cell-
sorting according to mitochondrial staining.  
Noteworthy, sperm with polarised mitochondria seem to also present other important 
cellular attributes, and to constitute a more functional subpopulation of sperm, most likely one 
with a higher fertilisation potential. To this extent, when compared to MT-G negative sperm, 
subpopulations of MT-G positive sperm presented a) a lower level of nuclear DNA 
fragmentation; b) a higher percentage of capacitated sperm; c) a higher percentage of sperm 
with intact acrosomes (Sousa, A.P., Amaral, A. et al., in preparation).  Likewise, using a 
similar approach, others have shown that subpopulations of sperm with polarised 
mitochondria, separated using either DiOC6(3) or CMX-Ros, also presented normal 
morphology, higher motility and higher capacity to respond to induced acrosome reaction 
(Gallon et al., 2006). Consequently, these and other reports (Chapter V, Marchetti et al., 
2002) stress that sperm MMP is a very good indicator of sperm quality. 
MMP maintenance depends on the activity of the ETC, the only cellular apparatus that 
is encoded by both the nuclear and the mitochondrial genomes. Moreover, the expression of 
mtDNA-encoded proteins, such as COXI, is controlled by nuclear-encoded factors, including 
POLG, the sole mtDNA polymerase. It has been demonstrated here that subpopulations of 
sperm with polarised mitochondria presented a higher expression of both POLG and COXI, 
when compared to subpopulations presenting depolarised mitochondria. This suggests that the 
expression of these mitochondrial proteins (among, of course, other factors) might contribute 
for the maintenance of MMP in human sperm, and thus for mitochondrial function and sperm 
motility. 
Similar outcomes were obtained in subpopulations of sperm fractionated accordingly 
to the ability to swim; i.e., migrated sperm subpopulations obtained by swim-up had a higher 
percentage of sperm expressing POLG and COXI than their non-migrated counterparts. This 
Chapter IV 
113 
confirms that the expression of these proteins is associated with sperm motility, as has been 
previously demonstrated, not only for motility, but also for sperm concentration and 
morphology, using sperm samples of patients with distinct aetiologies (see Chapter II, Amaral 
et al., 2007). Interestingly, the results presented here for the expression of POLG and COXI 
seem to suggest that the separation of sperm using MT-G and a cell-sorter is more efficient 
than the classical swim-up method. Indeed, for POLG and COXI expressions, the distinction 
between MitoTracker positive and MitoTracker negative sperm was more pronounced (and 
also statistically more significant) than the one observed by comparing migrated and non-
migrated sperm. This is in accordance with the results obtained for other sperm parameters 
(Sousa, A.P., Amaral, A. et al., in preparation) and suggests that fractionation of sperm 
according to MMP can be used as a tool to isolate the best sperm in a sample. 
In conclusion, it is clear that human sperm contain subpopulations with distinct 
mitochondrial functionality, which can similarly be analysed using diverse mitochondrial 
probes, including MT-G, MT-R and JC-1. Analysis of subpopulations of sperm indicated that 
the expression of POLG and COXI seem to be related with sperm MMP and confirmed their 
association with sperm motility, and also validated the evaluation of MMP as a reliable 
indicator for sperm function. 
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Abstract 
The clinical value of classical semen evaluation is doubtful. For this reason, a number 
of tests have been developed to evaluate distinct sperm functional traits. However, most the 
studies have analysed these parameters individually.  
In the present study, freeze-thawed sperm samples, from healthy donors and 
normozoospermic and oligoasthenozoospermic (OA) patients, were fractionated into high and 
low quality fractions through density gradient centrifugation. The two fractions and the three 
distinct quality groups of samples were compared for the following sperm functional 
parameters: mitochondrial membrane potential, membrane integrity, acrosomal status and 
chromatin status. 
The distinct parameters significantly correlated with each other, as well as with sperm 
motility. The higher quality sperm fractions presented lower sperm counts, but more motile 
cells, as well as more sperm with polarised mitochondria, integral membrane, intact acrosome 
and normal chromatin. The distinctiveness of each group (donors, normozoospermic and 
OAs) was evident when comparing sperm motility, membrane integrity and MMP. The 
acrosome and chromatin status seemed less relevant, as only the OA samples had a lower 
incidence of intact acrosomes.  
Although all the traits analysed seem to be significant, none of them appear to be 
superior to sperm motility in describing sperm quality. However, further analyses will need to 
be performed in order to determine the importance of these parameters in predicting fertilising 
potential. 
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1. Introduction 
The diagnosis of male infertility is traditionally dependent on the descriptive 
evaluation of human semen, particularly on the assessment of sperm concentration, motility 
and morphology. Based on these criteria, the World Health Organization (WHO, 1999) has 
defined threshold values that characterize a normal semen profile. However, there are doubts 
on the absolute clinical value of a semen analysis. This is especially so for three main reasons: 
first, there is a lack of standardisation in semen analysis between laboratories (Keel, 2004); 
second, there are differences in the sperm characteristics in distinct ejaculates of the same 
man (Alvarez et al., 2003); and third, sperm analysis outcomes cannot completely predict if a 
man can be a father or not (Kvist and Bjorndahl, 2002). This is best exemplified in the so-
called idiopathic patients, who present a normal semen profile, and whose female partners are 
fertile, but are nevertheless unable to conceive. 
In the last few years, a number of tests have been developed to evaluate distinct 
characteristics of sperm function (Aitken, 2006; Lewis, 2007), including survival, motility 
patterns, mitochondrial membrane potential (MMP), acrosome and chromatin status, among 
others. In addition, there are different in vitro tests to monitor sperm-oocyte interactions, from 
zona pelucida binding to oocyte penetration (Muller, 2000; Liu and Baker, 2002). The former 
are particularly useful in predicting sperm fertilising ability, but involve elaborate protocols, 
as well as the use of biological material, which precludes routine use in the clinics.  
Sperm viability, an obvious essential functional feature, can be monitored by the 
assessment of sperm membrane integrity by either dye exclusion (using trypan blue or eosin 
Y) or the classical hypo-osmotic swelling test (HOS; based on the principal that only sperm 
tails with intact membrane will swell under hypo-osmotic conditions). Fluorescent DNA-
binding dyes can also be used, as is the case for the LIVE/DEAD Sperm Viability Kit (see 
Chapter IV). Routinely, live sperm are selected from the whole population using sperm 
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preparation methods such as density gradient centrifugation, to separate sperm from both 
seminal plasma and round cells (Gorus and Pipeleers, 1981). Additionally, this method 
permits the isolation of a fraction of mature, motile, morphologically normal sperm, which is 
then used to perform ART (Pousette et al., 1986; reviewed in Henkel and Schill, 2003). 
The evaluation of sperm MMP seems to constitute an important sperm functional test. 
The relationship between human sperm MMP and sperm motility and fertilising potential has 
been clearly demonstrated (see Chapter IV). 
The integrity of the sperm chromatin, which is highly compacted due to its unique 
composition, is essential for the correct transmission of paternal genetic information. 
However, sperm chromatin organization and/or DNA structure can be perturbed when defects 
in chromatin packaging occur, or when cells are subjected to oxidative stress or abortive 
apoptosis (reviewed in Aitken and Krausz, 2001; Erenpreiss et al., 2006). Sperm chromatin 
status can be assessed using a variety of techniques (for reviews see Agarwal and Said, 2003; 
Shamsi et al., 2008), such as the single cell gel electrophoresis assay (COMET), the terminal 
deoxynucleotidyl transferase-mediated transferase dUTP nick end labelling (TUNEL), the 
sperm chromatin structure assay (SCSA) and the acridine orange test  (AOT). In addition, 
chromatin status can also be monitored in a very simple way, using any Diff-Quik-like stain 
(Sousa et al., 2008). Mounting evidence has shown that sperm DNA damage and/or other 
sperm chromatin defects are negatively associated with fertility potential both in vivo and in 
vitro (Evenson et al., 1999; Larson et al., 2000; Spano et al., 2000; Duran et al., 2002, just to 
give a few examples). For this reason, the evaluation of sperm chromatin structure/DNA 
damage has been indicated as a valuable tool to assess male fertility potential and predict 
assisted reproduction outcomes (Bungum et al., 2007; Erenpreiss et al., 2008).  
Another proposed sperm functional test consists on the analysis of acrosome integrity. 
The binding of capacitated sperm to the zona pellucida triggers the acrosome reaction, an 
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exocytotic process that involves the fusion of the acrosomal membrane with the sperm plasma 
membrane, ultimately resulting in the release of acrosomal contents, including hydrolytic 
enzymes that assist the penetration of sperm through the oocyte‟s protective layers 
(Yanagimachi, 1994). The occurrence of the acrosome reaction is an absolute condition for in 
vivo fertilisation, and it must occur at a precise moment: when sperm is bound to the zona 
pellucida. Sperm that undergo the acrosome reaction prematurely (or that do not possess an 
acrosome) lose their ability to fertilise in vivo. There are a variety of methods to assess sperm 
acrosomal status, including labelling with antibodies against acrosome components (Wolf et 
al., 1985; Gallo et al., 1991; Albert et al., 1992) or with lectin conjugates (Kallajoki et al., 
1986; Mortimer et al., 1987; Holden et al., 1990). Pisum sativum agglutinin (PSA), for 
example, is a lectin that binds to the acrosome contents of permeabilised acrosome-intact 
sperm, particularly to glycoproteins present in the acrosomal matrix (Liu and Baker, 1988). 
This lectin, normally conjugated with fluorescein isothiocyanate (FITC-PSA) can thus be 
used to determine sperm acrosomal status. Importantly, using this and other methods, it has 
been shown that human samples containing a low proportion of sperm with intact acrosome 
also present low in vitro fertilising potential (Liu and Baker, 1988; Albert et al., 1992; Chan 
et al., 1999). 
Therefore, besides being motile and morphological normal, sperm must possess other 
attributes to be functionally competent. It is however worth mentioning that most of the 
studies performed so far assessed these functional parameters individually, and each group 
tend to claim its “own selected attribute” as the one that better predicts sperm functionality. In 
the present study, the status of distinct cell components (plasma membrane, mitochondria, 
chromatin and acrosome) was determined in distinct sperm samples from both healthy donors 
and patients. The aim was to determine: 1) if, and how, these parameters are correlated with 
each other and with motility, a classical sperm quality parameter; 2) which (if any) of these 
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parameters is a better predictor of sperm fertilising potential. It is important to mention that 
the present study is a preliminary approach, and that a multicenter study, with access to a 
larger number of samples, will be required to fulfil the aims proposed.  
2. Materials and methods 
Chemicals  
All chemicals were supplied by Sigma Chemical Company (St. Louis, MO, USA) 
unless stated otherwise. 
Biological Material 
Healthy donors and patients undergoing fertility treatment were recruited from the 
Fertility Clinic (Tambre Clinic, Madrid, Spain) and all signed informed consent forms. Fresh 
semen samples were obtained by masturbation after 3 to 5 days of sexual abstinence, and 
were used in accordance with the appropriate ethical and Institutional Review Board (IRB) of 
the Tambre Clinic. Routine seminal analysis was performed according to the World Health 
Organization Guidelines (WHO, 1999) and samples were categorised based on sperm 
concentration and motility. 
Sample freezing 
Samples were frozen in TEST buffer with 6% (w/v) glycerol and 10% (w/v) egg yolk 
as cryoprotectants, as previously described (Alvarez and Storey, 1992), and were kept in 
liquid nitrogen until further processing. 
Sample thawing and pos-thawing processing 
Semen samples were thawed by incubation in a water bath for 10 min at 37ºC. After 
determination of sperm concentration and motility, samples were prepared by density gradient 
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centrifugation using ISolate
®
 Sperm Separation Medium (Irvine Scientific, Santa Ana, CA, 
USA) according to the manufacturer‟s protocol. The two sperm fractions (higher density, 
which corresponds to higher quality sperm, and lower density, corresponding to lower quality 
sperm) were separately recovered, washed and resuspended in Sperm Preparation medium 
(Medicult, Jyllinge, Denmark). For each fraction, sperm concentration and motility were 
determined. 
Determination of mitochondrial membrane potential (MMP) and of membrane 
integrity 
Sperm mitochondrial membrane potential and membrane integrity were evaluated 
using MitoTracker Green FM (M-7514; Molecular Probes, Eugene, OR, USA) and the 
LIVE/DEAD® Sperm Viability Kit (L-7011, Molecular Probes), respectively. A general 
procedure was performed as described previously (Chapter IV, Materials and methods 
section). However, as live sperm suspensions were prepared in Sperm Preparation medium, 
this medium was used to prepare secondary stock solutions of MitoTracker Green, SYBR-14 
and propidium iodide. 
Determination of acrosomal status 
Acrosomal status was determined using the acrosome content marker Pisum sativum 
agglutinin, linked to fluorescein isothiocyanate (FITC-PSA). Sperm were attached to 
coverslips and were fixed, permeabilised and blocked as previously described (Chapter II, 
Materials and methods section). Samples were then incubated with FITC-PSA (diluted 1:200 
in blocking solution) for 20 min at 37º C. After rinsing, coverslips were mounted as formerly 
described (Chapter II, Materials and methods section), and observed using a Zeiss Axiophot II 
microscope (Carl Zeiss, Göttingen, Germany) equipped with a triple band pass filter. Sperm 
showing green staining in the whole acrosomal region were considered to present an intact 
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acrosome. Unstained sperm, or sperm presenting green staining in the equatorial region or an 
irregular staining in the acrosome region, were considered acrosome-reacted. In order to 
determine the percentage of sperm presenting intact acrosome 200 sperm were counted, in at 
least four fields. 
Determination of chromatin status 
Chromatin status was evaluated using the Diff-Quik stain set (Dade Behring Inc., 
Newark, USA), as recently established (Sousa et al., 2008). This protocol is based on the 
intensity of nuclei staining: normal sperm nuclei stain lightly, while abnormal nuclei 
(containing damaged chromatin, i.e., either decondensed or presenting fragmented DNA) 
stain dark. Sperm smears were prepared in microscope slides and sequentially exposed to the 
three components of the stain set (10 sec each): 1) methanol (fixation); 2) eosin (stains basic 
proteins red); 3) thiazin (stains DNA blue). After rinsing in water, slides were allowed to air-
dry and were then examined using an optical microscope. The percentage of sperm with dark 
nuclei was determined by counting 200 sperm, in at least four different fields. 
Statistical analysis 
Statistical analysis was carried out using SPSS for Windows (version 13, Chicago, IL, 
USA).  All variables were checked for normal distribution using the one-sample Kolmogorov-
Smirnov test. Pearson‟s and Spearman‟s tests, for parametric and non-parametric data, 
respectively, were applied to assess the correlations between the distinct variables. 
Independent-samples T-test (or the non-parametric Mann-Whitney test, when distributions 
were not normal) was used to compare the results for the distinct sperm quality fractions. The 
One-way ANOVA test was used to compare results for the three groups of samples. Post-Hoc 
analyses were done using either Tukey‟s or Dunnet‟s tests, depending on whether equal 
variances were assumed or not.  P < 0.05 was considered significant. 
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3. Results 
Spermiogram results in fresh and freeze-thawed samples  
This study included a total of 48 semen samples: 21 from healthy donors and 27 from 
patients undergoing fertility treatment (Table I). Of these, 17 were normozoospermic (i.e. 
concentration ≥ 20 millions of sperm/ml, ≥ 50% motile sperm) and 10 were 
oligoasthenozoospermic (OA; samples with low concentration and motility). As expected, 
after freeze-thawing, both the concentration and motility of the samples had changed. 
However, and importantly, donors‟ samples preserved better characteristics when compared 
to both normozoospermic and OA samples (Table I). 
Table I. Concentration and progressive motility of the sperm samples used in this study (n=48). Data are 
expressed as means ± SEM. Superscripts a, b and c denote significant differences between groups (Ps < 0.05). 
Concentration Motility Concentration Motility
(10
6
 sperm /ml) (%  a+b) (10
6
 sperm/ml) (%  a+b)
Donors (n=21) 96.0 ± 7.0
a
66.8 ± 2.6
a
51.2 ± 5.8
a
36.2 ± 3.2
a
Normo (n=17) 56.6 ± 4.9
b
55.4 ± 2.9
b
33.2 ±  5.7
ab
19.1  ± 3.3
b
OA (n=10) 12.5 ± 3.8
c
27.8 ± 3.4
c
20.9 ± 10.7
b
9.9  ± 2.8
b
FRESH SAMPLES FREEZE-THAWED SAMPLES
 
Abbreviations: Normo – normozoospermic; OA – Oligoasthenozoospermic.  
Correlations between the distinct sperm functional parameters  
In order to understand the possible significance of different sperm functional 
parameters as novel tools to better evaluate sperm quality, distinct cellular features were 
analysed in all the samples included in the study. These were: sperm mitochondrial membrane 
potential (MMP; expressed as the percentage of sperm presenting MitoTracker Green staining 
in the midpiece; Fig. 1a), sperm membrane integrity (evaluated by means of the dual SYBR-
14/PI probes, and expressed as the percentage of sperm stained with SYBR-14 only, i.e, those 
with intact membrane; Fig. 1a), acrosome status (percentage of sperm presenting an intact 
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acrosome, as judged by PSA-FITC staining; Fig. 1b) and chromatin status (percentage of 
sperm presenting dark nuclei, i.e., those with abnormal chromatin, as assessed by a recently 
established method using the Diff-Quik stain; Figs. 1c,c‟). The correlations between these 
parameters with each other and with both total (% a+b+c) and progressive (% a+b) motility 
were established (Table II). Essentially, all the parameters correlate positively and 
significantly with each other, except for chromatin status, which, as expected, presented 
negative correlations with the other parameters. Importantly, the highest correlations were 
found between sperm motility, MMP and membrane integrity. 
 
Figure 1. Human sperm functional characteristics can be monitored using distinct markers and 
observed under fluorescence (A and B) or light (C and C‟) microscopy. A) Sperm presenting 
polarised mitochondria and integral membrane after staining with both MitoTracker Green (green 
midpiece) and the Live/Dead sperm viability kit (green head). B) Sperm presenting an intact 
acrosome after staining with FITC-conjugated Pisum sativum agglutinin (green acrosome). 
Nuclear DNA was counterstained with DAPI (blue head). C, C’) Sperm samples stained with the 
Diff-Quik set present both pale (C – normal chromatin) and dark (C‟ – abnormal chromatin) heads. 
Note that the scales of the distinct pictures are different. 
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Table II. Values for the significant correlations (R; upper numbers) between the distinct sperm parameters 
analysed. P values are also indicated (lower numbers). 
Progressive 
motility
MMP
Membrane 
integrity
Acrosomal 
status
Chromatin 
status
0.982 0.866 0.860 0.332 -0.339
<0.001 <0.001 <0.001 0.001 0.001
0.840 0.834 0.345 -0.358
<0.001 <0.001 0.001 <0.001
0.986 0.329 -0.343
<0.001 0.001 0.001
0.328 -0.333
0.001 0.001
Total motility
Progressive Motility
MMP
Membrane integrity
 
Details: Total motility - % a+b+c (WHO grades); Progressive motility - % a+b; Mitochondrial membrane 
potential (MMP) - sperm with polarised mitochondria; Membrane integrity - sperm with intact 
membrane; Acrosomal status - sperm presenting intact acrosome; Chromatin status - sperm presenting 
abnormal chromatin. 
Comparison between different quality sperm fractions 
In order to understand the relevance of the sperm parameters analysed, samples were 
fractionated using a density gradient centrifugation, and two subpopulations were recovered 
from each sample: sperm from the higher and the lower density fractions, corresponding to 
higher and lower quality sperm, respectively. For each sample, the percentage of sperm 
recovered in each fraction was determined (“recovered sperm”; calculated by dividing the 
concentration of sperm in each fraction by the total concentration of sperm in the non-
fractionated sample). The percentage of sperm recovered in the higher quality fraction (33.7 ± 
2.6) was significantly lower than the percentage of sperm in the lower quality fraction (66.3 ± 
2.6; P < 0.001; Table III). On the other hand, and as expected, the higher quality sperm 
fraction presented a significantly higher percentage of motile sperm, as well as a higher 
percentage of sperm with progressive motility (Ps < 0.001; Table III, Fig. 2). Likewise, this 
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fraction showed higher percentage of sperm presenting a) polarised mitochondria; b) 
membrane integrity; c) intact acrosome; d) normal chromatin (Ps < 0.05; Table III, Fig. 2). 
 
Figure 2. Comparison between higher- and lower quality sperm fractions (obtained by gradient 
centrifugation; n = 48) for the following parameters: progressive motility (% a+b), mitochondrial 
membrane potential (MMP; sperm with polarised mitochondria); membrane integrity (sperm with 
intact membrane); acrosomal status (sperm presenting intact acrosome); chromatin status (sperm 
presenting abnormal chromatin). *P < 0.05; **P < 0.01; ***P < 0.001. 
 
  
 
Table III. Sperm functional parameters in distinct fractions/samples. Data are expressed as means percentage ± SEM. Comparison between higher and lower quality sperm 
fractions obtained through density centrifugation: *P < 0.05; **P < 0.01; ***P < 0.001. Comparison between different quality samples (donors; normozoospermic; 
oligoasthenozoospermic - OAs) for the higher quality fractions: superscripts a, b and c denote significant differences between groups (Ps < 0.05). 
Recovered 
sperm 
Total motility
Progressive 
motility
MMP
Membrane 
integrity
Acrosomal 
status
Chromatin 
status
Higher-quality sperm fraction 33.7 ± 2.6*** 42.5  ± 3.5*** 38.9 ± 3.2*** 50.0 ± 3.8*** 48.2 ± 3.7*** 55.5 ± 2.7* 57.4 ± 2.8**
Lower-quality sperm fraction 66.3 ± 2.6 9.7 ± 1.1 6.8 ± 0.9 19.8 ± 2.0 18.5 ± 1.7 46.8 ± 1.8 69.4 ± 2.6
Donors 40.8 ± 3.8
a
58.0 ± 3.4
a
53.8 ± 2.9
a
67.9 ± 3.3
a
64.6 ± 3.5
a
58.8 ± 4.5
a 54.7 ± 4.8
Normozoospermic 31.1 ± 4.1
ab
40.1 ± 5.2
b
36.0 ± 4.8
b
45.6 ± 5.5
b
44.9 ± 5.5
b
58.6 ± 3.6
a 53.6 ± 4.4
OAs 22.1 ± 5.3
b
14.3 ± 5.7
c
12.4 ± 4.7
c
19.7 ± 6.0
c
19.5 ± 6.5
c
40.8 ± 4.3
b  69.6 ± 3.4
 
Details: Recovered sperm - % sperm recovered in each fraction; Total motility - % a+b+c (WHO grades); Progressive motility- % a+b (WHO grades); Mitochondrial 
membrane potential (MMP) - % sperm with polarised mitochondria; Membrane integrity - % sperm with intact membrane; Acrosomal status - % sperm presenting 
intact acrosome; Chromatin status - % sperm presenting abnormal chromatin. 
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Comparison between different quality sperm samples 
To further determine the relevance of the sperm functional parameters analysed in this 
study, the three groups of samples (donors, normozoospermic and OAs) were also compared. 
When comparing the higher quality sperm fractions, the ones used in ART, the three groups 
were found to be distinct from each other (Ps ≤ 0.01) for total and forward motility, MMP, 
and membrane integrity (Table III; Fig. 3); with donors presenting the best results and OAs 
presenting the worst. Furthermore, the percentage of sperm recovered in the higher quality 
fraction was significantly higher in the donors compared to the OA group (P < 0.05). Also, 
both the donors and the normozoospermics presented more sperm with intact acrosomes, 
when compared to the OAs (Ps < 0.05).  
 
 
Figure 3. Comparison between the higher quality sperm fractions of distinct sperm samples: 
donors (n=21); normozoospermic (n=17); and oligoasthenozoospermic (OAs; n=10). Details: 
progressive motility (% a+b); mitochondrial membrane potential (MMP; sperm with polarised 
mitochondria); membrane integrity (sperm with intact membrane); acrosomal status  (sperm 
presenting intact acrosome); chromatin status (sperm presenting abnormal chromatin). 
Superscripts a, b and c denote significant differences between groups for each of the parameters 
analysed (Ps < 0.05). 
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As anticipated, the differences between groups were less significant in the lower 
quality fractions, although donor samples still presented the best characteristics (data not 
shown). 
4. Discussion 
The standard semen parameters (sperm concentration, morphology and motility), 
while indicative of some degree of semen quality, do not assess sperm function, and their 
clinical significance in predicting fertility has been debated (Polansky and Lamb, 1988; 
Bonde et al., 1998; Guzick et al., 2001). To be able to fertilise an oocyte, a semen sample 
must contain functionally competent sperm. Understanding which sperm functional attributes 
are essential for fertilisation and establishing cut-off values for each parameter are among the 
most challenging subjects in modern andrology. 
In the present study, a number of sperm functional parameters has been evaluated, not 
only in distinct quality sperm samples, but also in different fractions of each sample. Besides 
viability, a basic and essential cellular feature, the function of the three main components of 
sperm was analysed: the head (by assessing both chromatin and acrosomal status), the 
midpiece (mitochondrial membrane potential) and the tail (whose function was indirectly 
assessed through motility analysis).  
The results for these distinct parameters were significantly correlated. Particularly, and 
as expected, sperm membrane integrity and MMP were highly correlated with each other, as 
well as with motility. Similar outcomes have been described by others, using similar 
techniques, not only in humans (Evenson et al., 1982; Auger et al., 1989; Troiano et al., 1998; 
Donnelly et al., 2000; Marchetti et al., 2002), but also in other mammals, including bovines 
(Garner et al., 1997; Thomas et al., 1997; 1998), stallions (Love et al., 2003) and boars (Huo 
et al., 2002). Moreover, although to a lesser extent, these parameters were also correlated with 
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both acrosomal and chromatin integrities. Similarly, others have described negative 
correlations between chromatin defects and sperm viability, motility and MMP (Donnelly et 
al., 2000; Marchetti et al., 2002; Varum et al., 2007; Sousa et al., 2008). Likewise, a 
relationship between sperm acrosomal integrity and motility and viability has been 
demonstrated both in humans (Liu and Baker, 1988) and bovines (Thomas et al., 1997; 1998), 
where a correlation with MMP was also reported. Taken together, these results suggest that 
sperm have the property of maintaining a functional equilibrium in the distinct cellular 
compartments, and that when this homeostasis is perturbed, all the elements are affected.  
The relevance of the sperm parameters analysed here was demonstrated by the 
comparison between distinct quality sperm fractions/samples. Fractionation of sperm using 
density gradient centrifugation is a worldwide technique used to select sperm for many ART 
procedures (reviewed in Henkel and Schill, 2003). This method permits the recovery and 
subsequent comparison of two sperm fractions from each sample: one enriched in motile, 
morphologically normal sperm (high density fraction), and another containing mainly dead 
sperm and immature cells (low density fraction). In conformity with this, the results presented 
here have shown that the two fractions were indeed significantly different, not only for 
motility and viability (membrane integrity), but also in terms of mitochondrial, chromatin and 
acrosomal status. Likewise, it has been shown that sperm from low density fractions present, 
not only a higher incidence of nuclear DNA fragmentation, but also more large-scale 
deletions in the mitochondrial genome (O'Connell et al., 2003), as well as enhanced ROS 
formation (Aitken and West, 1990). These outcomes confirm the usefulness of the density 
gradient centrifugation as a method to select the more functional sperm of a sample, on one 
hand, and illustrate the significance of the various parameters analysed, on the other. 
Interestingly, it has been shown that the majority of sperm in each sample belonged to 
the lower quality fraction, thus supporting the necessity of efficient sperm preparation 
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techniques. In addition, and as expected, the percentage of sperm recovered in the higher 
quality fraction was higher in donor samples when compared to OAs. The distinctiveness of 
each group (donors, normozoospermic and OAs) was also evident from the comparison 
between sperm motility, membrane integrity and MMP. The acrosome and chromatin status 
seemed less relevant, as only the OA group presented a lower percentage of sperm with intact 
acrosome. 
Thus, apart from motility, conventionally evaluated in any semen analysis, sperm 
viability and MMP seem to constitute the more relevant functional parameters. Using fresh 
semen samples, others have suggested that analysis of MMP is, together with viability, 
nuclear DNA fragmentation and ROS production, the most sensitive test to determine sperm 
quality (Marchetti et al., 2002). The results of the present work suggest, however, that sperm 
membrane integrity and mitochondrial function are almost coincident aspects, at least in 
frozen samples analysed immediately after thawing and processing. Whatever the case may 
be, MMP seems to be a good indicator of sperm quality, not only because better quality 
samples present more sperm with polarised mitochondria (present work, Marchetti et al., 
2002; Wang et al., 2003; Liu et al., 2004), but also because this functional parameter seems to 
be correlated with in vitro fertilising potential (Kasai et al., 2002; Marchetti et al., 2002; 
2004). The high correlation found between sperm motility and MMP seems to validate the 
importance of mitochondrial-produced ATP for sperm movement. 
The relevance of the sperm acrosome is best exemplified in those infertile men whose 
sperm present round acrosomeless heads and are not able to penetrate zona-free hamster 
oocytes (Weissenberg et al., 1983; Jeyendran et al., 1985; Lalonde et al., 1988). Such a 
condition is, however, rare. Nevertheless, sperm samples with low percentages of intact 
acrosomes seem to be associated with in vitro failed fertilisations (Liu and Baker, 1988; Chan 
et al., 1999). The outcomes presented here are in agreement with this idea, as both lower-
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density sperm fractions and poorer-quality sperm samples (OAs) possessed the lowest 
proportion of sperm with intact acrosome.  
Sperm DNA/chromatin integrity has been suggested to be one of the most sensitive 
tests to assess sperm quality (Bungum et al., 2007; Erenpreiss et al., 2008). In accordance 
with this notion, this parameter seems to be impaired in infertile men (Agarwal and Said, 
2005; Shamsi et al., 2008). Although the results presented here could not fully corroborate 
this idea (at least when comparing the three groups of samples), it has been shown that lower 
quality sperm fractions presented a higher prevalence of chromatin anomalies. Sperm 
chromatin abnormalities may be particularly relevant post-fertilisation, as the activation of the 
paternal genome only occurs between the four- to eight-cell stages (Braude et al., 1988). 
Concomitantly, these anomalies seem to negatively correlate with embryo development rates 
and with the establishment of clinical pregnancies, but not with fertilisation rates (Sousa et 
al., 2008). 
To conclude, although all the sperm functional traits analysed in the present study 
were shown to be significant, none of them seem to be better in describing sperm quality than 
the conventional parameter “motility”. This study is, however, incomplete, as fertilisation 
potentials have not been determined yet. The sperm samples evaluated here are being used to 
perform ART and, in the future, the results will be correlated with clinical outcomes. 
Moreover, to validate the usefulness of any of the parameters analysed in predicting sperm 
fertilising potential, a multicenter study will be carried out. Indeed, the involvement of 
various institutions in this kind of studies is critical, not only to increase the number and types 
of samples available, but also because distinct laboratories often use distinct technical 
protocols, both to evaluate and prepare the male and female gametes, and to perform distinct 
ARTs.  
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Although the relative significance of mammalian sperm OXPHOS versus glycolysis in 
terms of the production of the ATP necessary for sperm motility remains controversial, 
mounting evidences have supported the concept that the integrity of mitochondria and their 
genome are critical in human sperm function. In the present study, diverse mitochondrial traits 
were analysed in human sperm samples, and their possible biological and clinical 
significances were assessed. These included: mtDNA copy number; the expression of ETC 
proteins (COXI and COXVIc); the expression of nuclear factors involved in mtDNA 
maintenance (POLG and TFAM); POLG polymorphisms and MMP. 
First, it has been shown that high quality sperm have very low levels of mtDNA 
compared to fully differentiated somatic cells (Chapter II). The possible biological 
significance of this could be to facilitate the elimination of paternal mtDNA following 
fertilisation and thus ensure maternal inheritance of this genome. At any rate, a minimum 
content of functional mtDNA molecules might be necessary to ensure the expression of 
mitochondrial-encoded proteins, such as COXI, which has been shown to be related with 
sperm quality. On the other hand, poorer quality sperm presented higher mtDNA copy 
numbers, which suggests that there are errors in the regulation of mtDNA replication in men 
who will ultimately present poor quality sperm. The high mtDNA content in poor quality 
samples may be an indicator of defective spermiogenesis, and may also reflect problems in 
energy metabolism in both testicular cells and mature male gametes.  
The outcomes also suggested that POLG, possibly in conjunction with other factors, 
may play a role in regulating mtDNA copy in human sperm, although the exact mechanism 
remains unclear. To completely understand this regulation, the analysis of ejaculated sperm is 
not sufficient. Instead, it seems necessary to consider the distinct cellular stages of human 
spermatogenesis and spermiogenesis and, possibly, epididymal maturation. To this extent, 
both mtDNA content and POLG expression should be analysed in testicular/epididymal 
Alexandra Amaral 
138 
biopsies or using post-mortem organs. The study of POLG at the RNA level should also be 
considered, to test the hypothesis of the existence of testis-specific transcripts isoforms.  
Nevertheless, it became clear that the expression of mtDNA maintenance factors and 
of components of the ETC (either mtDNA- or nuclear DNA-encoded) is associated with 
sperm quality. The expression of other factors involved in mtDNA maintenance (such as 
POLG2 or mtSSB) or of components of other ETC complexes should also be examined.  
The analysis of POLG CAG-repeat polymorphisms has shown an association between 
the heterozygous genotype and very poor quality sperm (Chapter III). However, the biological 
significance of these variants remained uncertain, as these do not seem to affect POLG 
expression, or to impair mtDNA maintenance, or the expression of sperm mitochondrial 
proteins. Moreover, no correlations were found between POLG genotypes and each of the 
three principal sperm parameters. The clinical relevance of these polymorphisms is thus 
doubtful. It should however be noticed that this does not exclude the involvement of POLG 
mutations in male infertility. Thus, analysis of the entire POLG coding region in distinct 
quality sperm samples is warranted. Moreover, genes for a) other components of the mtDNA 
replication machinery (such as Twinkle); b) factors involved in mitochondrial nucleotide 
metabolism (such as ANT1 or TK2); c) ETC complexes subunits; should also be regarded as 
candidates for involvement in male infertility. 
Furthermore, it has been shown that human sperm samples are very heterogeneous, 
containing, for instance, subpopulations with better mitochondrial functionality (Chapters IV 
and V), which seem to be precisely the ones with higher fertilisation potential. Sperm MMP, 
an indicator of mitochondrial function, could be similarly monitored using MT-G, MT-R and 
JC-1 (Chapter IV). However, none of the mitochondrial probes seemed to be dynamic enough 
to reveal modifications in MMP occurring after cellular incubation. Analysis of 
subpopulations of sperm seemed to indicate that the expression of POLG and COXI is related 
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with sperm MMP and to confirm their association with sperm motility (Chapter IV). This 
study also showed that the evaluation of MMP is a reliable indicator of sperm function. It is 
tempting to indicate mitochondrial probes as possible tools to select the best sperm for ART: 
the detrimental effects of the use of sperm stained with these probes in ART are theoretical 
low, as sperm mitochondria are degraded upon fertilisation. However, the use of such an 
approach in humans is certainly unviable, at least without appropriate controls. 
Lastly, the analysis of distinct-quality sperm samples/fractions validated the 
importance of MMP in sperm function (Chapter V). Unfortunately, the absolute clinical 
significance of this has not been determined, as fertilising potential could not be fully 
assessed. Efforts are currently underway to involve various institutions in these kinds of 
studies. Nevertheless, it has been shown that sperm MMP is a relevant functional parameter, 
which seems to reflect other important cellular traits. The high correlation found between 
MMP and sperm motility further suggests that OXPHOS produces at least some of the ATP 
used by the human sperm flagellum. To completely reveal the role of mitochondria in sperm 
motility, it would be interesting to analyse the male gametes in the female reproductive tract 
environment, where they can persist for some time until fertilisation takes place. It would thus 
be useful to mimic such conditions in vitro, i.e., to maintain sperm “cultures” and analyse 
their behaviour.  
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